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CHAPTER 1 
1.1 Layman’s description 
 
The general purpose of this PhD research was to develop polymers for use in a biomedical context. A 
difficult question that was raised during this PhD work, not by famous professors or fellow scientists but 
by the man in the street was, “So you are putting plastic into a human being? “ In order to answer this 
question we can compare the human body with the earth globe. Some people are standing on a shore, let 
us say the Belgian coast and they want to correspond with somebody standing on the coastline of Dover. 
They throw a bottle, containing a message in the sea, hoping that the person in Dover will receive this. A 
few things can be done to increase the chance of reaching the person in Dover. You could just increase 
the number of bottles, increasing the chance that one of these bottles will reach the other coast. This is 
barely efficient and one depends on a lot of uncontrollable factors that influence the final destination of 
your bottle, it might as well end up in the Netherlands or France. In addition the sea can be really harsh 
and your bottle may break due to the current or it can be eaten by a large fish. This could be counteracted 
by making a stronger bottle that can endure the sea. However, this is still not an efficient way to deliver 
your message as you rely on the current of the sea that determines the destination of the message. So we 
propose the following: wouldn’t it be possible to make a vessel which is not visible, such as a submarine, 
which protects the bottle from the dangers of the sea and can be directed to the correct coordinates. 
Instead of throwing a hundred bottles in the sea, in the hope that one of them will ever reach the coast, 
you can make a “stealth” vessel with GPS enhanced delivery and protect the message from the sea. 
Even though such a sea-submarine would be feasible, as a molecular analogue for drug delivery, this is 
of course pure fantasy. Nonetheless, encapsulation of an active compound in a biocompatible polymer 
can protect it from the immune system and enhance its bioavailability. As such, the polymer will protect 
the message (bioactive compound) from the harsh conditions in the body such as the immune system, 
renal clearance or the blood current. Molecular recognition could aid to deliver the message/drug to a 
specific target, which will help in reducing the side effects. However, the pharmaceutical community still 
mostly focusses on the development of low molecular weight drug molecules rather than macromolecules. 
It is not easy to introduce macromolecules in this conservative field and a more objective and open view 
is needed to advance innovations in drug formulation and delivery.  
In this thesis, we focused on one specific submarine/type of polymer, namely the biocompatible pseudo-
peptides called poly(2-alkyl-2-oxazoline)s (PAOx). The PAOx are also known as the precursors for linear 
poly(ethylene imine) (L-PEI), a key reference in non-viral vectors for gene delivery. Therefore, in this PhD 
work, both the development of PAOx and L-PEI for biomedical applications will be examined. First, there 
will be a thorough examination of the partial hydrolysis of PAOx to understand the copolymer distribution 
along the chain, which is important to understand the properties and further modification of the resulting 
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PAOx-PEI copolymers. Subsequently, instead of hydrolysing the usual suspects poly(2-ethyl-2-oxazoline) 
(PEtOx) and poly(2-methyl-2-oxazoline) (PMeOx), the hydrolysis of poly(2-n-propyl-2-oxazoline)s 
(PPrOx) will be examined resulting in more hydrophobic cationic copolymers that will be explored for 
gene delivery. In the final part, the further modification of PEI and PEtOx-PEI polymers will be developed 
for the preparation of PAOx copolymers with side chain functional groups. A first class was developed by 
using PEI and PEtOx-PEI for the synthesis of fluorescent copolymers by reaction with super critical CO2. 
The second class was obtained by coupling methyl ester containing side-chains onto the copolymers of 
PEtOx-PEI and their subsequent modification by direct amidation. Finally the reductive amination 
modification of PEtOx-PEI with carbohydrates yielding sweet polymers was investigated.  
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1.2 Polymers in a biomedical context 
Imagine yourself in a world without polymers? There would be no plastic bottles, no car interior, no 
electricity housing, etc. Polymers are everywhere around us in the world as it is today in both positive and 
negative aspects. In less obvious fields, such as medicine polymers are omnipresent in different 
morphologies, topologies and sizes. However these polymers need to fulfill certain properties to make 
them applicable in biological context. These strict requirements for polymer properties can be defined in 
a biological manner or from a chemical point of view.  
First of all the polymer needs to be biocompatible. Biocompatibility is defined as the acceptance or 
rejection of artificial materials by the surrounding tissues or the appropriate immune response. Therefore, 
so-called stealth behaviour is important as this means that the active compound is not recognized by the 
immune system. In order to achieve this stealth behaviour, the nonspecific protein adsorption (fouling) 
has to be minimized. This non-fouling behavior influences the lack of response of the immune system and 
surrounding tissue. The interaction with the immune system is influenced by the chemical composition 
or the surface of this polymer material. This controls not only the toxicity, but also the positive effects of 
the materials.1 Different interactions at the interface can influence the biocompatibility: 1) chemical 
structure (branched or linear) and functional groups 2) types and quantity of charges 3) molar mass of the 
polymer, 4) structural flexibility of the polymer 5) hydrophobicity/hydrophility.1 Depending on the 
application these properties can be altered. For biomedical applications the polymers should meet the 
following chemistry related requirements:  
 Minimisation of the heterogeneity of the polymer. A single molecule such as a drug only contains 
one mass and one specie.2 On the other hand, polymers have a (broad) statistical mass and size 
distribution which can have important implications. The different masses (and sizes) may induce 
important complications, e.g. for renal clearance. The size distribution complicates everything 
from a pharmaceutical point of view and for regulatory affairs. Therefore, polymers for use in 
biomedicine should  be as defined as possible, in other words, they should have a narrow size 
distribution. 
 Ideal control over the synthetic route makes it possible to tune the physicochemical properties to 
introduce multiple chemical functionalities.  
 The up scaling should be possible and reproducible, including a thorough purification. 
 Appropriate formulation, long term stability. 
 Characterization of the absorption, distribution, metabolism and excretion (ADME) of the 
polymer therapeutic. 
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 It needs to be known what the interaction of the polymer interface is with the biological parts, 
tissue or fluids, thus mapping the different immunological reactions.  
In the early days, the biomedical polymers were used as plasma expanders, wound dressing and 
antiseptics. In a field dominated by PEG the first polymer-drug-conjugate entering phase I and II of clinical 
trials was N-(2-hydroxypropyl-methacrylamide)-doxorubicin (HPMA-DOX).3 The biocompatible 
polymers can have a degradable or non-degradable behaviour. Examples of degradable polymers are 
poly(glycolic acid) (PGA), polypeptides,4 dextran, hyaluronic acid, hydroxyethyl starch (HES) and  
polylactide3 (FDA approved). Non degradable polymers include PEG, HMPBA, poly(vinyl pyrrolidone) 
(PVP),5 and poly(ethylene imine) (PEI).  
 
Polymers used in a biomedical context can be divided in 3 different classes depending on size; a 
macroscopic class, a microscopic class and a nano class. The macroscopic class contains implantable 
medical devices, artificial organs, prostheses, dentistry, bone repair or hydrogels. The polymer is either 
the object itself or the coating.6 The second class is the micro class6 consisting of micro particles, and 
micro needles.6 In the nano class, drug delivery plays an important role. Polymers in the nano class can 
have different functions depending on the form of the polymer, the interaction with an active compound 
and its composition. The polymer drugs are used because small molecules tend to diffuse in the body and 
hence only a small amount arrives at the desired tissues. The drugs often have low water solubility and 
are prone to degradation therefore the polymer is used to increase the drug concentration and shell life 
by solubilisation of drugs into polymer nanoparticles that may protect the drug. Depending on the form 
of the polymer therapeutic different classes are defined. (Figure 1-1): 
 Polymeric drug /sequestrant 
 Polymer-protein/peptide conjugates 
 Polyplex 
 Polymer-drug conjugate  
 Block copolymer micelles. 
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Figure 1-1 Different types of polymer therapeutics 2 With five possible types for the nano class: polymeric drug or 
sequestrans, polymer-protein conjugate, polyplex, polymer drug conjugate, polymeric micelle. 
 
As seen in Figure 1-1 5 different classes of polymers are shown. The first class are the polymeric 
drug/sequestrant , such as Renagel. Renagel is a poly(allylamine)s cross linked with epichlorhydrin and is 
used to bind phosphates.3 The second class is the polymer-protein conjugate, the polymer dissolves or 
protect the peptide from the biological environment.2 The third class is the class of polyplexes, here the 
polymer interacts with the genetic material often via a cationic charge.2,7 In the fourth class the polymer 
is linked with a drug via a linker and optional there is a targeting residue linked on the polymer.6,3 In the 
last class the drug is often water insoluble and a hydrophobic core is needed to solubilize the drug, the 
hydrophilic corona makes it possible to have a water soluble vehicle. 
 
Polymer drug conjugates generally consist of three parts, the polymer, a linker and drug/bioactive 
molecule(Figure 1-1).2 The polymers can prevent premature degradation and enhance uptake of the drug, 
while maintaining drug concentration in the therapeutic window, thereby reducing side effects. For its 
application in polymer therapeutics, the polymer has to be bio-inert, protein resistant and non-fouling.8. 
The most popular polymers that are currently being developed up to clinical trials are PEG and HPMA. A 
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large drawback of these polymers is the non-degradability and the potential accumulation in different 
tissue.3 This can increase the local concentration in certain tissues above the toxicity level. This will 
activate the immune system and anti-polymer antibodies will be generated. These drawbacks, especially 
for PEG will be discussed in section 1.4. The focus of polymer therapeutics lays often in cancer research, 
frequently conjugated drugs are paclitaxel,9 doxorubicin and camptothecin( quinolone alkaloid found in 
Campotheca acuminate, aka “the happy tree”).10 The different types of polymers for polymer-therapeutics 
are still rather limited. Table 1 summarizes the polymers which have been used in clinical trials. 
 
Table 1 Examples of polymer therapeutics in clinical trials and current status3 
 
Class Example Composition Disease status 
Polymeric 
drugs 
Copaxone11 Glu, Ala, Tyr, lysine 
copolymer(glatiramer) 
Multiple sclerosis Market 
 Vivagel Lysine based 
dendrimer 
HIV/Sex Health Market 
 Synvisc-One Hyaluronic acid Osteoarthritis Market 
Polymeric 
sequestrants 
Renagel/Welchol12 Cross linked poly(allyl 
amine) 
Lowering phosphate 
levels in kidney 
diseases 
Market 
Polymer-
protein 
conjugates13 
Zinostatin Stimaler Polystyrene-comaleic 
acid 
Cancer market 
PEGylated 
proteins 
Cimzia14 PEGylated anti TNF fab Arthritis/chronical 
diseases 
Market 
 Mircrera PEGylated EPO Kidney diseases Market 
Polymer-
drug 
conjugate 
Opaxio Poly-glutamic acid-
paclitaxel 
Cancer Phase III 
 Prolindac15 HPMA-copolymer-
DACH platina 
Ovarian Cancer Phase II 
 XMT-100116 Polyacetal-
camptoherin derivate 
Cancer Phase II 
 
 
The biomedical world is continuously evolving and many diseases are better understood and new targets 
are found. More and more bioactive molecules are used as medicine to interact with newly found 
molecular targets. Therefore, new delivery systems are needed as molecules like nucleic acids and peptides 
have to be protected due to their fragility in the hostile biological environment. Polymer-drug conjugates 
need to be inactive and stable during circulation while releasing the active agent in the target tissue, 
reducing side effects and avoiding an immune response. The control over the chemistry 
(hydrophilic/hydrophobic), presence of hydrogen bond donating and accepting groups and 
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stereochemistry controls are all important factors that influence the biological properties. The field of 
polymer therapeutics is rapidly expanding, and therefore new polymers are needed to further explore this 
field. New cures for diseases give new opportunities and new research questions. Therefore there is an 
urge to create new types of polymers and to develop new systems that are better than the older systems. 
The choice of poly(2-alkyl-2-oxazoline) will be discussed and explained. 
 
1.3 Poly(2-alkyl-2-oxazoline)s  
The field of polymer therapeutics can benefit from the research in poly(2-alkyl-2-oxazoline)s (PAOx) as 
certain PAOx have been shown to be biocompatible. The large potential chemical versatility makes this 
class of polymers a real competitor in the field. In each step of the synthesis different functionalities can 
be introduced. 
PAOx are polymers based on the heterocyclic 2-oxazoline monomer. Different methods can be used for 
the synthesis of 2-oxazolines, (Figure 1-2).17 Starting from nitriles, carboxylic acids or aldehydes, a large 
chemical diversity (toolbox) can be obtained due to the broad range of monomers with different 2-
substituents that end up as the corresponding PAOx side chains. Together with this diversity a broad 
range of physical and chemical behaviour can be introduced ranging from very hydrophilic (poly(-2-
methyl-2-oxazoline)) to hydrophobic polymers (poly(2-butyl-2-oxazoline). The monomers can be 
polymerised via the cationic ring opening polymerisation (CROP), Figure 1-2. This means that the 
monomers cannot have nucleophilic groups as these will interfere with the CROP, which can be overcome 
with protecting groups. In Figure 1-2 the CROP of 2-oxazolines is depicted. It is a typical chain growth 
polymerisation, which can be divided in three parts: initiation, propagation and termination. It is a living 
polymerisation under the ideal conditions, with no termination nor transfer reactions. Since nucleophiles 
can terminate the polymerisation or induce transfer reactions, extensive measures have to be taken before 
the polymerisation to ensure the purity of the monomer, solvent and initiator.  
The polymerisation (Figure 1-2) is initiated by a nucleophilic attack of the 2-oxazoline monomer onto 
the electrophilic initiator. In the subsequent propagation step, the newly formed oxazolinium species 
reacts with the ring of the 2-oxazoline.17 The polymerisation can be terminated by the addition of a 
nucleophile. In every step of the polymerisation, functionalities can be introduced. This by using a 
functional initiator, functional monomers with a functional R side groups or a functional terminating 
agent. As such the polymers can be tailored to the envisioned application. 
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Figure 1-2 Schematic representation of the cationic ring opening polymerisation of 2-oxazolines. The polymer is 
initiated by the nucleophilic attack of the oxazoline on the initiator. The activated species is subsequently attacked 
by the oxazoline. Termination is done via a nucleophilic group.  
 
The solution behaviour of PAOx can also be controlled by variation of the 2-substituent of the monomer. 
Therefore polymers with a different side chain and accompanied different solubility behaviour can be 
made. Ranking the polymers from water soluble to water insoluble leads to the following order poly(2-
methyl-2-oxazoline) (PMeOx) > poly(2-ethyl-2-oxazoline) (PEtOx) (≈ PEG) > poly(2-iso-propyl-2-
oxazoline) (PiPrOx) > poly(2-cyclopropyl-2-oxazoline) (PcPrOx) > poly(2-n-propyl-2-oxazoline) (PnPrOx) 
> poly(2-butyl-2-oxazoline) (PBuOx) with PMeOx being fully water-soluble and PBuOx being fully water 
insoluble. This control can be used for the synthesis of amphiphilic block copolymers by combining the 
hydrophilic polymers (PMeOx or PEtOx) with one of the hydrophobic monomers. Such block copolymers 
can self-assemble into micelles, which can be used for drug loading and delivery.18 This application will 
be further discussed in section 5 of this chapter. In some cases, polymers with so called lower critical 
solution temperature (LCST) behavior are obtained meaning that the polymers are soluble in water below 
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the cloud point temperature (Tcp). Heating the polymer solution above the TCP leads to phase separation 
and makes the polymer solution to turn opaque. This interesting property will be discussed in chapter 3. 
The LCST behaviour can be used for the preparation of responsive surfaces by coating the surface with 
poly(2-isopropyl-2-oxazoline). The resulting substrate has a different protein and cell adsorption 
depending on the temperature, whereby the reversible adsorption is much lower below the Tcp induced 
by the higher hydrophilicity.19  
 
1.4 Poly(2-alkyl-2-oxazoline)s vs 
Poly(ethylene glycol) 
 
PEG polymers are without doubt the gold standard in polymer therapeutics, PEG has a large commercial 
availability and is the best known polymer in the medical field due to its excellent biocompatible behavior. 
As discussed before it is important to search for alternatives because PEG has some major drawbacks. 
Despite that, several PEG based therapeutics have gained FDA approval and are used in the clinic. 
Therefore both the pro and contras of PEG will be discussed here and the polymer is compared to PAOx 
as potential alternative. 
Polymer drug conjugates, such as PEG,20 can reduce protein adsorption and aggregation, increase 
circulation and bioavailability. Most of the drugs are hydrophobic and attachment of a water soluble 
polymer increases drug circulation and may enhances uptake by the addition of targeting motifs. 
However, we have to consider that every week papers are published using polymer therapeutics and 
thereby suggesting a potential cure for the disease. Even though these studies look very promising, only a 
small part makes it into clinical trials, because in vitro or even in vivo data from mouse models do not 
guarantee any success in clinical trials on humans.21 
PEG is in this context still the most used polymer for developing polymer drug conjugates as it reduces 
the non-specific adsorption of proteins, including plasma protein adsorption, which is reduced up to 70%. 
It is, however, not only the reduction of protein adsorption that plays a role in the stealth effect, it is the 
specific adsorption of certain proteins to the PEG layer that has been suggested to be crucial.22 When PEG-
coated particles were exposed to macrophages without prior protein treatment, the macrophages 
eliminated the particles, indicating that they could detect the polymer layer. This means that the 
adsorption of specific types of protein is crucial for the stealth behavior. In fact the clusterin, part of the 
family of the apolipoproteins, was identified to be crucial. When clusterin adsorption onto PEG was 
ensured, no uptake in macrophages was observed.22 This absorption of plasma proteins helps the PEG to 
avoid recognition by the immune system making the polymer behave as a stealth vessel. 
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However, several drawbacks to PEG appeared such as the non-degradability and the increased 
immunogenicity upon repeated treatment.5 Especially at higher dose treatments, the lack of degradability 
causes the accumulation of PEG in the body via vacuolization, i.e., the formation of vacuoles. Toxicity 
problems could potentially occur when the concentration of polymer becomes higher than the toxicity 
threshold of the systems. The immune response is also a concern, as anti-PEG antibodies have been found 
in multiple cases for PEG causing problems in chronic diseases.23,24 The anti-PEG antibody is induced by 
the huge amount of products in pharma and consumer products containing PEG. The antibodies induce 
inflammation and a faster clearance of these polymer therapeutics making them less effective. There is 
also a concern for oxidative degradation of PEG in vivo. The reason why PEG is still the gold standard lays 
with the commercial availability in large quantities, in a large range of molar mass and good quality. This 
is an important asset as a lot of labs do not have the in-house expertise to make the polymers with the 
required properties. As medicine is quite conservative in changing protocols and they tend to stick to the 
already approved polymer materials such as PEG, new technologies find it difficult to reach the market.  
 
PAOx receives significant interest as a competitor for PEG because it has similar biomedical properties 
in combination with some advantages. The pros and cons of PEG and PAOx are listed in Table 1-2. The 
polymerisation of PEG is often difficult as ethylene oxide is explosive and hazardous. The formed polymers 
are only stable at low temperatures (-20°C), which is a liability for the shelf life. The limited chemical 
versatility of PEG provokes low drug loading and difficult active targeting as PEG can only be modified via 
the end groups. Next to this limited chemical versatility, the above discussed vacuolization and anti-PEG 
antibodies are in disfavor. To further elaborate on the stealth effect, the protein corona was examined for 
both PEG and PAOx. They both showed low nonspecific cellular uptake by macrophages, reducing 
immunologic responses.25 PEtOx showed less protein adsorption than PEG in fetal calf serum. Remarkably 
two independent papers report corresponding adsorbed protein patterns with small differences revealing 
that the formation of the protein corona by specific adsorption of plasma proteins is influenced by the 
structure of the polymer.22 Rather than no protein adsorption, the selective adsorption of proteins appears 
to be important for the stealth behavior. Furthermore, a minor uptake of PEG into macrophages was 
shown while PEtOx was not taken up in a comparative study.25 
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Table 1-2 PEG vs PAOx 
 
The PAOx polymers also show some disadvantages such as difficult monomer synthesis and 
purification. For the polymerisation a nucleophile free environment is required, nucleophiles can induce 
termination of the polymerisation which is also true for PEG. However, besides these disadvantages the 
PAOx polymer appears to be superior, especially with regard to the large chemical versatility, (Figure 1-2). 
This helps to tailor the desired polymer for a certain application. As not only the bioactive molecule can 
be coupled but also targeting ligands onto the polymer chain. This helps to tailor the perfect polymer for 
every specific application. However the main limitation of PAOx is the absence of FDA approved 
therapeutics posing an important risk as it is uncertain how they will behave in humans.  
  
PEG PAOx 
Difficult polymerisation, explosive gaseous monomer Non explosive, no straightforward purification  
Oxidation forms peroxides No oxidation 
Stable at low temperature (-20°C) Stable in water and at ambient temperature 
Diol content No diol 
Highly viscous Low viscosity 
Low drug loading High drug loading 
Difficult for active targeting Active targeting easy accessible (chemical versatility) 
Vacuolization Cleared from the body 
Anti-PEG antibodies Not enough biological assay and no FDA 
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1.5 Biomedical application of Poly(2-alkyl-2-
oxazoline)s  
Since the inception of the PAOx-field numerous biomedical applications have been developed and 
published. The focus of the PAOx field is mainly on polymer therapeutics, namely polymeric micelles, and 
polymer protein/drug conjugates. 
 
Figure 1-3 Overview of the use of PAOx polymers for polymer therapeutics.26 
 
PAOx are gaining interest as biomedical polymers and are often referred to as pseudo-peptides because 
they are structural isomers of peptides. Similar to other biomedical polymers, a classification of PAOx-
based polymer therapeutics can be made in: polymer-drug conjugates, polymeric-drugs, polymer micelles, 
polymer aggregates, polymer nanoparticles and polyplexes(Figure 1-2).27 The latter will be discussed in 
section 7, that focuses on gene therapy and PEI. In the case of a polymer drug conjugate the water 
solubility is critical, therefore, PMeOx and PEtOx are valuable candidates, although the latter has a Tcp 
around 65°C, which, is not relevant in a biomedical context. Next to the solubility, the biocompatibility 
plays a crucial role, which has been tested for PMeOx and PEtOx in different cell lines such as MCF7, HEP 
G2, CATH cells.28 The polymers exhibited no toxic effects. In vivo data showed excellent behavior for 
PMeOx as it increased blood circulation times of drugs and is nontoxic against THP-1 cells (acute 
monocytes leukaemia).29 The excellent biocompatibility is caused by suppression of protein adsorption 
although as previously mentioned, specific plasma proteins adsorption may also play a role. This was 
shown by coating of different surfaces with PMeOx, acting as an anti-fouling coating.8 Similar, no 
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hemolytic effect was found for pure PEtOx. PEtOx copolymers with a zwitterionic side chain showed no 
adverse reaction with human blood, regarding platelet activation or immune system while excellent 
coagulation behaviour was observed.30 By using thiolated silica nanoparticles grafted with PMeOx, PEtOx 
or PPrOx it was shown that PMeOx coated particles had higher mucus penetration. The diffusion speed 
was correlated with the hydrophilicity, with higher hydrophilicity showing faster diffusion.31 Similar 
conclusions were reported for PEtOx and PiPrOx coated poly(organosiloxane) nanoparticles with a 
rhodamine B core.25,19 The PEtOx grafted particles showed similar biocompatibility as PEG as discussed in 
the PAOx vs PEG section. The antibody recognition and cell uptake properties where examined to scan 
for potential cytotoxicity of PMeOx. The procedure included an alkyne modified tobacco mosaic virus 
which was coupled to azide containing polymers. An equal immunological response was observed as for 
PMeOx and the PEGylated virus.32 Also PMeOx and PEtOx containing lipophiles were made by the 
coupling of distearoyl phosphatidyl ethanolamine to increase blood halftime and to lower liver uptake in 
mice. This test showed that the PEtOx performs worse than PMeOx in the context of blood clearance and 
a minor uptake in liver and spleen was observed. This difference was ascribed to the small change in 
hydrophilicity.33 
Not only the PAOx homopolymers showed excellent biocompatibility, various PAOx (tri)block 
copolymers also showed excellent biocompatible behavior.28,34 PEtOx-b-PPhOx block copolymers were 
self-assembled into nanoparticles and examined in a neurotoxicity assay revealing no neurotoxicity. 
Eventhough there was no apoptosis or necrotic effects, some of the polymers showed activation of the 
complement system at higher concentration levels.35 
The excellent biocompatibility of PAOx makes it possible to find a broad range of biomedical 
applications. In the following, selected biomedical applications of PAOx will be discussed with a 
distinction on the size of the polymer structure, ranging from the  macroscopic level via the microscopic 
level to the nanoscopic level. At the macroscopic level different topics are discussed, such as 
thermoresponsive surfaces, bandages, antifouling surfaces and hydrogels. 
Different types of anti-fouling surfaces have been developed with different PAOx. The control of surface 
properties is important as this controls the interface between the material and the blood. It is however a 
subtle balance, the surface should not be prone to bacterial adsorption as this induces infections and 
corresponding repelling effects. On the other hand the material needs to be compatible with the tissue, if 
this is not the case it could induce immunological reactions of the guest organism. As an example polymer 
brushes on amino-functionalized silicon substrates with different PAOx were discovered to control cell 
and protein adsorption. Surfaces containing PEtOx or PMeOx showed low cell adsorption.36 In similar 
research, copolymers of PiPrOx and PEtOx and PNonOx (poly(2-nonyl-2-oxazoline) were used to make 
temperature changing surfaces with switchable cell adsorption.37 Similar anti-fouling containing surfaces 
were designed based on zwitterionic PAOx to replace heparin. Heparin is an often used anti thrombosis 
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agent. The coating on implantable devices can prevent thrombosis and opsonisation of proteins which 
can induce rejection. The zwitterionic PAOx are made starting from PEtOx-PButenOx (poly(2-butenyl-2-
oxazoline). The amine is introduced on the double bond using a thiol-ene reaction with cysteine and 
subsequently a sulfobetaine or a carboxybetaine is prepared. These surfaces showed promising results in 
the field of anti thrombogenics.30 Pure PEtOx was spincoated on gold slides and silicon reducing protein 
adsorption.38 Poly(l-lysine)-PMeOx were compared with PLL-PEG on a Nb2O5 surface yielding non-
fouling surfaces. The PMeOx copolymer was reported to be more stable than PEG in physiological and 
oxidative environment.39,40 To act as an anti-bacterial agent amines are coupled to the initiator and/or 
terminator site of PAOx. This helps to disrupt the bacterial cell wall.41 Different PAOx were developed as 
anti-micro bacterial materials by the introduction of cationic charges.41,42 Antibacterial biofilms were 
developed by making triblock PMeOx-b-Polydimethylsiloxane-b-PMeOx with amine end groups.43 
The company GATT® showed that PAOx is ready to enter the commercial field of haemostatic agents. 
The product contains a coating with an electrophilic activated PAOx with excellent biodegradability, 
strong adhesiveness and haemostatic properties.44 This agent makes use of a methyl ester containing 
polymers which will be discussed in chapter 5. The procedure developed in this work was used to couple 
an ethylene diamine on the polymer.45 
 
The last examples for the macroscopic application of biomedical polymers are hydrogels, which are 3D 
water swollen structures. As PAOx is biocompatible and ideal for cell culture, different types of hydrogels 
can be synthesized for this purpose. Further applications of hydrogels are found in the area of drug 
delivery. Two different methods are used for hydrogel synthesis whereby in the first method the cross 
linked network is formed during the CROP and in the second method a post-polymerisation coupling 
method is used. The first method is based on the presence of a bifunctional monomer inducing network 
formation in situ during polymerisation. The network is formed however a solvent exchange needs to be 
done as no water can be present during the CROP. This means that an extra step is needed as the solvents 
need to be switched. The second method uses the functional groups on the polymer and cross-linkers to 
form the hydrogels during a post-polymerisation coupling reaction.46,47 Such PAOx hydrogels have been 
used as a scaffold for all kinds of cell growth. PEtOx-PUndecylOx has a undecenyl side chain with a 
terminal double bond which is cross-linked via a dithiol linker. These hydrogels were used for fibroblast 
growth and to enhance cell recognition a RGD peptide was added.48,49 Degradable hydrogels were 
synthesized by using copolymers with a degradable middle block, namely PEtOx-b-Poly(D,L-lactide)-b-
PEtOx. These gels were used to grow skin fibroblast.50 A triblock polymer, PEtOx-P(Ɛ-caprolactone)-
PEtOx, with a thermoresponsive behavior was used to embed the antibody bevacizumab (Avastin). This 
product prevents neovascularization in certain diseases, such as diabetes.51 Co-networks were formed with 
PEtOx and poly(2-hydroxyethyl methacrylate (PHEMA) and poly(hydroxypropyl acrylate) (PHPA) to 
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release ibuprofen in a controlled way.52 PEtOx and acrylic acid induced a pH sensitive hydrogel by using 
γ-gamma irradiation with ibuprofen as model drug.53  
Hydrogels could not only be used for cell growth but also filter DNA out of solution. During the 
polymerisation of PEtOx-BocOx was introduced along the chain. This BocOx monomer contains a BOC 
(tert-butyl oxycarbonyl groep) protected amine in the side chain. After deprotection of the amine a part 
of the amines are used in crosslinking with chloro-epoxides. The primary amines and the formed 
secondary amines were demonstrated to interact and bind with DNA.54 
If we take a step closer to the bottom towards the use of PAOx for microscopic polymer therapeutics, 
there are only very few examples. Nonetheless microbeads of biodegradable PMeOx were used to grow 
stem cells. A telechelic PMeOx was formed by using methacrylic end groups. The degradable linker 
contained a disulfide bridge that is cleaved under reductive conditions and the formation of the 
microbeads was performed in micro fluidic channels.55  
 
We all know that there is plenty of room at the bottom, to cite Richard Feynman. Therefore, and because 
it is closest to the molecular world of chemists, the nanoscopic polymer therapeutics area has been the 
broadest research field for PAOx. It is however remarkable that most research groups often use the same 
model anticancer drugs, such as doxorubicin and paclitaxel. An overview is provided of the reported PAOx 
drug conjugates (Table 1-3) as well as PAOx micelles that are used for drug encapsulation in the 
hydrophobic core (Table 1-4) 
 
The most advanced results have been reported by the company Serina therapeutics that is developing a 
PAOx-drug conjugate to treat Parkinsons’ disease, which is currently being evaluated in phase I clinical 
trials. Serina uses the abbreviation POZ instead of PAOx, which is only a difference in nomenclature. In 
addition, a manifold of products are in the pipeline of this company: the treatment of  epilepsy with PAOx-
cannabidiol (SER-228) and treating nausea and vomiting induced by chemotherapy by POZ-
tetrahydrocannabinol (SER-232). SER-214 is the first PAOx conjugate in clinical trials and is based on click 
chemistry to couple the rotigotine to the side chains of PEtOx (DP200) via cleavable ester linkage. The 
coupling is performed via an alkyne-functionalized 2-oxazoline monomer which was copolymerised with 
water soluble PAOx polymers.56 
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Table 1-3 PAOx-drug conjugates 
 
Table 1-4 PAOx-micelles for drug delivery 
 
 
PAOx Linker  Kind Drug 
PBuOx-b-PEtOx; PBuOx-b-
PMeOx and homo PMeOx 
Amidation reaction end 
group; NHS Amidation 
enzyme Horse radish peroxidase57 
PMeOx Azyde-alkyne 
cycloaddition (click) 
viral Model virus32 
PMeOx/PEtOx Amine termination Amino-Peptide HCPC58 
PMeOx/PEtOx/poly(2-(4-pent-
4-ynyl)-2-oxazoline) 
Cycloaddition(click) Protein cage Icosahedral Virus like 
particles (180 QB copies) 59 
PMeOx-b-PDMS-b-PMeOx streptavidin Macrophage (target) A1 Biotinylated ligands60 
PMeOx-co-P4-(2-
aminophenyl)-2-oxazoline)-BSA 
DMTMM (amine+COOH) Matrix Antigen coupling61 
PMeOx-b-PDMS-b-
PMeOx(poly G) 
Biotin functionalisation Pravastin Cholesterol inhibitor62 
PMeOx/PEtOx 
 
NHS  Insulin and enzyme63 
PEtOx Hydrazone linker Drug Doxorubicin (micelle 
formation)64 
PAOx Kind Drug 
PBuOx/PMeOx and PBuOx/PEtOx enzyme Horse radish 65peroxidase 
 enzyme Superoxide 65dismutase 
PMeOx-b-X-b-PMeOx 
(x=PNonOx,PtBuOx,PBuOx,PiPropenOx,PPhenOx,PHepOx)l 
Drug Paclitaxel66–
70,Docetaxel67,69Ampoterin 
B(antifungal),Cyclosporine 
A(immune suprenant), 
etoposide(cancer)68,17-AAG27,69, 
etopside69,bortezomib69,70  
Folic acid-PEtOx-b-poly(Ɛ-caprolactone) Near infrared 
dye 
Indocanine/folic acid(target)71 
PiPropOx/PEtOx Organo 
siloxane NP 
Rhodamine19,25 
Star shape PPCL-b-OEGMA(oligo-2-ethyloxazoline)methacrylate Drug Doxorubicine72 
Poly(l-lactide)-b-PEtOx-b-poly(l-lactide) Drug Doxorubicine73 
PLLA-PEtOx drug Doxorubicine74 
PEtOx-b-PCL drug Plaxitaxel75 
PMeOx-g-PCL drug Different types of drug76 
PMeOx-b-PDMS-b-PMeOx(poly G) Pravastin Cholesterol inhibitor62 
PEtOx-Poly(2-decenyl-2-oxazoline)-fluorescein model Fluorescein 77 
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1.6 The hydrolysis of Poly(2-alkyl-2-
oxazoline)s 
Before the excellent qualities of PAOx in biomedical applications were discovered, the polymer was 
mainly known as the precursor of linear poly(ethylene imine) (L-PEI) (IUPAC name: poly(imino 
ethylene)),previously only branched PEI (b-PEI) could be obtained by the ring opening of aziridines. The 
acidic and basic hydrolysis of the PAOx polymers made it possible to obtain L-PEI for the first time. Via 
this method it became also possible to synthesise copolymers containing both PEI and the original PAOx. 
Four different research groups reported the synthesis of PAOx via CROP in 1966.78–81 The publication of 
Kagiya et al showed that after hydrolysis of the PMeOx, linear PEI (L-PEI) could be obtained by releasing 
the side chain, herewith forming acetic acid. In a next step the PEI was acetylated with acetic anhydride 
showing that a post-polymerisation modification of L-PEI is feasible, in this case yielding the original 
PAOx.78 Tomalia et al reported that during the acidic hydrolysis of PMeOx in sulfuric acid an acetic acid 
smell was observed; however no full hydrolysis was obtained. In this paper also the alkaline hydrolysis was 
reported with corresponding acetic acid smell.80  
Long before the hydrolysis of PAOx into L-PEI, b-PEI was synthesised via the cationic ring opening 
polymerisation of aziridines (Scheme 1-1).82 Therefore in nomenclature PEI is referred to either b-PEI 
making an explicit distinction between both polymers. The b-PEI was first synthesized in 1938 by I.G. 
Farbenindustry.83 The b-PEI contains primary, secondary and tertiary amino groups with a 1:2:1 ratio 84 
while the L-PEI only contains secondary amines. The b-PEI is water soluble and is 20% protonated at 
physiologic pH, depending on the polymer concentration.  
The ring opening of aziridines yields the b-PEI (Scheme 1-1). The ring opening is initiated by the attack 
of the aziridine ring onto a Lewis acid. The resulting aziridinium ion is attacked by nucleophiles obtaining 
the ring opened aziridinium and a new aziridinium ion at the terminus of the chain. The chain is elongated 
by addition of a new monomer, whereby the formed secondary amine can also further react to a tertiary 
amine to induce a branching point. A nucleophilic attack terminates the polymerisation, which can occur 
with nucleophilic impurities or upon deliberate addition of a terminating nucleophile. 
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Scheme 1-1 Schematic representation of the ring opening polymerisation of aziridine resulting in b-
PEI 
 
The cationic ring-opening polymerisation of substituted aziridines is another option to obtain linear 
PEI (Scheme 1-2).83 The aziridines are substituted with different bulky groups lowering the reactivity for 
the branching points, which promotes the formation of a linear polymer even though 100% linearity is not 
always reached. Aziridines substituted with different functionalities, such as alkyl, benzyl, sulfonyl, and 
perfluoro acyl groups have been polymerised. In a final step, some of these linear polyaziridines could be 
deprotected via cleavage of the side chain yielding linear PEI.85–87 The branching could also be minimised 
by using N-(2-tetrahydropyranyl)aziridine (THPA), this group could be cleaved under mild conditions to 
obtain L-PEI as was shown by Goethals et al.88  
 
 
Scheme 1-2 Ring opening polymerisation of substituted aziridine and subsequent deprotection 
obtaining L-PEI 
 
The best method to obtain linear PEI is still the full hydrolysis of PAOx under either basic or acidic 
conditions. During the acid hydrolysis the amides are activated by the protonation of the carbonyl 
functionality and the formed amines are protonated, which heavily influences the reaction speed and the 
cleavage of the side chain. The protonation of the PEI units plays an important role because this influences 
the hydrolysis and solubility in water. Under acidic hydrolysis conditions, the amides of the starting 
polymer are protonated due to the high acid concentration.89 The influence of the PEI units was examined 
on a 25% hydrolysed PAOx showing a change in dielectric constant during titration.90 This was ascribed 
to the presence of the side chain which influences the protonation in two ways. First, there is a reducing 
effect as the electrostatic repulsion decreases, which increases the chance of protonation. The second 
weaker effect, being the electron withdrawing effect of the amide, reduces the protonation, the reduction 
of electrostatic repulsion dominates and hence the amide side chains promotes the protonation. The 
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article implied that the average distance between two amines in a partially hydrolysed PEtOx (25% PEI) 
is lower than 8 atoms and it could be assumed that the formed PEI units are neighbouring groups.90,91 
Two types of L-PEI can be found depending on the presence of a counter-ion. The first type is protonated 
as the Cl--ions are still present, hence the PEI units are protonated and the L-PEI is water soluble. The 
second type, which is called the free base, is not protonated and can be obtained by boiling the polymer 
in NaOH. To dissolve the free base linear PEI in water, the temperature has to be higher than its melting 
temperature (50-68°C) because the PEI forms stable crystalline domains.92 The free base form is insoluble 
in water at room and body temperature while the protonated form is water soluble at those temperatures. 
This protonation is of importance as it heavily influences the different applications of PEI. The PEI 
solubilised in water acts as a poly-base due to the secondary amine groups. However, no straightforward 
description of the pKa value of the polymer can be found as the large amount of amine groups heavily 
influence each other’s protonation leading to a broad pKa range. This situation is different compared to 
small molecules, in dilute conditions small molecules have a discrete pKa and the protonation is only 
influenced by the acidity of the fluid. For PEI this is more complex. A description of the complexity can 
be given with three neighbouring PEI units. Protonation of the first amino group will be straightforward 
with a pKa of 9.5. However, due to the presence of this first positive charge there will be charge repulsion, 
which lowers the pKa down to 7 for the second protonation. The protonation of the third part will be even 
more difficult with an associated pKa of less than 7.93 In the case of PEI, both branched and linear, all 
amines are chemically correlated as they are always at a two atom distance. Therefore PEI is called a weak 
polyelectrolyte. In the case of b-PEI the presence of tertiary, secondary and primary amines can further 
complicate the pKa regime, this will not be discussed. This means that the protonation is not 
straightforward and difficult to predict as there is a broad pKa regime. Besides the repulsion effect, the 
charges are present on the backbone and an extra conformational degree comes in to place making it 
more difficult to predict the protonation.93 Similar as in small molecules the addition of salt influences 
the pKa as the addition of salt can change the protonation strength.94 When an acidic solution of PEI is 
made basic by titration, Goethals and coworkers observed that the polymer solution becomes turbid and 
a drop in the pH value is observed at pH 9.4. It was shown that PEI has a pH dependent protonation, this 
will influence the endosomal escape as the pH in the lysosome is lowered from 7.4 to 5 by an influx of 
protons as will be further discussed in section 7 of this chapter. 
The preparation of L-PEI starts often with PMeOx or PEtOx as parent polymer due to their commercial 
availability in large quantities, atom economy and good water solubility. The first reported reaction 
condition were often alkaline (NaOH) at 98°C for 3h.91,95 In addition to the above mentioned polymers 
both poly(2-phenyl-2-oxazoline) PPhOx and PiPrOx have been used for the acidic hydrolysis.96,97 In the 
following part, the basic and acidic hydrolysis of PAOx are discussed in further detail. 
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At first the basic hydrolysis will be discussed,(Scheme 1-3) which was reported in different occasions.98,99 
The reaction is second order (𝑟𝑎𝑡𝑒 = 𝑘2[𝑎𝑚𝑖𝑑𝑒][𝑂𝐻−]). In the first step the OH- attacks the carbonyl 
function and subsequently this tetrahedral intermediate is deprotonated and the carboxylate is released 
irreversibly.  
  
 
Scheme 1-3 Basic hydrolysis of PAOx: The basic hydrolysis of the PAOx starts with the attack of the OH-
on the amide bond forming the tetrahedral intermediate. After protonation of the nitrogen there is 
an irreversible release of the carboxylic acid. 
 
Tanaka et al reported an attempt for the basis hydrolysis of PPhOx, however they failed.96 The basic 
hydrolysis can be controlled by the amount of base added as was shown by Chujo et al.100 A major 
drawback of this approach is that partial backbone degradation occurs during hydrolysis.101 In our labs 
similar observations have been made, yet unpublished. It is, however, unclear how this backbone 
degradation appears and in which quantity. 
The acidic hydrolysis is more promising and the first hydrolysis of PEtOx, PMeOx and PPhOx was shown 
in 1979 by Kem using HCl (Scheme 1-4).91 The hydrolysis of PMeOx91 and PEtOx102,103 was investigated in a 
more detailed way. In a first step (Scheme 1-4) the amide is protonated making the attack of water easier, 
which is the rate determining step. The formed tetrahedral intermediate is promptly converted to the 
amine under the release of a carboxylic acid. This is accompanied by the corresponding smell of either 
acetic acid, propionic acid or in the case of PPrOx, butyric acid. As discussed the formed PEI is protonated 
due to the acidic conditions (pKa ~ 10). When the reaction equilibrium is pushed to the end it is difficult 
to protonate all the amine groups due to repulsion effects. The acidic hydrolysis of PAOx is an accurate 
and reproducible method to obtain L-PEI or PAOx-PEI copolymers, which is easily controlled by 
temperature. The temperature plays a crucial role as the hydrolysis is accelerated when the temperature 
rises. It was however also shown that at higher temperatures, above 180°C under pressurized conditions, 
the polymer backbone degrades during acid hydrolysis.102 Due to the protonation of the formed amines 
after hydrolysis, there is an effective consumption of protons implying that the overall pH will increase 
and in this perspective the amount of acid controls the amount of PEI. It may by anticipated that there 
will still be the possibility to form new PEI units but this will be slow due to the slow exchange of the 
protons. In normal time frames this will not happen (hours).102 Next to this discussed hydrolysis 
mechanism, the acidic hydrolysis maybe accelerated by the formation of seven ring like intermediate with 
neighboring groups. The proton on the protonated amine gives intramolecular hydrogen bonds which 
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makes the amide more susceptible to a nucleophilic attack. This was shown by the acceleration at the 
beginning of the hydrolysis of PEtOx103 and PPrOx104 and will be further discussed in chapter 3. The 
protonation of the formed amine is important and therefore the polyelectrolyte effect is discussed since 
repulsion of charges can decrease the reaction speed91 and stretch the polymer chain. This influences the 
kinetics as it lowers the reaction speed when more amines are protonated, thus with higher hydrolysis 
degree. This is confirmed with the decrease of the reaction rate at higher hydrolysis degree.93 The 
hydrolysis of PEtOx with different chain length showed that the degree of polymerisation (DP) has no 
influence on the rate of hydrolysis and on the molar mass distribution (i.e dispersity) of the resulting 
polymer. In the same study it was also shown that the PMeOx hydrolyses faster than PEtOx, whereby the 
kinetics showed that PMeOx had linear kinetics until 80% and PEtOx up to 60% due to the better 
solubility of the first. The polymer concentration was examined and showed no effect, at least under very 
acidic conditions where pseudo first order kinetics are achieved.105 The acid concentration does play a role 
as protons are consumed during the hydrolysis.106 The amount of acid controls the amount of PEI units 
formed in partially hydrolysed copolymers.102,107 This provides a controlled and robust way to make 
partially hydrolysed polymers with a certain amount of PEI. 
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Scheme 1-4 Acid hydrolysis of PAOx: The acid hydrolysis starts with a protonation followed by the 
formation of the tetrahedral intermediate via water. This step is the rate determining step. The last 
step removes the carboxylic acid from the polymer obtaining the PEI. In the square at the bottom the 
seven ring is shown which may facilitate the hydrolysis of a neighbour amide. 
 
The above discussed hydrolysis reactions mainly focused on full hydrolysis of PAOx to obtain L-PEI. 
The reaction can also be stopped at incomplete conversion to obtain a copolymer with a certain degree of 
PEI units and the original polymer. Partial hydrolysis was already demonstrated by Kem in 1979 and they 
assumed that the new polymers could be used in copolymer synthesis.91 The partial acidic hydrolysis of 
PEtOx and PPrOx is discussed further on in this PhD work, cfr. chapter 3. The obtained PEtOx-PEI 
copolymers have been demonstrated to be still biocompatible up to 25% hydrolysis.103 
Partial hydrolysis was also explored with triblock or diblock copolymers aiming to prepare PAOx-b-L-
PEI block copolymers. The hydrophobic block was 4-t-butylphenyl-2-oxazoline or 2-undecyl-2-oxazoline 
and the hydrophilic middle block was PEtOx.106 Via this method block PEI parts were synthesised due to 
the selective hydrolysis of the hydrophilic part while only (25%) of the hydrophobic parts were hydrolysed. 
To obtain a more selective hydrolysis, a lower PEtOx concentration and lower temperatures were used.106 
Different methods were developed for the synthesis of pure block PEI-PAOx copolymers. The difference 
in solubility was explored to induce selective hydrolysis. Often a hydrophilic block, PMeOx or PEtOx was 
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combined with a more hydrophilic block. Both triblocks and diblocks copolymers were used. The triblock 
copolymers can consist of PPhOx-b-PEtOx-b-PPhOx where the middle block is hydrolysed. Also some 
efforts have been made to perform acidic hydrolysis in different solvents. Studies have been done on the 
acidic hydrolysis of PMeOx, PEtOx, PPhOx in 80-20 ethanol water mixtures. The experiment with PMeOx-
b-PPhOx and PMeOx-b-PEtOx block copolymers showed that the PMeOx was preferentially hydrolysed 
although the PPhOx was also partially hydrolysed.106,108–110 The PMeOx-PEtOx-was less selective although 
the PMeOx was hydrolysed faster than the PEtOx block. The use of random or block copolymers showed 
that due to the phase separation of the blocks the methyl block is cleaved off easier.101  
 
Application of linear PEI in gene transfection experiments will be discussed in section 7 of this chapter. 
Here, the application potential of L-PEI in other fields will be briefly discussed. The polymers have often 
been used to chelate heavy metals111 such as Hg2+,98,112 Cu2+,84,98,112,113 Cd2+,84,98,112 Co2+,84 Ni2+,84,112 Zn2+ 84 and 
even Ca2+,112. Further applications include the role as retention aid in paper manufacturing, textile 
softeners and ion exchange resins. Again in the field of metal chelation partially ethoxylated PEI was 
applied for filter applications for many heavy metals such as Cu2+ and Ni2+ and Cd2+. They are applied as 
electrolytes in batteries as they form polymer-salt complexes with alkali metals (NaSO3CF3).114,115 L-PEI 
was used as a single ion conductor in batteries, increasing the ion conductivity.116 L-PEI has also been used 
in gas scrubbers for removal of CO2 gas out of gas streams however problems with recycling appear, this 
will be discussed in chapter 4.117 PEI was also used as a stabilizer for gold nanoparticles. The gold 
interacting alkene chain was coupled via its acid chloride in a nucleophilic attack of the amine of the L-
PEI.118 SiO2 was also combined with PEI via an epoxide containing silica groups which where condensed 
into silica particles an used as a conducter.119 Finally, applications are found in beauty products for 
perfume delivery120 and dermal applications for antibacterial applications.37 
 
1.7 Gene therapy and Poly(ethylene imine) 
The main application of L-PEI can be found in gene delivery, due to the presence of the positive charges. 
These charges interact with the negative charged genetic material such as DNA, and RNA. One out of 
three atoms on the backbone can bear a positive charge creating a high overall charge density along the 
backbone. Different modification where proposed ensuring better transfection efficiency. A lot of efforts 
and different adaptions have been done on L-PEI which will be discussed in this section. 
As PEI is a key reference for non-viral gene therapy experiments, a brief introduction will be given about 
this topic. PEI is often used as reference to compare gene transfection efficiency of new vectors. Gene 
therapy is the treatment of diseases by inducing gene expression of a certain gen of interest. This is done 
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by using gene carriers to import exogenous nucleic acids into cells. In recent years, a lot of genetic diseases 
are recognized and potential targets are identified.121 In gene therapy the cells are provided with genetic 
information to produce therapeutic proteins thereby overcoming problems with the direct administration 
of therapeutic proteins, such as degradation. Different types of genetic material can be introduced e.g. 
plasmid DNA, antisense oligonucleotides, shorter interfering RNA, micro RNA and messenger RNA. A 
gene delivery system is crucial to protect the genes from the harsh conditions in the body and to enhance 
cell delivery because the nucleic acids are often prone to degradation and do not enter cells. The gene 
carrier can be viral or non-viral. Still the major contribution is led by viral vectors, almost 70% of the 
existing gene therapies use genetically modified viruses.122,123 However, these viruses are not always safe as 
they can alter the guest genetic code permanently by self-replication leading to severe immune and 
inflammatory reactions124,125 and even leukemia. Therefore there is a constant need for alternatives.126 
Viruses such as adenovirus, adeno associated viruses, lentivirus and retro virus have been used.121,127,128 The 
viruses are hazardous and the formed complexes are vulnerable during work up obstructing 
straightforward handling. A major drawback is that only a small amount of genetic material can be used 
and upscaling is difficult.123 
Different non-viral systems can be used, but with lower transfection efficiency than viruses. These 
systems have lower immunogenicity, higher biocompatibility and more scale up potential. Liposomes, 
cationic lipids129,130, peptides, polymers and dendrimers (PAMAM) are examples of non-viral gene vectors. 
They are often biocompatible polymers and have limiting undesired side reactions with proteins and non-
targeted cells. Polymeric vectors are based on, e.g., PEG, PPI dendrimers, poly(l-lysine),131 
polymethylacrylate,132 cyclodextrins,133,134 PEI-cyclodextrines135 and polypeptides.136 The following non-
viral vectors are commercial available: Poly(l-lysine),132,7 L-PEI and polyamidoamine dendrimers 
(PAMAM).136,137 The most used L-PEI is the 22 kg/mol PEI as this is used as a benchmark in the majority 
of in vivo genetic experiments.132,138 
The polymeric vector forms a complex with the nucleic acid and protects the gene from degradation.139 
The nucleic acids are negatively charged therefore polymers with a positive charge are used to condense 
them. These complexes between nucleic acids and positively charged polymers are referred to as 
polyplexes.137 Remarkably, L-PEI is  the best of the other polymers vectors as they are still 105 less efficient 
in gene delivery than the viral counterpart.122,140,141 PEI is better in transfection than many other polymer 
non-viral vectors because the uptake and release of the genetic material is so efficient. PEI based 
polyplexes have a better escape from the lysosome and localization in the nucleus.142 However there is a 
thin line between the number of cationic charges and the corresponding cytotoxicity. The positive charges 
induce more interactions with proteins present in the blood and more non-specific interactions. There 
are problems with injection of PEI polyplexes, such as liver necrosis and (cell)death.143 The cytotoxicity of 
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the polymers is depending on the number of positive charges because this increases the tendency to 
interact with the negatively charged cell membranes.  
Partial hydrolysis of PAOx yields copolymers such as PEtOx-PEI, which can be used for gene 
transfection experiments.107 They perform better than the b-PEI. When an increased number of PEI units 
was introduced this induced a higher cytotoxicity. Copolymers of PEI were used as they can lower the 
cytotoxicity of the PEI by shielding of the positive charges and enhancing the water solubility. In this 
chapter the end group modifications will be discussed while the grafting will be discussed in the post 
polymerisation section 8 of this chapter. PEtOx-PEI end capped with a pyridine group was used for 
tracking the cellular pathway, by adding more positive charges a higher cytotoxicity was observed, 
whereby 30% of PEI units seems to be the limit.144 It was shown that with less cationic interacting amines 
the polymer cannot transfect the genes.145 In another approach the PEtOx-PEI was used as a macro 
initiator for the polymerisation of PEtOx herewith obtaining a polymer with (PEtOx-PEI)-b-PEtOx . The 
polymers were safe for both in vitro and in vivo use. This approach arise some doubts as the CROP should 
be nucleophile free while amines are present. Despite this doubt the authors reported low Đ values 
(between 1.08 and 1.12146). A PEtOx-PEI block was formed by coupling the PEtOx and PEI via disulfide 
bridge at the end group.147 Not related to the gene transfection part, it was shown that PMeOx-PEI 
copolymers could be used in the determination of melamine in milk.148 
Different PAOx could be used in gene transfection such as grafted PEI-g-PPhOx-g-PMeOx, the PEI 
block was hydrolysed in ethanol:water from PMeOx.108 PMeOx-s-PEI-b-PTHF-b- PEI-s-PMeOx were made 
starting from the corresponding PMeOx-b-THF-b-PMeOx however no transfection was observed.149 A 
gene transfection PAOx polymer with no PEI is also reported by using PMeOx-P(cationic 
polyoxazoline)(CPOx). This polymer contained an amine containing positive charge on the side chain. 
The positive charges make the polymer suitable for gene transfection.150 
PEG can be coupled to L-PEI to reduce side effects as it will shield the formed polyplexes. PEG-PEI block 
copolymers were obtained via maleimide NHS coupling combining both end groups.151 PEI was coupled 
via the terminator end with PEG via an NHS ester or an S-S coupling obtaining a disulphide bridge.152 Two 
different polymers containing poly(propylene glycol) (PPG) were synthesised being PEI-b-PPG and PEI-
PPG-PEI to see the difference in transfection. The PEI-b-PPG showed efficient plasmid DNA transfection, 
however no siRNA delivery. The PEI-PPG-PEI behave opposite because of the micelle which is formed.153 
PEI-was also coupled with linear cholesterol, T-shaped or the combination of both. The modification was 
done on the end-group hydroxyl of the PEI and the secondary amine (linear) or hydroxyl or the amine (T-
shaped).154 PEI with an amine group was coupled to an acrylate modified poly(beta-amino ester).155 A more 
complicated construct was made by coupling PEG, poly(l-lysine) and PEI in one construct with an 
antibody. The coupling between the construct of PEI and PEG-Poly(l-lysine) was done via a degradable 
disulfide bridge obtaining degradable polyplexes.156 Poly(l-lysine) grafted with poly(2-methyl-2-oxazoline) 
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was used for DNA delivery with excellent stability in biological medium.131 The coupling of chitosan and 
PEI was shown by using the amine to graft PEI on chitosan, it was however not clear whether this was an 
end-group modification or a backbone modification.157,158 PEI-Fe(III) complexes help condensing DNA by 
reducing the positive charge on the backbone and lowering cytotoxicity.159 
It is clear that PEI is excellent for gene transfection however sufficient for further in vivo use due to its 
toxicity. Finding new chemical modification is difficult as the amount of new variation become rare. It 
would be good to change the focus of the field towards different application where the cationic charge 
can be used. 
 
1.8 Post-polymerisation modification of 
Linear poly(ethylene imine) 
The outstanding chemical versatility of L-PEI initiated a new field where L-PEI was chemically modified. 
The modifications are straightforward as the amine on the L-PEI can act as a nucleophile. Thereby a new 
range of polymers is synthesised with a multiplicity of interesting properties. There are different 
modification routes possible such as, coupling with carboxylic acids, nucleophilic substitution, reductive 
alkylation/amination, ring opening and Michael addition.  
PEI modification can be done on the backbone for enhancing the gene transfection while lowering the 
toxicity. Despite the unique properties of PEI there are still drawbacks, which makes it difficult to apply 
as a gene transfection vector in biological systems. To bypass cytotoxicity, aggregation and opsonization 
problems, post-polymerisation modification reaction can be performed.160 
 
1.8.1 Amine modification with carboxylic acids 
PEI-g-PEG polymers were made via (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (EDC) coupling 
of PEG with a terminal acid on the secondary amine of L-PEI. The resulting polymers were used in nasal 
delivery.161 Dextran modified with a carboxylic acid was also coupled to the amine of L-PEI via EDC 
coupling showing better gene transfection than the dextran coupled via reductive amination.162 The 
preparation of L-PEI containing nucleic acids was possible by the (N,N’-dicyclohexylcarbodiimide) (DCC) 
coupling of 2-carboxyethyl derivate of the nucleic acid.163 
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1.8.2 Nucleophilic substitution 
The Schubert group coupled l-glutathione to L-PEI. L-glutathione enables a better crossing of the blood 
brain barrier. In the reported methodology, the polymer was partially functionalized with N-succinimidyl-
4-pentenate, introducing a double bond in the side chain (27%). The double bond was then used in a 
thiol-ene photo addition reaction. L-PEI was also fully modified with side chains containing the double 
bond and subsequently a partial modification was done with the glutathione amine group.164 An imidazole 
functionalized PEI was obtained via the reaction of an excess of 4(5)-(hydroxymethyl)imidazole in the 
presence of a base. The imidazole act as ribonuclease A mimicking RNA.165 PEI-dexamethasone was 
formed by reacting PEI with Trauts reagent (2-iminothiolane) forming a more reactive sulfhydryl group 
as a side chain. The dexamethasone-21-mesylate was coupled with this sulfhydryl group.166 Different 
methods are used to alkylate the amine via nucleophilic substitution of the coupling agent, in this case 
4(5)-bromo methylimidazole.167 The reaction between a bromide mesogenic reagent and subsequent 
quaternization led to the formation of crystalline polymers.168 A lot of effort was done in preparing 
alkylated L-PEI. via the nucleophilic substitution with benzyl bromide.169 PEI was grafted with nucleic 
acids, in a first attempt a propionic derivate of the nucleic acid was used in a DCC coupling, which was 
unsuccessful. By using an activated p-nitrophenyl ester the reaction was faster due to the better leaving 
group. A similar coupling was done with nucleic acid containing an acid chloride or bromine containing 
adenine or thymine.170–173 
For the synthesis of chelating polymers a styrene-PEI copolymer was carboxylated by using mono 
chloroacetic acid.112 With a similar system the mercapto-ethylation was done by the introduction of 
ethylene sulfide and carbon disulphide.174 PEI is often used in conducting polymers and was therefore 
grafted with lithium conductors. The reaction was done with 1,3-propane sulfone.116 
Hydrogels were made for the capturing of DNA. The PEI was modified with succinimidyl-4-pentenate 
which reacted with the amine obtaining a polymer with a double bond in the side-chain. The double bond 
was then used to make hydrogels via thiol-ene chemistry and a diol linker.54  
A modification of PEI was indirectly shown in industrial gas scrubbers. The amines of PEI are prone to 
react with CO2 to form carbamates. It was however shown that these carbamates groups form cyclic urea 
making the regeneration impossible.117 This side reaction could be controlled by increasing the gas stream 
moist.175Ferrocene groups were coupled to L-PEI via nucleophilic substitution depending on the required 
spacer.176–181 
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1.8.3 Reductive Alkylation/amination 
One of the first reports on the post polymerisation modification of PEI was reported as the Eschweiler-
Clarcke N-methylation. In the reaction between an amine and formaldehyde (Scheme 1-5) the methylated 
PEI is formed.96,182 More recently Lambermont-Thijs et al described different alkylated products made via 
reductive alkylation.169 
The amines on the PEI backbone can be modified via an oxidation step. The polymers were oxidized 
with hydroxyl moieties via the reaction of the amines with paraformaldehyde (Scheme 1-5), this reaction 
is an oxidation reaction however when the reaction is pushed an alkylated PEI is obtained. In this article 
also an epoxide is used to react with the primary alcohol hereby introducing glycidol.183 
 
 
Scheme 1-5 Introduction of formaldehyde on PEI and further reductive alkylation 
 
A similar modification was done by the oxidation of the amine, obtaining PEI-co-glycine copolymers. 
Different oxidizing groups were used obtaining hydroxylamine which is then converted to oxaziridine. 
Herewith the amide group is located in the backbone giving degradable polymers.184 The polysaccharide 
dextran was coupled via reductive amination onto the amines of PEI, but the EDC coupling showed a 
more efficient gene transfection.162 
L-PEI was also modified with ferrocene obtaining high current density polymers which can act as anodes 
in a biosensor. The polymer was cross-linked with a diglycidyl ether. The coupling was done via reductive 
amination with a ferrocenecarboxyaldehyde.176–181 
 
1.8.4 Ring opening epoxide 
Alkane modified polymers were made by reacting the amine with an 1,2 epoxydecane.185 The reaction of 
PEI with ethylene oxide formed a tertiary amine with an alcohol in the side chain.87  
 
1.8.5 Michael addition 
PEI-grafted with a methyl ester containing part on the side chain was prepared by Michael addition of 
methyl methacrylate onto L-PEI. The methacrylate reacted with the amine groups and subsequently, the 
ester groups  could be either amidated or hydrolysed. This approach showed similarities with the 
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amidation reaction discussed in chapter 6 where methyl ester were formed and used for an amidation 
reaction186 In a similar approach the polymer could change its charge by hydrolysing the ester, before 
hydrolysis the polymer was cationic and afterward it became a partial zwitterion.187 PEI grafted on 
polystyrene was used to react with acrylic acid by Michael addition.112 The coupling of a histidinylated 
LPEI was achieved by coupling a methacrylate modified histidine.188 
 
1.9 Post-polymerisation modification of 
poly(2-oxazoline)-poly(ethylene imine) 
copolymers 
The copolymers obtained by the partial hydrolysis of PAOx contain the reactive secondary amines with 
nucleophilic properties. These copolymers can be used in gene transfection however they are valuable 
precursors in the synthesis of new PAOx copolymers. The use and post-polymerisation modification of 
copolymers has some great advantages relative to new monomer synthesis. First of all, new monomers 
have to be synthesised which is a large burden from both synthetic and purification point of view. Often 
the polymer distribution is not controllable as it can change depending on the reactivity of the monomers 
and the solubility rate of the new polymers. The introduction of new monomer groups make it difficult to 
obtain well defined polymers with narrow dispersity. Some groups, especially the nucleophilic groups, 
need to be protected as they could interfere with the CROP. The polymerisation of EtOx, MeOx and PrOx 
is highly optimized and these polymers are easily accessible in great quantities, larger MW and low Đ.189 
By submitting these homopolymers to a partial hydrolysis a controlled amount of secondary amino groups 
can be introduced. This was discussed in the part of the partial hydrolysis of PAOx (chapter 1-6), there is 
a control of both the amount of PEI and the reaction speed. Difficulties can appear when the reaction is 
not complete, however this does not occur that often and can prevented by using excess of reagent. 
Different copolymer of PAOx-PEI are used in a broad range of applications such as hydrogels. 
 
PMeOx-hydrogels were developed by partial hydrolysis followed by the DCC coupling to modify the 
polymers with an anthracene containing a disulfide bond. A redox and photosensitive gel was formed with 
a bridged system by coupling of two anthracene moieties (Figure 1-4).190 The same polymer was also used 
for the formation of a disulfide containing hydrogel which was formed after reductive gelation, the 
anthracene was a leaving group to expose the SH groups. The gel formation was induced by the oxidative 
conditions forming the new S-S bonds out of the SH groups. In the same publication other bifunctional 
disulfide cross linkers were used: 3,3’dithiodipropanoic acid, the acid chloride of 3,3’dithiodipropanoic 
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acid and an isocyanate. Due to the presence of the disulfide bridge, reductive conditions such as sodium 
borohydride or triphenylphosphine were used to degrade the hydrogels and obtain the linear polymers.191 
The same author used the functional group bipyrydyl to modify PAOx, making a thermally and redox 
reversible hydrogel with either Mn2+, Fe2+ or Co2+. The coupling was done via the DCC coupling as 
described before.192–194 Different types of hydrogels were synthesised by using PMeOx-PEI and react them 
with hexamethylene diisocyanate or diacid chloride(adipoylchloride) as a cross linker.100 A hydrogel was 
also developed by using a coumarin dye which was coupled via DCC coupling to the PEI part. The 
coumarin dye can photo reversibly form a cyclobutane ring with another coumarin dye inducing 
gelation.99 From the same authors, hydrogels were reported by the Diels Alder reaction between 
maleimide modified PMeOx and a furan modified polymer, both were prepared via DCC coupling of the 
reactive moieties onto the L-PEI.195 Also a DCC coupling onto carbon nanotubes containing carboxylic 
acids was shown with PMeOx-PEI.196 
 
 
 
Figure 1-4 Post-polymerisation modification of PMeOx forming an anthracene bridged system 
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Similar as with PEI homopolymer the amine on the backbone can be used as reactant for coupling of 
nucleotides for example via a DCC coupling of thymine propionic acid.171 For the synthesis of fluorescent 
PAOx, pyrene was coupled to both PMeOx and PEtOx. The pyrene contained a carboxyl functionality 
which was then coupled via N,N-diisopropylcarbodiimide (DIC) coupling. In the same publication also 
gels were made via crosslinking with hexamethylene diisocyanate in the presence of (1,8-
diazabicycloundec-7-ene) (DBU).197 Lecommandoux and coworkers found a method for making hydrogels 
starting from PEtOx-PEI. The cross linker used was a bisglycidyl ether (1,6 hexanediol diglycidyl ether) 
with two epoxides. These epoxides are attacked by the amine.198 A similar approach was used for the 
formation of a degradable hydrogel by using hydroxyethyl disulfide-bis-di-glycidyl ether. These nanogels 
showed also a dual character as the addition of an acid protonated the PEI present and induced a swelling 
while the addition of a reductive agent cleaved the nanogel by breaking the S-S bond.199 
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1.10 Goal of the thesis 
The use of polymers in biomedical applications shows a huge potential in improving and developing 
therapeutic strategies.3,200,201 Three classes of polymers can be distinguished based on size; a macroscopic 
class, microscopic class and a nanosized class.2 The polymer itself plays a different role depending on the 
size. The macroscopic class contains implantable medical devices, artificial organs, prostheses, 
applications for dentistry, bone repair or hydrogels202 either as the object itself or as coating203 against the 
immune system.6,204 The micro class includes micro particles, implants for slow release205 and 
microgels.46,206,207 In the nano class, drug delivery plays an important role and polymers can be used as 
polymer therapeutics. In this class the polymer acts as a vehicle for the drug/active compound making it 
invisible to the body or improving its solubility in water.3,21,208 The nano class is highlighted in this thesis 
as PAOx is mainly involved in this class of polymer therapeutics including polymer-drug conjugates, 
polymeric micelles and polymer-protein conjugates (Figure 1-1 and Figure 1-3 ) PEI, that originates from 
PAOx, plays and important role in gene transfer as it can form polyplexes with genetic material. 
The polymer materials used need to be biocompatible, suppress nonspecific protein adsorption and not 
induce an inflammatory response.209,210 The stealth behaviour, i.e being unrecognized by the immune 
system, is important as it increases the bioavailability of the bioactive compound and reduces the side 
effects. This stealth behavior is allied with the specific protein adsorption, which guarantees no 
immunological responses. The choice of polymers is therefore of vast importance as this affects the 
properties of the conjugate. PAOx (co)polymers show a great potential in the field of polymer therapeutics 
as they show stealth effect and are biocompatible, which is similar to PEG while the synthetic and 
structural versatility of PAOx is much higher. 
Next to the biological properties, the biomedical polymers give the possibility for chemical modification. 
The polymer can act as a platform for the coupling of bioactive molecules, ranging from proteins, drugs, 
nucleic acids and imaging agents. PAOx was chosen in this doctorate because this class of polymers shows 
a large chemical modification potential and versatility in potentially coupled groups, including great 
orthogonality. The PAOx polymers can be modified via three different pathways. The first method utilises 
the end groups to introduce functionalities, both at the initiation and termination side. The second 
method utilise the polymerisation to introduce functional groups by copolymerisation with functional or 
alkyl monomers. In the last modification method a post polymerisation modification is possible herewith 
modifying the side chains of the polymer, the end group or doing a hydrolysis of the side chain. During 
the hydrolysis amines are introduced on the backbone which can further be modified via numerous 
reactions. The hydrolysis can either be complete yielding L-PEI or can be partially to obtain the PAOx-
PEI. Even though the end group modification and synthesis of new monomers is important however the 
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focus of this work lays on post polymerisation modification and hydrolysis of PAOx into L-PEI or PAOx-
PEI copolymers. 
The synthesis of L-PEI is based on either an acid or basic hydrolysis to cleave of the side chain of the 
PAOx releasing the carboxylic acid. The basic hydrolysis of PAOx is not straightforward as it degrades the 
backbone partially, therefore the acid hydrolysis was chosen as preferred method.91,98,195 Next to the full 
hydrolysis of PAOx the partial hydrolysis of PAOx can be of vast importance for the field. The new polymer 
obtained after hydrolysis contains two major parts, the first parts still contains the original PAOx with all 
of its interesting biological properties, the second part is the amine part. This can be used as a gene 
transfection agent or as a chemical modification platform. Indeed the amines in the PEI units can act as a 
nucleophile to react with all kinds of chemical functionalities ranging from epoxides, acid chlorides, 
carboxylic acids, etc. Using the hydrolysis approach to introduce functionalities has great benefits relative 
to a polymerisation approach. First of all the synthesis of the starting PAOx polymers, often PEtOx and 
PMeOx, is optimized and polymers with narrow Đ and high molecular weight can be found 
commercially.189 The multiple purification steps and the need of water free environments makes it hard 
to introduce the polymerisation of new oxazoline monomers into non specialized labs. This disadvantage 
is overcome by the straightforward coupling onto the secondary amine of PAOx-PEI. Therefore we further 
investigated the potential of the PAOx-PEI platform, especially the PEtOx-PEI platform. We focused on 
the introduction of bioactive functionalities which can then be used in a biomedical context. 
To explore the PEtOx-PEI platform, a detailed understanding of the systems is needed. The mechanism 
and kinetics of the acid hydrolysis were investigated in many occasions,91,102,103,109 although the copolymer 
distribution along the chain was never thoroughly investigated. Therefore, in chapter 2 a detailed 
investigation is reported to unravel the distribution of PEI-units in PAOx-PEI copolymers. This 
distribution could be randomly or block like and is important as its influences the composition of the new 
copolymer and its further reactivity. Answering this question will give valuable information for further 
chemical modification and gene transfection properties. The use of titration would introduce difficulties 
for unambiguous interpretation and thus a thorough examination via NMR spectroscopy was performed. 
Polymers such as PMeOx, PEtOx, and PPhOx are often used in hydrolysis experiments but no 
description was given for the hydrolysis of PPrOx. The hydrolysis of PPrOx was explored in chapter 3. This 
polymer is no first choice as it has a Tcp around 25°C. Above this temperature the polymer becomes 
insoluble and crashes out of solution, which may influence the hydrolysis rate at elevated temperatures. 
However if the hydrolysis could be successful the introduction of the amine units along the chain could 
influence the resulting Tcp. The use of viral vectors for gene transfection is still superiorly compared to 
non-viral gene vectors. Therefore there is a constant search for better non-viral systems. The introduction 
of PEI units makes it possible for the PPrOx-PEI polymers to interact with DNA to form polyplexes, which 
will also be discussed in chapter 3. 
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By fully understanding the copolymer distribution, the chemical toolbox of PEtOx-PEI can be expanded. 
In chapter 4 carbamates are formed by using the well-known reaction between an amine and CO2. This 
reaction forms zwitterionic carbamates with fluorescent properties due to the presence of the lowest 
unoccupied molecular orbital (LUMO) and highest occupied molecular orbital (HOMO) in proximity on 
the carbamate. Earlier reports already showed that the b-PEI and CO2 can react. However the b-PEI has 
the higher reactive primary amines.211 Prior, the reaction of L-PEI and CO2 was explored in the context of 
gas scrubbers. Exploring this reaction further for making fluorescent PAOx or L-PEI is of great interest as 
this potentially could expand the toolbox and only a few fluorescent PAOx derivates are known none of 
which have intrinsic fluorescence.  
As mentioned before PAOx could play an important role for polymer therapeutics. The coupling of a 
bioactive compound onto the polymer is often performed by using “click chemistry”. The development of 
new methods to couple the bioactive molecules onto a platform has to be explored and one of these 
methods is shown in chapter 5. To ensure a large versatility, four different linkers where chosen to link 
the polymer and the bioactive molecule. The linker carries on the one hand a part which can react with 
the amine and on the other hand a methyl ester. This methyl ester is a latent functionality and coupling 
of the bioactive linker onto the platform can be performed via an amidation reaction between the methyl 
ester and an amine present on the molecule. However the reaction needs to be optimized first and 
therefore different kind of amines where chosen to react with the ester to form various amides. 
In chapter 6 a further expansion of the toolbox is demonstrated for the coupling of carbohydrates. It is 
needless to say that carbohydrates play a crucial role in all kind of different biological processes and 
signaling pathways and are thus crucial part of a living organism. Therefore a method was developed 
which was already successful on b-PEI, the reductive amination. This amination uses the aldehyde on the 
ring opened version of the carbohydrate to couple to the amine. The reaction is developed for simple 
carbohydrates such as maltose and glucose. The biological properties and solution behavior are examined 
and discussed. 
  
  
  
 
 
41 
 
CHAPTER 1 
1.11 References  
(1)  Wang, Y.-X.; Robertson, J. L.; Spillman, W. B.; Claus, R. O. Pharm. Res. 2004, 21 (8), 1362. 
(2)  Duncan, R. Nat. Rev. Drug Discov. 2003, 2 (5), 347. 
(3)  Duncan, R.; Vicent, M. J. Adv. Drug Deliv. Rev. 2013, 65 (1), 60. 
(4)  Barz, M.; Luxenhofer, R.; Zentel, R.; Vicent, M. J. Polym. Chem. 2011, 2 (9), 1900. 
(5)  Qi, Y.; Chilkoti, A. Curr. Opin. Chem. Biol. 2015, 28, 181. 
(6)  Merkle, H. P. Eur. J. Pharm. Biopharm. 2015, 97, 293. 
(7)  Kwoh, D. Y.; Coffin, C. C.; Lollo, C. P.; Jovenal, J.; Banaszczyk, M. G.; Mullen, P.; Phillips, A.; Amini, 
A.; Fabrycki, J.; Bartholomew, R. M.; Brostoff, S. W.; Carlo, D. J. Biochim. Biophys. Acta 1999, 1444 
(2), 171. 
(8)  Konradi, R.; Pidhatika, B.; Mühlebach, A.; Textor, M. Langmuir 2008, 24 (3), 613. 
(9)  Singer, J. W.; Baker, B.; De Vries, P.; Kumar, A.; Shaffer, S.; Vawter, E.; Bolton, M.; Garzone, P. Adv. 
Exp. Med. Biol. 2003, 519 (L), 81. 
(10)  Duncan, R. Nat. Rev. Cancer 2006, 6 (9), 688. 
(11)  Weeratunga, G.; Horne, S. WO2004043995A2, 2004. 
(12)  Plone, M. A.; Petersen, J. S.; Rosenbaum, D. P.; Burke, S. K. Clin. Pharmacokinet 2002, 41 (7), 517. 
(13)  Maeda, H.; Ueda, M.; Morinaga, T.; Matsumoto, T. J. Med. Chem. 1985, 28, 455. 
(14)  Goel, N.; Stephens, S. Landes Biosci. 2014, 2 (2), 137. 
(15)  Nowotnik, D. P.; Cvitkovic, E. Adv. Drug Deliv. Rev. 2009, 61 (13), 1214. 
(16)  Yurkovetskiy, A. V.; Fram, R. J. Adv. Drug Deliv. Rev. 2009, 61 (13), 1193. 
(17)  Verbraeken, B. K. H. R. In Encyclopedia of Polymer Science and Technology; 2014; pp 1–39. 
(18)  He, Z.; Wan, X.; Schulz, A.; Bludau, H.; Dobrovolskaia, M. A.; Stern, S. T.; Montgomery, S. A.; Yuan, 
H.; Li, Z.; Alakhova, D.; Sokolsky, M.; Darr, D. B.; Perou, C. M.; Jordan, R.; Luxenhofer, R.; Kabanov, 
A. V. Biomaterials 2016, 101, 296. 
(19)  Koshkina, O.; Lang, T.; Thiermann, R.; Docter, D.; Stauber, R. H.; Secker, C.; Schlaad, H.; Weidner, 
S.; Mohr, B.; Maskos, M.; Bertin, A. Langmuir 2015, 31 (32), 8873. 
(20)  Bailon, P.; Won, C. Expert Opin. Drug Deliv. 2009, 6, 1. 
(21)  Duncan, R.; Gaspar, R. Mol. Pharm. 2011, 8 (6), 2101. 
(22)  Schöttler, S.; Becker, G.; Winzen, S.; Steinbach, T.; Mohr, K.; Landfester, K.; Mailänder, V.; Wurm, 
F. R. Nat. Nanotechnol. 2016, 11 (February), 1. 
(23)  Armstrong, J. K.; Hempel, G.; Koling, S.; Chan, L. S.; Fisher, T.; Meiselman, H. J.; Garratty, G. Cancer 
2007, 110 (1), 103. 
(24)  Pasut, G.; Veronese, F. M. Adv. Drug Deliv. Rev. 2009, 61 (13), 1177. 
(25)  Koshkina, O.; Westmeier, D.; Lang, T.; Bantz, C.; Hahlbrock, A.; Würth, C.; Resch-Genger, U.; 
Braun, U.; Thiermann, R.; Weise, C.; Eravci, M.; Mohr, B.; Schlaad, H.; Stauber, R. H.; Docter, D.; 
Bertin, A.; Maskos, M. Macromol. Biosci. 2016, No. 16, 1287. 
(26)  Luxenhofer, R.; Han, Y.; Schulz, A.; Tong, J.; He, Z.; Kabanov, A. V; Jordan, R. Macromol. Rapid 
Commun. 2012, 33, 1613. 
(27)  Luxenhofer, R.; Han, Y.; Schulz, A.; Tong, J.; He, Z.; Kabanov, A. V; Jordan, R. Macromol. Rapid 
Commun. 2012, 33 (19), 1613. 
(28)  Luxenhofer, R.; Sahay, G.; Schulz, A.; Alakhova, D.; Bronich, T. K.; Jordan, R.; Kabanov, A. V. J. 
Control. Release 2011, 153 (1), 73. 
(29)  Mero, A.; Fang, Z.; Pasut, G.; Veronese, F. M.; Viegas, T. X. J. Control. Release 2012, 159 (3), 353. 
(30)  Tauhardt, L.; Pretzel, D.; Kempe, K.; Gottschaldt, M.; Pohlers, D.; Schubert, U. S. Polym. Chem. 
  
 
42 
 
CHAPTER 1 
2014, 5 (19), 5751. 
(31)  Mansfield, E. D. H.; Sillence, K.; Hole, P.; Williams, A. C.; Khutoryanskiy, V. V. Nanoscale 2015, 7 
(32), 13671. 
(32)  Bludau, H.; Czapar, A. E.; Pitek, A. S.; Shukla, S.; Jordan, R.; Steinmetz, N. F. Eur. Polym. J. 2016, 1. 
(33)  Xili, T.; District, D.; District, H. Chem. Pharm. Bull. Adv. Publ. 2013. 
(34)  Naka, K.; Nakamura, T.; Ohki, A.; Maeda, S. Macromol. Chem. Phys. 1997, 198 (1), 101. 
(35)  Donev, R.; Koseva, N.; Petrov, P.; Kowalczuk, A.; Thome, J. World J. Biol. Psychiatry 2011, 12 (S1), 
44. 
(36)  Zhang, N.; Pompe, T.; Amin, I.; Luxenhofer, R.; Werner, C.; Jordan, R. Macromol. Biosci. 2012, 12 
(7), 926. 
(37)  Dworak, A.; Utrata-Wesołek, A.; Oleszko, N.; Wałach, W.; Trzebicka, B.; Anioł, J.; Sieroń, A. L.; 
Klama-Baryła, A.; Kawecki, M. J. Mater. Sci. Mater. Med. 2014, 25 (4), 1149. 
(38)  Wang, H.; Li, L.; Tong, Q.; Yan, M. ACS Appl. Mater. Interfaces 2011, 3 (9), 3463. 
(39)  Pidhatika, B.; Rodenstein, M.; Chen, Y.; Rakhmatullina, E.; Mühlebach, A.; Acikgöz, C.; Textor, M.; 
Konradi, R. Biointerphases 2012, 7 (1–4). 
(40)  Zalipsky, S.; Hansen, C. B.; Oaks, J. M.; Allen, T. M. J. Pharm. Sci. 1996, 85 (2), 133. 
(41)  Waschinski, C. J.; Tiller, J. C. Biomacromolecules 2005, 6 (1), 235. 
(42)  Correia, V. G.; Bonifácio, V. D. B.; Raje, V. P.; Casimiro, T.; Moutinho, G.; da Silva, C. L.; Pinho, M. 
G.; Aguiar-Ricardo, A. Macromol. Biosci. 2011, 11 (8), 1128. 
(43)  Gonzalez-Perez, A.; Feld, K.; Ruso, J. M. J. Polym. Res. 2016, 23 (9), 1. 
(44)  Bender, J.; Boerman, M. a. TISSUE-ADHESIVE POROUS HAEMOSTATIC, 2016. 
(45)  Mees, M. A.; Hoogenboom, R. Macromolecules 2015, 48 (11), 3531. 
(46)  Kelly, A. M.; Wiesbrock, F. Macromol. Rapid Commun. 2012, 33 (19), 1632. 
(47)  Hartlieb, M.; Kempe, K.; Schubert, U. S. J. Mater. Chem. B 2015, 3 (4), 526. 
(48)  Dargaville, T. R.; Hollier, B. G.; Shokoohmand, A.; Hoogenboom, R. Cell Adhes. Migr. 2014, 8 (2), 
88. 
(49)  Farrugia, B. L.; Kempe, K.; Schubert, U. S.; Hoogenboom, R.; Dargaville, T. R. Biomacromolecules 
2013, 14 (8), 2724. 
(50)  Wang, X.; Li, X.; Li, Y.; Zhou, Y.; Fan, C.; Li, W.; Ma, S.; Fan, Y.; Huang, Y.; Li, N.; Liu, Y. Acta 
Biomater. 2011, 7 (12), 4149. 
(51)  Wang, C. H.; Hwang, Y. S.; Chiang, P. R.; Shen, C. R.; Hong, W. H.; Hsiue, G. H. Biomacromolecules 
2012, 13 (1), 40. 
(52)  Kostova, B.; Ivanova-Mileva, K.; Rachev, D.; Christova, D. AAPS PharmSciTech 2013, 14 (1), 352. 
(53)  El-Hag Ali, A.; AlArifi, A. S. J. Appl. Polym. Sci. 2011, 120, 3071. 
(54)  Hartlieb, M.; Pretzel, D.; Englert, C.; Hentschel, M.; Kempe, K.; Gottschaldt, M.; Schubert, U. S. 
Biomacromolecules 2014, 15 (6), 1970. 
(55)  Lück, S.; Schubel, R.; Rüb, J.; Hahn, D.; Mathieu, E.; Zimmermann, H.; Scharnweber, D.; Werner, 
C.; Pautot, S.; Jordan, R. Biomaterials 2016, 79, 1. 
(56)  Eskow Jaunarajs, K. L.; Standaert, D. G.; Viegas, T. X.; Bentley, M. D.; Fang, Z.; Dizman, B.; Yoon, 
K.; Weimer, R.; Ravenscroft, P.; Johnston, T. H.; Hill, M. P.; Brotchie, J. M.; Moreadith, R. W. Mov. 
Disord. 2013, 0 (0), 2. 
(57)  Tong, J.; Luxenhofer, R.; Yi, X.; Jordan, R. Mol. Pharm. 2010, 7 (5), 984. 
(58)  Velander, W. H.; Madurawe, R. D.; Subramanian, A.; Kumar, G.; Sinai-Zingde, G.; Riffle, J. S.; 
Orthner, C. L. Biotechnol. Bioeng. 1992, 39 (1992), 1024. 
(59)  Manzenrieder, F.; Luxenhofer, R.; Retzlaff, M.; Jordan, R.; Finn, M. G. Angew. Chemie - Int. Ed. 2011, 
50 (11), 2601. 
  
 
 
43 
 
CHAPTER 1 
(60)  Broz, P.; Benito, S. M.; Saw, C. L.; Burger, P.; Heider, H.; Pfisterer, M.; Marsch, S.; Meier, W.; 
Hunziker, P. J. Control. Release 2005, 102 (2), 475. 
(61)  Farkaš, P.; Korcová, J.; Kronek, J.; Bystrický, S. Eur. J. Med. Chem. 2010, 45 (2), 795. 
(62)  Broz, P.; Ben-Haim, N.; Grzelakowski, M.; Marsch, S.; Meier, W.; Hunziker, P. J. Cardiovasc. 
Pharmacol. 2008, 51 (3), 246. 
(63)  Viegas, T. X.; Bentley, M. D.; Harris, J. M.; Fang, Z.; Yoon, K.; Dizman, B.; Weimer, R.; Mero, A.; 
Pasut, G.; Veronese, F. M. Bioconjug. Chem. 2011, 22 (5), 976. 
(64)  Li, J.; Zhou, Y.; Li, C.; Wang, D.; Gao, Y.; Zhang, C.; Zhao, L.; Li, Y.; Liu, Y.; Li, X. Bioconjug. Chem. 
2015, 26 (1), 110. 
(65)  Yi, X.; Kabanov, A. V. J. Drug Target. 2013, 21 (10), 940. 
(66)  Schulz, A.; Jaksch, S.; Schubel, R.; Wegener, E.; Di, Z.; Han, Y.; Meister, A.; Kabanov, A. V; 
Luxenhofer, R.; Papadakis, X. C. M.; Jordan, R. ACS Nano 2014, 8 (3), 2686. 
(67)  Seo, Y.; Schulz, A.; Han, Y.; He, Z.; Bludau, H.; Wan, X.; Tong, J.; Bronich, T. K.; Sokolsky, M.; 
Luxenhofer, R.; Jordan, R.; Kabanov, A. V. Polym. Adv. Technol. 2015, 26 (7), 837. 
(68)  Luxenhofer, R.; Schulz, A.; Roques, C.; Li, S.; Bronich, T. K.; Batrakova, E. V.; Jordan, R.; Kabanov, 
A. V. Biomaterials 2010, 31 (18), 4972. 
(69)  Han, Y.; He, Z.; Schulz, A.; Bronich, T. K.; Jordan, R.; Luxenhofer, R.; Kabanov, A. V. Mol. Pharm. 
2012, 9 (8), 2302. 
(70)  Schulz, A.; Han, Y.; He, Z.; Bronich, T. K.; Kabanov, A. V.; Luxenhofer, R.; Jordan, R. Polym. Prepr. 
2012, 53 (1), 305. 
(71)  Yan, L.; Qiu, L. Nanomedicine 2015, 10, 361. 
(72)  Knop, K.; Pretzel, D.; Urbanek, A.; Rudolph, T.; Scharf, D. H.; Schallon, A.; Wagner, M.; Schubert, 
S.; Kiehntopf, M.; Brakhage, A. A.; Schacher, F. H.; Schubert, U. S. Biomacromolecules 2013, 14 (8), 
2536. 
(73)  Wang, C. H.; Wang, C. H.; Hsiue, G. H. J. Control. Release 2005, 108 (1), 140. 
(74)  Hsiue, G. H.; Wang, C. H.; Lo, C. L.; Wang, C. H.; Li, J. P.; Yang, J. L. Int. J. Pharm. 2006, 317 (1), 69. 
(75)  Lee, S. C.; Kim, C.; Kwon, I. C.; Chung, H.; Jeong, S. Y. J. Control. Release 2003, 89 (3), 437. 
(76)  Guillerm, B.; Darcos, V.; Lapinte, V.; Monge, S.; Coudane, J.; Robin, J.-J. Chem. Commun. (Camb). 
2012, 48 (23), 2879. 
(77)  Kempe, K.; Vollrath, A.; Schaefer, H. W.; Poehlmann, T. G.; Biskup, C.; Hoogenboom, R.; Hornig, 
S.; Schubert, U. S. Macromol. Rapid Commun. 2010, 31 (21), 1869. 
(78)  Kagiya, T.; Maeda, T.; Fukui, K.; Narisawa, S. Polym. Lett. 1966, 4, 441. 
(79)  Seeliger, W.; Aufderhaar, E.; Diepers, W.; Feinauer, R.; Nehring, R.; Thier, W.; Hellmann, H. 
Angew. Chem. Int. Ed. Engl. 1966, 5 (10), 875. 
(80)  Tomalia, D. a; Sheetz, D. P. J. Polym. Sci. Part A-1 Polym. Chem. 1966, 4 (9), 2253. 
(81)  Levy, A.; Litt, M. Polym. Lett. 1967, 5, 881. 
(82)  Lee, M. S.; Kim, M. G.; Jang, Y. L.; Lee, K.; Kim, T. G.; Kim, S. H.; Park, T. G.; Kim, H. T.; Jeong, J. 
H. Macromol. Res. 2011, 19 (7), 688. 
(83)  Kobayashi, S. Prog. Polym. Sci. 1990, 15 (5), 751. 
(84)  Kobayashi, S.; Hiroishi, K.; Tokunoh, M.; Saegusa, T. Macromolecules 1987, 20, 1496. 
(85)  Mannschott, C.; Hockera, H.; Kern, W. Makromoleculair Chem. 1981, 1350, 1337. 
(86)  Munir, A.; Goethals, E. J. Journa Polym. Sci. 1994, 19 (1981), 1985. 
(87)  Kern, W.; Mannschott, C.; H, H. Makromoleculair Chem. 1982, 183, 1413. 
(88)  Weyts, K. R.; Goethals, E. J. Polym. Bull. 1988, 19, 13. 
(89)  Weyts, K.; Goethals, E. Die Makromol. Chemie, Rapid Commun. 1989, 10, 299. 
(90)  Lee, H.; Son, S. H.; Sharma, R.; Won, Y.; Ei-r-eoz, P. P.; Lee, H.; Son, S. H.; Sharma, R.; Won, Y. J. 
  
 
44 
 
CHAPTER 1 
Phys. Chem. B 2011, 115, 844. 
(91)  Kem, K. M. J. Polym. Sci. Polym. Chem. Ed. 1979, 17, 1977. 
(92)  Herlem, G.; Lakard, B. J. Chem. Phys. 2004, 120 (19), 9376. 
(93)  Ziebarth, J. D.; Wang, Y. Biomacromolecules 2010, 11 (1), 29. 
(94)  Smits, R. G.; Koper, G. J. M.; Mandel, M. J. Phys. Chem. 1993, 97 (21), 5745. 
(95)  Saegusa, T.; Fujii, H.; Ikeda, H. Macromolecules 1972, 37 (1), 108. 
(96)  Tanaka, R.; Ueoka, I.; Takaki, Y.; Kataoka, K.; Saito, S. Macromolecules 1983, 16 (2), 849. 
(97)  Monnery, B. D.; Shaunak, S.; Thanou, M.; Steinke, J. H. G. Macromolecules 2015, 48 (10), 3197. 
(98)  Saegusa, T.; Kobayashi, S.; Yamada, A. Macromolecules 1975, 8 (4), 390. 
(99)  Chujo, Y.; Sada, K.; Saegusa, T. Macromolecules 1990, 23 (10), 2693. 
(100)  Chujo, Y.; Yutaka, Y.; Sada, K.; Saegusa, T. Macromolecules 1989, 22 (3), 1074. 
(101)  Lambermont-Thijs, H. M. L.; Heuts, J. P. A.; Hoeppener, S.; Hoogenboom, R.; Schubert, U. S. 
Polym. Chem. 2011, 2 (2), 313. 
(102)  de la Rosa, V. R.; Bauwens, E.; Monnery, B. D.; De Geest, B. G.; Hoogenboom, R. Polym. Chem. 
2014, 5, 4957. 
(103)  Van Kuringen, H. P. C.; Lenoir, J.; Adriaens, E.; Bender, J.; De Geest, B. G.; Hoogenboom, R. 
Macromol. Biosci. 2012, 12 (8), 1114. 
(104)  Mees, M.; Haladjova, E.; Momekova, D.; Momekov, G.; Shestakova, P. S.; Tsvetanov, C. B.; 
Hoogenboom, R.; Rangelov, S. Biomacromolecules 2016, 17 (11), 3580. 
(105)  Lambermont-Thijs, H. M. L.; van der Woerdt, F. S.; Baumgaertel, A.; Bonami, L.; Du Prez, F. E.; 
Schubert, U. S.; Hoogenboom, R. Macromolecules 2010, 43 (2), 927. 
(106)  Litt, M. H.; Lin, C. S. J. Polym. Sci. Part A-1 Polym. Chem. 1992, 30, 779. 
(107)  Jeong, J. H.; Song, S. H.; Lim, D. W.; Lee, H.; Park, T. G. J. Control. release  2001, 73 (2–3), 391. 
(108)  Vlassi, E.; Pispas, S. Macromol. Chem. Phys. 2015, 216, 873. 
(109)  Van Kuringen, H. P. C.; De La Rosa, V. R.; Fijten, M. W. M.; Heuts, J. P. A.; Hoogenboom, R. 
Macromol. Rapid Commun. 2012, 33 (9), 827. 
(110)  Jin, R. H. ChemPhysChem 2003, 4 (10), 1118. 
(111)  von Zelewsky, A.; Barbosa, L.; Schläpfer, C. W. Coord. Chem. Rev. 1993, 123, 229. 
(112)  Saegusa, T.; Kobayashi, S.; Yamada, A. J. Appl. Polym. Sci. 1977, 21, 2481. 
(113)  Lazaro-Martinez, J. M.; Rodriguez-Castellon, E.; Vega, D.; Monti, G. A.; Chattah, A. K. 
Macromolecules 2015, 48 (4), 1115. 
(114)  Harris, C. S.; Ratner, M. A.; Shriver, D. F. Macromolecules 1987, 20 (17), 1778. 
(115)  Llanos, J.; Camarillo, R.; Pérez, A.; Canizares, P. Sep. Purif. Technol. 2010, 73 (2), 126. 
(116)  Doyle, R. P.; Chen, X.; Macrae, M.; Srungavarapu, A.; Smith, L. J.; Gopinadhan, M.; Osuji, C. O.; 
Granados-Focil, S. Macromolecules 2014, 47 (10), 3401. 
(117)  Sayari, A.; Heydari-Gorji, A.; Yang, Y. J. Am. Chem. Soc. 2012, 134 (33), 13834. 
(118)  Tang, Q.; Cheng, F.; Lou, X.-L.; Liu, H.-J.; Chen, Y. J. Colloid Interface Sci. 2009, 337 (2), 485. 
(119)  Yang, Z.; Coutinho, D. H.; Yang, D. J.; Balkus, K. J.; Ferraris, J. P. J. Memb. Sci. 2008, 313 (1–2), 91. 
(120)  Bradbury, R.; Penfold, J.; Thomas, R. K.; Tucker, I. M.; Petkov, J. T.; Jones, C. J. Colloid Interface Sci. 
2016, 466, 220. 
(121)  Mulligan, R. C. Science (80-. ). 1993, 260 (5110), 926. 
(122)  Won, Y. Y.; Sharma, R.; Konieczny, S. F. J. Control. Release 2011, 152 (2), 326. 
(123)  Sung, L.-Y.; Chen, C.-L.; Lin, S.-Y.; Li, K.-C.; Yeh, C.-L.; Chen, G.-Y.; Lin, C.-Y.; Hu, Y.-C. Nat. Protoc. 
2014, 9, 1882. 
(124)  Hacein-Bey-Abina, S.; von Kalle, C.; Schmidt, M.; Mcormack, M. P.; Wulfraat, N.; Lebouch, P.; Lim, 
  
 
 
45 
 
CHAPTER 1 
A.; Osborne, C. .; PAwliuk, R.; Morillon, E.; Sorensen, R.; Forster, A.; Fraser, P.; Cohen, J. I.; de Saint 
Basile, G.; Alexander, I.; Wintergerst, U.; Febrourg, T.; Aurias, A.; Stoppa-Lyonnet, D.; Romana; 
Radford-Weiss, I.; Gross, F.; Valensi, F.; Delabesse, E.; Macintyre, E.; Sigaux, F.; Soulier, J.; Fischer, 
A.; Cavazzano-Calvo, M. Science (80-. ). 2003, 302 (5644), 415. 
(125)  Raper, S. E.; Chirmule, N.; Lee, F. S.; Wivel, N. A.; Bagg, A.; Gao, G. P.; Wilson, J. M.; Batshaw, M. 
L. Mol. Genet. Metab. 2003, 80 (1–2), 148. 
(126)  Check, E. Nature 2002, 420 (6912), 116. 
(127)  Merten, O. W.; Gaillet, B. Biochem. Eng. J. 2016, 108, 98. 
(128)  Konishi, M.; Kawamoto, K.; Izumikawa, M.; Kuriyama, H.; Yamashita, T. J. Gene Med. 2008, 10 (6), 
610. 
(129)  Meyer, O.; Kirpotin, D.; Hong, K.; Sternberg, B.; Park, J. W.; Woodle, M. C.; Papahadjopoulos, D. 
J. Biol. Chem. 1998, 273 (25), 15621. 
(130)  Sato, Y.; Hatakeyama, H.; Sakurai, Y.; Hyodo, M.; Akita, H.; Harashima, H. J. Control. Release 2012, 
1. 
(131)  von Erlach, T.; Zwicker, S.; Pidhatika, B.; Konradi, R.; Textor, M.; Hall, H.; Lühmann, T. 
Biomaterials 2011, 32 (22), 5291. 
(132)  Mintzer, M. A.; Simanek, E. E. Chem. Rev. 2009, 109 (2), 259. 
(133)  Chen, Y.; Zhou, L.; Pang, Y.; Huang, W.; Qiu, F.; Jiang, X.; Zhu, X.; Yan, D.; Chen, Q. Bioconjug. 
Chem. 2011, 22 (6), 1162. 
(134)  Lai, W.-F. Biomaterials 2013, 35 (1), 401. 
(135)  Forrest, M. L.; Gabrielson, N.; Pack, D. W. Biotechnol. Bioeng. 2005, 89 (4), 416. 
(136)  Yue, Y.; Wu, C. Biomater. Sci. 2013, 152. 
(137)  Rinkenauer, A. C.; Vollrath, A.; Schallon, A.; Tauhardt, L.; Kempe, K.; Schubert, S.; Fischer, D.; 
Schubert, U. S. ACS Comb. Sci. 2013, 15 (9), 475. 
(138)  Neuberg, P.; Kichler, A. Recent developments in nucleic acid delivery with polyethylenimines; 
Elsevier, 2014; Vol. 88. 
(139)  Jäger, M.; Schubert, S.; Ochrimenko, S.; Fischer, D.; Schubert, U. S. Chem. Soc. Rev. 2012, 41 (13), 
4755. 
(140)  Ferrari, S.; Moro, E.; Pettenazzo, A.; Behr, J. P.; Zacchello, F.; Scarpa, M. Gene Ther. 1997, 4 (10), 
1100. 
(141)  Coll, J. L.; Chollet, P.; Brambilla, E.; Desplanques, D.; Behr, J. P.; Favrot, M. Hum. Gene Ther. 1999, 
10 (10), 1659. 
(142)  Boussif, O.; Lezoualc’h, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix, B.; Behr, J. P. 
Proc. Natl. Acad. Sci. U. S. A. 1995, 92 (16), 7297. 
(143)  Chollet, P.; Favrot, M. C.; Hurbin, A.; Coll, J. L. J. Gene Med. 2002, 4 (1), 84. 
(144)  Shah, R.; Kronekova, Z.; Zahoranová, A.; Roller, L.; Saha, N.; Saha, P.; Kronek, J. J. Mater. Sci. Mater. 
Med. 2015, 26 (4), 157. 
(145)  Fernandes, J. C.; Qiu, X.; Winnik, F. M.; Benderdour, M.; Zhang, X.; Dai, K.; Shi, Q. Int. J. 
Nanomedicine 2013, 8, 4091. 
(146)  Lin, C.-P.; Sung, Y.-C.; Hsieu, G.-H. J. Med. Biol. Eng. 2012, 32 (5), 365. 
(147)  Hsiue, G.-H.; Chiang, H.-Z.; Wang, C.-H.; Juang, T.-M. Bioconjug. Chem. 2006, 17 (3), 781. 
(148)  Zhang, Y.; Chen, L.; Zhang, C.; Liu, S.; Zhu, H.; Wang, Y. Talanta 2016, 150, 375. 
(149)  Rasolonjatovo, B.; Pitard, B.; Guégan, P.; Cheradame, H. J. Biomater. Nanobiotechnol. 2014, 5, 53. 
(150)  He, Z.; Miao, L.; Jordan, R.; S-Manickam, D.; Luxenhofer, R.; Kabanov, A. V. Macromol. Biosci. 2015, 
15 (7), 1004. 
(151)  Ogris, M.; Walker, G.; Blessing, T.; Kircheis, R.; Wolschek, M.; Wagner, E. J. Control. Release 2003, 
  
 
46 
 
CHAPTER 1 
91 (1–2), 173. 
(152)  Bauhuber, S.; Liebl, R.; Tomasetti, L.; Rachel, R.; Goepferich, A.; Breunig, M. J. Control. Release 
2012, 162 (2), 446. 
(153)  Brissault, B.; Leborgne, C.; Scherman, D.; Guis, C.; Kichler, A. Macromol. Biosci. 2011, 11 (5), 652. 
(154)  Furgeson, D. Y.; Chan, W. S.; Yockman, J. W.; Kim, S. W. Bioconjug. Chem. 2003, 14 (4), 840. 
(155)  Zhao, J.; Yang, L.; Huang, P.; Wang, Z. Y.; Tan, Y.; Liu, H.; Pan, J. J.; He, C. Y.; Chen, Z. Y. J. Colloid 
Interface Sci. 2016, 463, 93. 
(156)  Li, J.; Cheng, D.; Yin, T.; Chen, W.; Lin, Y.; Chen, J.; Li, R.; Shuai, X. Nanoscale 2014, 6 (3), 1732. 
(157)  Lu, H.; Dai, Y.; Lv, L.; Zhao, H. PLoS One 2014, 9 (1). 
(158)  Jiang, H. L.; Kim, Y. K.; Arote, R.; Nah, J. W.; Cho, M. H.; Choi, Y. J.; Akaike, T.; Cho, C. S. J. Control. 
Release 2007, 117 (2), 273. 
(159)  Jorge, A. F.; Morán, M. C.; Vinardell, M. P.; Pereira, J. C.; Dias, R. S.; Pais, A. a. C. C. Soft Matter 
2013, 9 (45), 10799. 
(160)  Pandey, A. P.; Sawant, K. K. Mater. Sci. Eng. C 2016, 68, 904. 
(161)  Kichler, A.; Chillon, M.; Leborgne, C.; Danos, O.; Frisch, B. J. Control. Release 2002, 81 (3), 379. 
(162)  Ochrimenko, S.; Vollrath, A.; Tauhardt, L.; Kempe, K.; Schubert, S.; Schubert, U. S.; Fischer, D. 
Carbohydr. Polym. 2014, 113, 597. 
(163)  Takemoto, K.; Inaki, Y. In Advances in Polymer Science; 1981. 
(164)  Englert, C.; Trützschler, A.-K.; Raasch, M.; Bus, T.; Borchers, P.; Mosig, A. S.; Traeger, A.; Schubert, 
U. S. J. Control. Release 2016, 241, 1. 
(165)  Cheng, L.; Abhilas, K. G.; Breslow, R. Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (32), 12884. 
(166)  Kim, H.; Bae, Y. M.; Kim, H. A.; Hyun, H.; Yu, G. S.; Choi, J. S.; Lee, M. J. Cell. Biochem. 2010, 110 
(3), 743. 
(167)  Pavlisko, J. A.; Overberger, C. G. Journa Polym. Sci. 1981, 19, 1621. 
(168)  Masson, P.; Heinrich, B.; Frère, Y.; Gramain, P. Macromol. Chem. Phys. 1994, 1212, 1199. 
(169)  Lambermont-Thijs, H. M. L.; Bonami, L.; Du Prez, F. E.; Hoogenboom, R. Polym. Chem. 2010, 1 (5), 
747. 
(170)  Ludwick, A. G.; Overberger, C. G. J. Polym. Sci. Polym. Chem. Ed. 1982, 20, 2123. 
(171)  Ludwick, A. G.; Robinson, K. S.; Mccloud, J. J. Polym. Sci. Polym. Symp. 1986, 74 (1), 55. 
(172)  Overberger, C. G.; Kikyotani, S. J. Polym. Sci. Polym. Chem. Ed. 1983, 21 (2), 525. 
(173)  Wada, T.; Inaki, Y.; Takemoto, K. Polym. J. 1988, 20 (1), 1059. 
(174)  Saegusa, T.; Kobayashi, S.; Yamada, A. Polym. J. 1978, 10 (4), 403. 
(175)  Sayari, A.; Belmabkhout, Y. J. Am. Chem. Soc. 2010, 132 (18), 6312. 
(176)  Giffin, G. A.; Castillo, F. Y.; Frech, R.; Glatzhofer, D. T.; Burba, C. M. Polymer (Guildf). 2009, 50 (1), 
171. 
(177)  Glatzhofer, D. T.; Erickson, M. J.; Frech, R.; Yepez, F.; Furneaux, J. E. Solid State Ionics 2005, 176 
(39–40), 2861. 
(178)  Meredith, M. T.; Kao, D.-Y.; Hickey, D.; Schmidtke, D. W.; Glatzhofer, D. T. J. Electrochem. Soc. 
2011, 158 (2), B166. 
(179)  Merchant, S. A.; Iran, T. O.; Meredith, M. T.; Cline, T. C.; Glatzhofer, D. T.; Schmidtke, D. W. 
Langmuir 2009, 25 (13), 7736. 
(180)  Merchant, S. A.; Glatzhofer, D. T.; Schmidtke, D. W. Langmuir 2007, 23 (22), 11295. 
(181)  Merchant, S. A.; Meredith, M. T.; Tran, T. O.; Brunski, D. B.; Johnson, M. B.; Glatzhofer, D. T.; 
Schmidtke, D. W. J. Phys. Chem. C 2010, 114 (26), 11627. 
(182)  Fukuda, Y.; Abe, D.; Tanaka, Y.; Uchida, J.; Suzuki, N.; Miyai, T.; Sasanuma, Y. Polym. J. 2016, 48 
  
 
 
47 
 
CHAPTER 1 
(11), 1065. 
(183)  Englert, C.; Fevre, M.; Wojtecki, R. J.; Cheng, W.; Xu, Q.; Yang, C.; Ke, X.; Hartlieb, M.; Kempe, K.; 
García, J. M.; Ono, R. J.; Schubert, U. S.; Yang, Y. Y.; Hedrick, J. L. Polym. Chem. 2016, 7 (37), 5862. 
(184)  Englert, C.; Hartlieb, M.; Bellstedt, P.; Kempe, K.; Yang, C.; Chu, S. K.; Ke, X.; Garcĺa, J. M.; Ono, R. 
J.; Fevre, M.; Wojtecki, R. J.; Schubert, U. S.; Yang, Y. Y.; Hedrick, J. L. Macromolecules 2015, 48 
(20), 7420. 
(185)  Schroeder, A.; Dahlman, J. E.; Sahay, G.; Love, K. T.; Jiang, S.; Eltoukhy, A. A.; Levins, C. G.; Wang, 
Y.; Anderson, D. G. J. Control. Release 2012, 160 (2), 172. 
(186)  Liu, X.; Yang, J. W.; Miller, A. D.; Nack, E. A.; Lynn, D. M. Macromolecules 2005, 38 (19), 7907. 
(187)  Liu, X.; Yang, J. W.; Lynn, D. M. Biomacromolecules 2008, 9 (7), 2063. 
(188)  Bertrand, E.; Gonçalves, C.; Billiet, L.; Gomez, J. P.; Pichon, C.; Cheradame, H.; Midoux, P.; Guégan, 
P. Chem. Commun. (Camb). 2011, 47 (46), 12547. 
(189)  Hoogenboom, R.; Monnery, B. D. Method for the preparation of uniform, High molar mass cyclic 
imino ether polymers. WO 2016:008817, 2016. 
(190)  Chujo, Y.; Sada, K.; Nomura, R.; Naka, A.; Saegusa, T. Macromolecules 1993, 26 (21), 5611. 
(191)  Chujo, Y.; Sada, K.; Naka,  a; Nomura, R.; Saegusa, T. Macromolecules 1993, 26 (5), 883. 
(192)  Chujo, Y.; Sada, K.; Saegusa, T. Macromolecules 1993, 26 (24), 6320. 
(193)  Chujo, Y.; Sada, K.; Saegusa, T. Macromolecules 1993, 26 (24), 6315. 
(194)  Chujo, Y.; Sada, K.; Saegusa, T. Polym. J. 1993, 6, 599. 
(195)  Chujo, Y.; Sada, K.; Saegusa, T. Macromolecules 1990, 23, 2636. 
(196)  Guo, C.; Zhou, L.; Lv, J. Polym. Polym. Compos. 2013, 21 (7), 449. 
(197)  Chen, C.-H.; Niko, Y.; Konishi, G. RSC Adv. 2016, 6 (49), 42962. 
(198)  Legros, C.; Wirotius, A.; Tam, K. C.; Taton, D. Biomacromolecules 2014. 
(199)  Legros, C.; De Pauw-Gillet, M.-C.; Tam, K. C.; Lecommmandoux, S.; Taton, D. Polym. Chem. 2013, 
4 (17), 4801. 
(200)  Rangelov, S.; Pispas, A. Polymer and Polymer-Hybrid Nanoparticles: From Synthesis to Biomedical 
Applications; 2013. 
(201)  Bawa, P.; Pillay, V.; Choonara, Y. E.; du Toit, L. C. Biomed. Mater. 2009, 4 (2), 22001. 
(202)  Navarro, M.; Michiardi, A.; Castaño, O.; Planell, J. A. J. R. Soc. Interface 2008, 5 (27), 1137. 
(203)  Suwandi, J. S.; Toes, R. E. M.; Nikolic, T.; Roep, B. O. Wiley, Inter Sci. 2007, 33, 97. 
(204)  Stevens, M. M.; George, J. H. Science 2005, 310 (November), 1135. 
(205)  Tayalia, P.; Mooney, D. J. Adv. Mater. 2009, 21 (32–33), 3269. 
(206)  Miyata, T.; Uragami, T.; Nakamae, K. Adv. Drug Deliv. Rev. 2002, 54 (1), 79. 
(207)  Van Vlierberghe, S.; Dubruel, P.; Schacht, E. Biomacromolecules 2011, 12 (5), 1387. 
(208)  Vicent, M. J.; Ringsdorf, H.; Duncan, R. Adv. Drug Deliv. Rev. 2009, 61 (13), 1117. 
(209)  Chen, H.; Yuan, L.; Song, W.; Wu, Z.; Li, D. Prog. Polym. Sci. 2008, 33 (11), 1059. 
(210)  Papadimitriou, S. A.; Salinas, Y.; Resmini, M. Chem. A Eur. J. 2016, 22 (11), 3612. 
(211)  Kanazaki, K.; Sano, K.; Makino, A.; Homma, T.; Ono, M.; Saji, H. Nat. Sci. Reports 2016, 6 (August), 
33798. 
 
  
  
 
48 
 
CHAPTER 1 
 
  
  
 
 
  
Chapter 2 : 
Understanding the partial hydrolysis of poly(2-alkyl-2-
oxazolines: Is it random or is it block-like?
 
 
Contributors to this chapter: 
Prof. José C. Martins, Department of Organic and Macromolecular Chemistry, Ghent University 
Dr. Dieter Buyst Department of Organic and Macromolecular Chemistry, Ghent University 
Timotee Courtin, Department of Organic and Macromolecular Chemistry, Ghent University   
Contributions of the candidate 
Synthesis and full characterization of all the polymers 
Manuscript submitted 
  
 
50 
 
CHAPTER 2 
  
  
 
51 
 
CHAPTER 2 
Prologue 
The acidic hydrolysis of PAOx is the best known method to obtain L-PEI. The partial hydrolysis of PAOx 
is also interesting to obtain PAOx-PEI. This copolymer can be used in either gene transfection experiments 
or as a reaction platform herewith creating new PAOx copolymers. The reaction mechanism for the 
(partial) hydrolysis of PAOx is described in the introduction. It is, however, unclear what the monomer 
distribution is along the PAOx-PEI polymer chain. This is of vast importance in the further chapters as 
this will influence the change in Tcp and gene transfection efficiency described in chapter 3. The 
distribution of different reactive groups along the polymer chain will be important for the post-
polymerisation modification procedures as described in chapter 4,5 and 6. 
 
2.1 Introduction 
The story of linear poly(ethylene imine) (PEI) and poly(2-alkyl-2-oxazolines) (PAOx) started in 1966.1–4 
The newly discovered PAOx, in this case poly(2-methyl-2-oxazoline) (PMeOx) was hydrolysed under both 
basic and acidic conditions. The release and corresponding smell of acetic acid after hydrolysis and 
formation of linear PEI (L-PEI) confirmed that the precursor polymer was indeed PAOx. Like-wise the 
first post-polymerisation modification reaction of L-PEI was proposed. The hydrolysed L-PEI was reacted 
with acetic anhydride thereby regenerating the original PMeOx.1,5 The hydrolysis of PAOx is one of the 
best methods for obtaining L-PEI6 next to the ring opening polymerisation of substituted aziridines. 7–11L-
PEI has found applications as a chelating agent for Cu ions12–14 and other metals13,14, as charge carrier in 
electrochemistry 15–17 and as a surfactant in cosmetics.18–20 However, the most broadly explored application 
is the use of L-PEI as non-viral gene delivery due to its high positive charge density in the protonated form 
enabling strong electrostatic interaction with genetic material.7,21–23 Furthermore the secondary amino 
groups of L-PEI can also be chemically modified, enhancing the gene transfection efficiency or lowering 
the cytotoxicity.7,23–30 
Similarly, copolymers containing L-PEI can be generated through partial hydrolysis of PAOx resulting 
in PAOx-PEI copolymers that combine the beneficial properties of the parent PAOx, such as low toxicity, 
non-immunogenic and tuneable physicochemical properties, with those of L-PEI.23–25,31–35 These partially 
hydrolysed PAOx-PEI copolymers have been used, e.g., for gene transfection25,31,35, as a coating material 
for melamine determination in milk36 and as a complexation agent for indocyanine green, used as an 
imaging agent for tumours37. The (partial) hydrolysis of PAOx can be performed via a hydrolysis reaction 
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using acidic33,34,38–42 or basic 1,14,38,39,41,43 conditions. Several PAOx polymers have been used for the 
hydrolysis namely homo or copolymers of PMeOx14,38,39,44,45, poly(2-ethyl-2-oxazoline)(PEtOx),33,34,38 
poly(2-propyl-2-oxazoline)(PPrOx)35 and poly(2-phenyl-2-oxazoline).1,38–40,46 The acidic hydrolysis is the 
preferred route as protonation of the formed secondary amino groups keeps the polymer in solution while 
basic hydrolysis has been reported to lead to partial main chain degradation of the PAOx, which was 
however not quantified.38,39 The acidic hydrolysis of PAOx is illustrated in Figure 2-1. The amount of 
ethylene imine units in partially hydrolysed copolymers can be easily and accurately controlled via 
temperature, time and acid concentration.33,34,38 The resulting PAOx-PEI copolymers can be utilized as 
starting materials for further modification reactions with various electrophiles, such as acid chlorides, 
carboxylic acids (e.g. via DCC coupling), isocyanates and alkyl halides.7 A wide range of functionalities 
have been introduced into PAOx using such modification reactions of partially hydrolysed PAOx-PEI, 
including a redox sensitive anthracene group,45 furan and maleimide polymers for Diels Alder cross 
linking47 or methyl ester side chains for further modification with amines through direct amidation.48 Also 
bipyrydyl groups have been introduced as a ligand for Co(III) yielding hydrogels upon metal 
complexation.49 Likewise hydrogels have been formed by reacting the L-PEI units with bifunctional 
epoxides as cross linker.50,51 Moreover, the secondary amines have been used for the introduction of 
carbohydrates via reductive amination.52  
Despite the numerous studies on the partial acidic hydrolysis of PAOx and the high potential of the 
resulting polymers for various applications and as reactive platform for making functional PAOx, to date 
the exact structure of the formed PAOx-PEI is unknown. More specifically, it remains to be established 
whether hydrolysis of the amide side chains occurs randomly along the PAOx chain or that block-like 
regions of L-PEI are generated as schematically depicted in Figure 2-1. Insight in the distribution of the L-
PEI units is crucial for the use of PAOx-PEI copolymers in gene delivery as the protonation of L-PEI is 
strongly influenced by neighbouring L-PEI units.53,54 Furthermore, the distribution of L-PEI units will 
control the distribution of functional groups upon further reaction, which can significantly alter the 
properties of such materials, e.g. for cross-linking and hydrogel formation.  
Within this work, we took up the challenge to unravel the L-PEI distribution in PAOx-PEI copolymers 
resulting from partial acidic hydrolysis of PAOx. Therefore, detailed 1H and 13C NMR as well as HMBC and 
HSQC NMR spectroscopy were performed at high field. Comparative NMR analysis of the parent PEtOx, 
a partially hydrolysed PEtOx-PEI copolymer and the fully hydrolysed L-PEI was performed enabling us to 
determine the PEI distribution. 
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Figure 2-1 Schematic overview of the acidic hydrolysis of PAOx following a random pathway (left) or block-
like pathway (right). The red squares represent the amide functionality surrounded by a methylene group on each 
side and the orange stars represent the amine of the PEI with a methylene group on each side. The formed amines 
can be protonated in acidic medium. The PEI shown is the free base PEI. 
 
  
  
 
54 
 
CHAPTER 2 
2.2 Materials and methods 
2.2.1 Instrumentations 
Size exclusion chromatography (SEC) was performed using an Agilent HPLC equipped with a 1260 
refractive index detector (RID) a 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) containing 20 mM sodium 
trifluoroacetate as eluent, which was dried with molecular sieves (3 Å). The flow rate during the 
measurements was 0.53 mL/min (HFIP-SEC) and polymethylmethacrylate (PMMA) standards were used 
as standards to calculate the molar mass values. Measurements were performed with a column set 
consisting of two PSS PFG 300*8Ǻ gel 5 µm MIXED-D columns and a similar guard column (PSS) in series 
with a molar mass range from 100 - 1 000 000 in a column oven set at 35 °C. Chromatograms were analysed 
with Agilent Chemstation software using the GPC add-on. 
 
2.2.2 Materials 
The synthesis of defined PEtOx400 with a degree of polymerisation (DP) of 400 with Mn = 40600 g/mol 
and Ð = 1.06 has been reported elsewhere.55 . PEtOx100 with a DP of 100 (Mn = 9700 g/mol; Ð = 1.13) was 
synthesized following a previously reported protocol.56,57 Poly(2-n-propyl-2-oxazoline)s with DP of 75 
(PPrOx75; Mn 13,000 g/mol, Đ=1.04) was synthesized following the procedure described elsewhere.20 
Hydrogen chloride, sodium hydroxide and dichloromethane (CH2Cl2) were obtained from Sigma-Aldrich 
and used as received. The hydrolysis reactions were performed in a single mode microwave Biotage 
initiator eight reactor using temperature control based on the IR temperature sensor (Biotage, Uppsala, 
Sweden). NMR measurements were performed using a Bruker AVANCE II spectrometer operating at 
700.13 MHz for 1H and at 176.74 MHz for 13C, except for routine measurements that were performed at 300 
MHz using a Bruker AVANCE instrument. All analysis were executed with the Spinworks 4.2 Software. 
 
2.2.3 Procedures 
For the detailed NMR study of the partial hydrolysis. 20 mg of polymer was dissolved in 0.6 ml 
deuterated solvent. Depending on solubility of the polymer an optimum solvent was chosen. CDCl3 for 
PEtOx and PEtOx-PEI and CD3OD for the L-PEI. No precipitation was observed in all samples. Other 
routine measurement samples were prepared by dissolving approximately 10 mg of sample in the 
deuterated solvent. 
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Partial hydrolysis of PEtOx400 to PEtOx307-PEI93 
PEtOx400 (2 g, DP 400) was dissolved in 7.5 mL of water under stirring. Then, 7.5 mL of a 36 wt% solution 
of HCl (concentrated HCl) was added and the mixture was heated to 140 °C in the microwave for 40 min. 
After the hydrolysis reaction, the volatiles were removed on a rotary evaporator. The polymer was basified 
to pH 10-11 by addition of a 2 M NaOH solution. The solution was then lyophilized and the solid polymer 
was dissolved in dichloromethane while the formed salts remained in the flask. Next, the organic phase 
was filtrated and the solvent was removed under reduced pressure to yield a solid white product. The 
integral ratio between the peaks at 2.56-2.8 ppm (PEI backbone) and 3.15-3.6 ppm (PEtOx backbone) in 
the 1H-NMR spectrum were used to calculate the degree of hydrolysis revealing 23% hydrolysis. 
PEtOx307-PEI93: 1H NMR (δ in ppm, CDCl3):  = 0.9 – 1.25 (m, 3H,CH2-CH3, 5); 2.1 – 2.50 (m, 2H,CO-
CH2-CH3, 4), 2.56 – 3.0 (m, 4H, NH-CH2, 6); 3.15 – 3.60 (m, 4H,NCH2, 2). 13C NMR (δ in ppm, CDCl3):  
= 9.4 (CH2-CH3, 5); 25.9 and 26.2 (CO-CH2-CH3, 4); 43–51 (N-CH2, 6 and 2); 173-175 ppm (N-C=O, 3). 
SEC: Mn = 33980 g/mol; Ð =1.17. 
 
Full hydrolysis of PEtOx400 to PEI400 
PEtOx400 (2g,DP 400) was dissolved in 7.5 mL of water under stirring. Then, 7.5 mL of a 36 wt% solution 
of HCl (concentrated HCl) was added and the mixture was heated to 140 °C in the microwave for 3 hr After 
the hydrolysis, the volatiles were removed on a rotary evaporator. The polymer was basified to pH 10-11 by 
addition of NaOH pellets and stirring until the polymer was dissolved. After filtration the powder was 
lyophilized. A white powder was obtained. 
1H NMR (δ in ppm, CD3OD):  = 2.7-28 (s, 2H, CH2-NH-CH2,6). 13C NMR (δ in ppm, CD3OD):  = 49.7–
51 (HN-CH2, 6); SEC: Mn = 41000 g/mol; Ð = 1.07. 
Partial hydrolysis of PEtOx (DP = 100, 200 or 400) to PEtOx-PEI with different degrees of hydrolysis. 
The hydrolysis PEtOx100 was performed similar to the previously described partial hydrolysis of PEtOx400. 
However, depending on the sample and desired degree of hydrolysis, either microwave heating, or 
conventional heating were used. Also different temperature regimes were used (78 °C,100 °C or 140 °C). 
The work up was similar as described for the partially hydrolysed PEtOx400 for all samples. The integral 
ratio between the peaks at 2.56-2.8 ppm (PEI backbone) and 3.15-3.6 ppm (PEtOx backbone) in the 1H-
NMR spectra were used to calculate the degree of hydrolysis. 
PEtOxDP-x-PEIx: 1H NMR (δ in ppm,CDCl3): 1H NMR (δ in ppm, CDCl3):  = 0.9 – 1.25 (m, 3H, CH2-CH3, 
5); 2.1 – 2.50 (m, 2H, CO-CH2-CH3, 4), 2.56 – 3.0 (m, 4H, NH-CH2, 6); 3.15 – 3.60 (m, 4H, NCH2, 2). 13C 
NMR (δ in ppm, CDCl3):  = 9.4 (CH2-CH3, 5); 25.9 and 26.2 (CO-CH2-CH3, 4); 43–51 (N-CH2, 6 and 2); 
173-175 ppm (N-C=O, 3). 
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Partial hydrolysis of PPrOx75 to PPrOx-PEI with different degree of hydrolysis 
PPrOx75 (3 g, DP75) was dissolved in 50 mL of a 6 M HCl solution and subjected to hydrolysis for certain 
periods of time to obtain the desired degree of hydrolysis according to the kinetic study reported in 
chapter 3.35 After the reaction, the solutions were neutralized with NaOH and lyophilized. The copolymers 
were subsequently extracted with CH2Cl2, and after removing the solvent, water was added. A dry powder 
was obtained after lyophilisation. The integral ratios of the peaks at 2.6-2.8 ppm and 3.2-3.5 ppm were 
utilized to calculate the degree of hydrolysis. All SEC data can be found in chapter 3.35 
1H NMR (300 MHz, δ in ppm, CDCl3): 1-1.2 (3 H, CH2-CH3), (2 H, CH2-CH3); 2.3-2.5 (2H, CH2-CH2-CH3); 
2.6-2.8 (4 H, CH2-NH); 3.2-3.5 (4 H, CH2NCH2). 
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2.3 Results and discussion 
A true understanding of the acidic hydrolysis mechanism of PAOx is crucial to determine the 
distribution of L-PEI units along the polymer backbone. In Scheme 2-1 the mechanism of the acidic 
hydrolysis of PAOx is shown. The majority of the carbonyl groups of the amide will be protonated during 
the reaction due to the high acid concentration (generally ~1-6 M; step 1 in Scheme 2-1). This protonation 
enhances the electrophilicity of the carbonyl group making it more prone to nucleophilic attack. In the 
second step of the reaction, water acts as a nucleophile towards the carbonyl group accompanied by an 
electron shift towards the oxonium creating the tetrahedral intermediate, which is the rate determining 
step. The tetrahedral intermediate is subsequently deprotonated by water that acts as a base. In this third 
step, the nitrogen group on the backbone is converted into a good leaving group by protonation. In the 
fourth step there is a rearrangement of electrons with release of the side chain as carboxylic acid, thereby 
creating the protonated amine (due to acidic conditions) of PAOx-PEI. The proposed hydrolysis 
mechanism in Scheme 2-1 is strictly speaking only valid for the first few hydrolysis reactions onto the 
PAOx chain as it does not take into account the neighbouring amine groups that will be present as 
hydrolysis proceeds. The protonation of the amine will have an effect at higher hydrolysis degree because 
more protonated amines are present potentially limiting the formation of more charges on the polymer 
chain. This effect is observed in the kinetic curve of the hydrolysis because at higher degree of hydrolysis 
the reaction speed decreases. In principle, two extreme cases may be described for the partial hydrolysis 
of PAOx, as schematically shown in Figure 2-1. If the presence of an amine on either or both sides of a 
PAOx do not influence the rates and equilibria during the hydrolysis (left branch in Figure 2-1), the 
hydrolysis will occur randomly along the chain and the formation of neighbouring L-PEI units will be 
statistically controlled, i.e. increasing with increasing conversion. Alternatively, the presence of a 
protonated amine may influence the reaction or shift the equilibria during hydrolysis, thereby facilitating 
the hydrolysis of PAOx units immediately neighbouring the generated PEI units (right branch in Figure 
2-1). Such a rate accelerating neighbouring group effect will, in the extreme case, lead to the formation of 
growing blocks of L-PEI rather than a randomized distribution for the distribution of PEI-units in PAOx-
PEI. This is observed in earlier work of our group, the kinetic curve has an s-shape for both the hydrolysis 
of PEtOx34 and PPrOx (chapter 3).35 
Focusing on individual monomeric units, these two extreme cases should translate in distinctly different 
environments around the L-PEI units at moderate hydrolysis degrees. In the case of a block-like L-PEI 
distribution, a particular PEI unit will mostly reside inside a L-PEI block and thus be surrounded by two 
other PEI units (star) and no PEtOx (squares) causing ‘all-star’ triads and ‘all-triangle’ triads (right branch, 
Figure 2-1) to be the dominant triad forms in the partly hydrolysed PEtOx-PEI. For a random distribution, 
individual PEI units will mostly be surrounded by PEtOx units and only occasionally by another L-PEI 
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unit, which will lead to triads containing a L-PEI at the center surrounded by PEtOx units (left branch 
Figure 2-1). The different constitution of L-PEI containing triads in block-like versus randomly hydrolysed 
PEtOx copolymers should allow them to be distinguishable by NMR structure analysis, thus allowing to 
distinguish whether the hydrolysis of PAOx is random or block-like. 
 
 
Scheme 2-1 Hydrolysis mechanism of PAOx (1) Protonation of the amide group; (2) nucleophilic attack 
of water (slow); (3) proton transfer to water; (4) rearrangement and release of the carboxylic acid and 
protonation of the formed secondary amine due to acid environment yielding a protonated PEI unit.  
1D 1H-NMR and 13C-NMR spectroscopy were used as starting points to unravel the PEtOx-PEI copolymer 
distribution. As a model we used well-defined PEtOx400, the partially hydrolysed PEtOx307-PEI93 (23% 
hydrolysis) and the fully hydrolysed L-PEI400 (100% hydrolysis). Both the L-PEI and PEtOx-PEI are 
hydrolysis products obtained from the parent PEtOx400. Figure 2-2 shows the stacked 1H-NMR spectra of 
these polymers with the signal assignments. Note that the polymerisation initiator and terminating agent 
cannot be seen due to the high DP of the utilized polymer. This PEtOx was partially hydrolysed in 6M HCl 
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solution yielding the PEtOx307-PEI93 copolymer and the corresponding 1H NMR spectrum is shown in 
Figure 2-3, middle plot. Due to removal of the amide side chains the CH2-group of the L-PEI units H(6’and 
6”) appear at 2.8 ppm. The percentage of PEI is calculated from the integral of the PEI CH2 resonance H(6’ 
and 6”) relative to that of all methylene units (i.e. the sum of resonances H(2) and H(6’ and 6”) revealing 
a degree of hydrolysis of 23%. The methylene resonance at 2.8 ppm appears to be composed of two, 
partially overlapping signals, indicating the existence of two distinct chemical environments that we will 
refer to these as H(6’) and H(6”). The 1H NMR spectrum of the fully hydrolysed PEI400 is shown in Figure 
2-2, top plot. Only one peak is present at 2.8 ppm (see also the zoom in Figure 2-3) corresponding to the 
protons of the methylene groups H(6) indicating full hydrolysis of PEtOx. 
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Figure 2-2 Stacked plot of the 1H-NMR spectra of PEtOx400 (bottom, CDCl3), PEtOx307-PEI93 (middle, CDCl3) and pure 
PEI400 (top, CD3OD) with assignments;.  
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Figure 2-3 : Overlaid zoom of the 1H NMR spectra of PEtOx307-PEI93 (black) and PEI400 (red) 
 
The full, assigned 13C-NMR spectra of the three polymers are shown in Figure 2-4. A zoom of the range 
from 43 to 50 ppm that shows the main differences between the PEtOx400 and the partially hydrolysed 
PEtOx-PEI, is shown in Figure 2-5. Clearly, additional peaks appear in between 48-50 ppm upon 
hydrolysis, indicative of the appearance of PEI units. The top spectrum of L-PEI is shown in Figure 2-4 
shows that upon complete hydrolysis, the convoluted methylene region simplifies to a single PEI 
resonance, expectedly showing only one population and thus a single chemical environment for the CH2 
groups. Information on the type and distribution of the triads can be extracted from the 13C signature of 
the methylene area, provided the latter can be deconvoluted into the contributions from individual 
structures and triads, this allowing the elucidation of the distribution of L-PEI units in the PEtOx-PEI 
copolymer. 
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Figure 2-4 13C-NMR spectra of PEtOx400(bottom) (CDCl3); PEtOx307-PEI93 (middle) (CDCl3 and PEI400 (top) (CD3OD) 
with assignments. 
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Figure 2-5 Overlay of the 13C-NMR spectra of the CH2-backbone regions of PEtOx400(black) and PEtOx307-PEI93 
(CDCl3). 
To assign the different methylene resonances in PEtOx307-PEI97, 2D 1H-{13C} HSQC and HMBC NMR 
measurements were performed. The full HSQC spectrum of the PEtOx307-PEI93 is shown in Figure 2-6 
(assignment of cross peaks is given in Table 1), and the area of highest interest is presented in Figure 2-7. 
In comparison with the HSQC spectrum of the starting polymer PEtOx400 (Figure 2-7), the PEtOx-PEI 
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copolymer shows additional cross peaks connecting the CH2 1H resonance of the PEtOx copolymer H(2), 
with carbon resonances in the 47-50 ppm area. The addition of the 13C dimension allows resolution of the 
mostly featureless 1H resonance H(2) into 3 separate cross peaks. Hence, the formation of 3 types of PEtOx 
CH2 environments should be considered upon partial hydrolysis. A similar conclusion can be drawn for 
the CH2 of the PEI backbone H(6’ and 6”). Again 3 cross peaks can be observed. Two intense cross peaks 
connect the H(6’) and H(6”) resonances to the 13C signals at 49.5 ppm and 48 ppm, respectively. A third, 
much weaker but discernible cross peak can be found correlating the H(6’) 1H resonance with a 13C signal 
at 53 ppm, which will be referred to as C(6’a). This C(6’a) signal lies below the level of detection in the 13C 
spectrum, yet becomes visible thanks to the higher signal to noise afforded by 1H excitation and detection 
in the 1H-{13C}-HSQC setup. The different chemical shifts for the methylene groups of both the PEtOx and 
PEI units in the copolymer show that distinct chemical environments exist, yet their nature still needs to 
be established. This was attempted using a 1H-{13C} HMBC experiment, which, in principle, allows to probe 
the chemical structures immediately surrounding the methylene groups across multiple bonds. 
 
Table 1 Cross peaks identified in the HSQC spectrum of PEtOx307-PEI93 
Type of CH2 
group 
Nr of atom 1H-NMR 
(ppm) 
13C-NMR 
(ppm) 
PEI 6’b 2.76 47.87 
PEI 6’a 2.81 52.52 
PEI  6” 2.69 49.2 
PEtOx 2 3.44 43.77 
PEtOx 2 3.43 45.87 
PEtOx 2 3.38 48.63 
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Figure 2-6 HSQC spectrum of PEtOx307-PEI93 (CDCl3). Red yellow shades indicated CH2, green blue shades indicate 
CH/CH3 
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Figure 2-7 HSQC spectrum of PEtOx307-PEI93 (CDCl3). 
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The full HMBC spectrum of PEtOx307-PEI93 is shown in Figure 2-9, while details of the areas of highest 
interest are presented in Figure 2-10 and Figure 2-11. Figure 2-10 shows the area of the CH2 groups of the 
PEI units of the copolymer. The cross peaks arising from long range nJHC couplings, with n typically 2 or 3 
are collected in Table 2. In a partially hydrolysed polymer, cross-peaks in this part of the HMBC spectrum 
can point to PEI-PEI, PEI-PEtOx or PEtOx-PEI diads. It should be noted that the latter two produce 
identical HMBC patterns and, therefore, cannot be distinguished. Four cross peaks A to D were observed. 
Peak A correlates H(6”) with C(6”) and peak B correlates H(6’’) with C(6’a) indicating that H(6”) is 
surrounded by two kinds of PEI CH2 groups. However the C(6’a) CH2 is located in another chemical 
environment. Remark that the difference between C(6’a) and C(6’b) can be made, however the adjacent 
protons, H(6’a) and H(6’b) can’t be distinguished and form a single peak H(6’) in the 1H-NMR spectrum. 
However the C(6’a) CH2 is located in another chemical environment. Two cross peaks(C&D) appear for 
H(6’), which both correlate with the CH2 of PEtOx C(2) at 45 ppm and 49 ppm. Thus, for the PEI CH2-
region we have 3 types of CH2 groups all correlating with different regions. The H(6”) and C(6”) regions 
only correlates with other PEI units while C(6’b) only correlates with PEtOx units. The third type, C(6’a) 
correlates with CH2 originating from PEI, itself and H(6”). Here it is also clear that for H(6”) and C(6”) 
there is no overlap with PEtOx CH2 (2) as no cross peaks can be identified. Also no interaction can be 
seen between  CH2(6’b) and CH2(6”). 
Figure 2-8 HSQC spectrum of PEtOx400 (CDCl3). 
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The second region of interest on the HMBC spectrum is in between 3.5 ppm and 3.28 ppm (Figure 2-11) 
where the CH2 groups of the PEtOx are located. Two cross peaks (E and F) are the cross peaks that were 
also seen in the HSQC spectrum (PEtOx-PEtOx units), see overlay of HSQC and HMBC in Figure 2-12. 
The cross peak G shows the correlation between C(6’b) and PEtOx CH2 H(2). The last cross peak correlates 
C(6’a) with H(2). 
 
 
Figure 2-9 HMBC spectrum of PEtOx-PEI400 (CDCl3). 
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Table 2 Cross peaks identified in the HMBC spectrum of PEtOx307-PEI93 
Cross peak  Type of CH2 
group 
CH2 group 
(1H NMR ) 
CH2 group (13C 
NMR) 
1H-NMR 
(ppm) 
13C-NMR 
(ppm) 
A PEI 6” 6” 2.69 49.12 
B PEI 6” 6’a 2.68 52.57 
C PEI 6’b 2 2.75 45.66 
D PEI 6’b 2 2 48.84 
E PEtOx 2 2 3.44 44.55 
F PEtOx 2 2 3.43 48.43 
G PEtOx 2 6’b 3.39 47.95 
H PEtOx 2 6’a 3.40 52.75 
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Figure 2-10 Zoom of the HMBC spectrum of PEtOx307-PEI93 region corresponding to the CH2 groups of PEI. (CDCl3) 
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Figure 2-11 Zoom of the HMBC spectrum of PEtOx307-PEI93 Corresponding to the CH2 groups of PEtOx.(CDCl3) 
 
 
Figure 2-12 Overlay of HMBC(orange) and HSQC (black) spectra of PEtOx307-PEI93 (CDCl3) 
 
The above discussion reveals that there are 6 types of CH2 groups. The first type of PEI (6”) is 
surrounded by other PEI (6” and 6’a) units (Figure 2-13). This is the middle star in a ‘triple-star’ triad 
indicating block-like L-PEI formation as statistically only very little PEI-triads should be present at 23% 
hydrolysis. The PEI (6’a) has a connection with the PEI (6”) and with PEtOx, which is the transition 
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between an L-PEI block-like structure and the PEtOx. The last PEI CH2 group (6’b) is located in between 
two PEtOx-units which indicates that there is not a perfect block-like hydrolysis, but rather a preferential 
block-like hydrolysis besides the also occurring random hydrolysis.  
 
 
Figure 2-13: Visualisation of the three types of PEI units present in PEtOx-PEI. The star shapes represent PEI units 
while the red blocks represent the PAOx units.  
 
To further investigate the distribution of L-PEI units in PEtOx-PEI, a range of partially hydrolysed PEtOx 
samples with different degree of hydrolysis that were available in our laboratory, was analysed by routine 
1H NMR spectroscopy (Figure 2-14). Note that all spectra were calibrated against residual solvent signals, 
but the presence of minor traces of salts induces different chemical shifts. The copolymer characterised 
by a low % of PEI (3.8%) only shows one broad PEI CH2 resonance corresponding with a situation expected 
for random hydrolysis. However, already starting from 10% PEI there is a small sharper peak 
corresponding to the PEI CH2 groups with two neighbouring PEI units (6”), which becomes more and 
more pronounced with increasing degree of hydrolysis. At 41 % hydrolysis the amount of block-like PEI 
units is larger than the randomly distributed PEI units and at 70% only the signal corresponding to block-
like PEI units is present. This probably explains why the reaction mixture becomes milky at higher 
hydrolysis degree as large PEI block can induce crystallization. To probe the effect of the PAOx side chain 
on the hydrolysis reaction, we also examined the distribution of both peaks 6’ and 6’’ in a series of partially 
hydrolysed PPrOx by routine 1H NMR spectroscopy (Figure 2-15).35 The hydrolysis of PPrOx will be 
discussed in-depth in chapter 3. Very similar to PEtOx, the sharp signal of block-like PEI units (6’’) already 
appears at rather low degree of hydrolysis, namely from 15% hydrolysis onwards.  
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Figure 2-14 Stacked plot of the different 1H-NMR spectra of PEtOx with varying degree of hydrolysis. 
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Figure 2-15 Stacked plot of the 1H NMR spectra of different PPrOx-PEI copolymers with varying degree of hydrolysis 
(CDCl3) 
Even though the stack plot of the individual 1H NMR spectra for partially hydrolysed PEtOx already 
indicates that the hydrolysis occurs in a block-like fashion, a more in-depth statistical analysis is required 
because during a random hydrolysis process also blocks of PEI units will be formed along the PEtOx chain 
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at higher degrees of hydrolysis. Therefore, the random distribution of PEI units can be modelled with 
Bernoulli statistics. This statistical model describes the random process of reaching into a large container 
containing two types of balls, to take the balls out both balls have equal chance to be taken. There is no 
influence on what happened in the past.58–60 Applying these statistics to the hydrolysis of PEtOx, means 
that the potential neighbouring group effects and steric effects are neglected, thereby describing the 
random hydrolysis model (Figure 2-1, left). If the experimental data show more pronounced formation of 
block-like distribution of L-PEI units than the Bernoulli statistical model, it can be concluded that 
hydrolysis occurs more in a block-like fashion.  
In the Bernoulli model the hydrolysis of a PEtOx unit is independent of the neighbouring group. The 
chance that a PEtOx units is hydrolysed into PEI is defined as P(PEI), while the formation of a block-like 
PEI containing three PEI units in a row is defined as P³(PEI) representing the PEI-triad. The blue plot in 
Figure 2-16 shows the formation of P3(PEI) as function of the hydrolysis degree following the random 
Bernoulli statistics. From the spectra in Figure 2-14 and 2-15, the experimental ratio between the peak 
containing the CH2 of the triad PEI (no PEtOx/PPrOx interaction; 6’’) and the CH2 of the random PEI 
units (with PEtOx-interaction; 6’) can be calculated. As such, the amount of PEI CH2 groups that have no 
contact with PEtOx, i.e. are present in block-like PEI, can be determined. It should be noted that this does 
not provide information on the length and number of PEI-blocks, but merely the amount of PEI CH2 units 
present in all PEI triads representing the L-PEI block-like structures. From Figure 2-16 it is clear that at 
low degree of hydrolysis the blue curve and black/red curves are distinctly different. This means that the 
formation of block-like PEI units is more pronounced in the experimental data than in the random 
hydrolysis model, providing direct proof that the hydrolysis takes place in a more block-like fashion and 
the distribution of the L-PEI units in PEtOx-PEI is block-like. Similarly, the hydrolysis of PPrOx also 
occurs in a more block-like fashion compared to the random hydrolysis Bernoulli model as a similar 
deviation from Bernoulli statistics was obtained for PEtOx and PPrOx(Figure 2-16 black line). Both the 
black and red curve are obtained from integration of the 1H-NMR spectra in Figure 2-14 and Figure 2-15, 
the difference between both curves lays within the standard deviation of the integration. This indicates 
that there is no significant difference in the distribution of PEI units in partially hydrolysed PEtOx-PEI 
and PPrOx-PEI. 
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Figure 2-16 Plot of the hydrolysis degree versus the amount of CH2 interaction within a PEI triad. The blue plot gives 
the theoretical amount of CH2 interaction in all PEI triads for a random Bernoulli distribution. The black plot gives 
the experimental data obtained from Figure 2-14 for PEtOx. The red plot gives the experimental data obtained from 
fig 2-15 for PPrOx. 
 
Even though we have not determined the exact underlying mechanism that favors the block-like 
hydrolysis of PEtOx and PPrOx, it may be speculated that it is either related to steric effects or electronic 
effects. Sterically, the presence of a PEI-unit may enhance the accessibility of the neighbouring amide 
groups making them more prone to hydrolysis. The occurrence of such steric effects would, however, lead 
to more pronounced block-like hydrolysis for PPrOx compared to PEtOx. As it was experimentally found 
that PEtOx and PPrOx show very similar block formation (Figure 2-16) it is unlikely that steric effects are 
the major driving factor for the observed neighbouring group effect during acidic hydrolysis. Hence, 
electronic effects may be at the basis of the neighbouring group effect. As previously pointed out by Kem 
et al38 this neighbouring group effect may be ascribed to the formation of a seven-membered ring like 
structure. The interaction of the protonated secondary amine group of L-PEI with the neighbouring 
carbonyl group of the amide is shown in Scheme 2-2. As such, the carbonyl is activated for attack of water 
favoring the block-like hydrolysis This mechanism should lead to acceleration of the hydrolysis at the 
beginning of the reaction, the formation of the first PEI units will have an autocatalytic effect. This 
acceleration was observed in earlier work of our group for the hydrolysis of PEtOx.34 In Chapter 3 such an 
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acceleration is also observed in Figure 3-2 showing the effect of the neighbouring group. The acceleration 
is undo at higher hydrolysis degrees due to the electrostatic repulsion of the protonated amines. This will 
decrease the reaction speed by charge repulsion effects and results in an overall s-shaped kinetic curve for 
the hydrolysis which has been observed in older work34 and in chapter 3 Figure 3-2. 
 
 
 
Scheme 2-2 Schematic representation of the seven-membered ring formation as possible mechanism 
for the observed neighbouring group effect during the acidic hydrolysis of PAOx. Valid at lower 
hydrolysis degrees. 
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2.4 Conclusion  
Driven by the increasing interest for partially hydrolysed PAOx for various applications as well as a 
reactive platform for making functional PAOx, we have investigated the partial acidic hydrolysis of PEtOx 
by detailed NMR spectroscopy. This allowed unraveling whether the PEI units are distributed in a random 
or more block-like fashion along the polymer chain. Therefore, three different polymers where studied 
having 0%, 23% and 100% of PEI units in the PEtOx-PEI copolymers. The 1H-NMR and 13C-NMR spectra 
revealed that the PEtOx-PEI showed additional peaks, ascribed to the PEI units. Further in-depth analysis 
by HSQC and HMBC revealed the presence of 6 different CH2 groups in PEtOx-PEI, namely 3 different 
CH2 groups corresponding to the PEtOx and 3 CH2 groups for the PEI. Assignment of these CH2 groups 
in the PEtOx307-PEI93 revealed the presence of PEI-CH2 groups that are connected with two other PEI 
units, so called all PEI triads. Thereby implying the formation of block-like PEI at this relatively low degree 
of hydrolysis. This was also demonstrated by analysing a series of PEtOx-PEI and PPrOx-PEI copolymers 
with different degrees of hydrolysis indicating the formation of block-like PEI units. Comparison with 
random hydrolysis as described by Bernoulli statistics confirmed that indeed the PEI units are distributed 
along the chain in a block like fashion and, thus, acidic hydrolysis occurs in a more block-like manner. 
This may be ascribed to a neighbouring group effect in which the protonated secondary amine interacts 
and activates the neighbouring amide carbonyl group facilitating its hydrolysis. 
This result is of vast importance for the field of PEI and PAOx polymers as it gives detailed information 
about the copolymer distribution along the chain. These results can help us to understand the hydrolysis 
of PPrOx in chapter 3 and the obtained data for its use in gene delivery. The functional group distribution 
of the new copolymer in chapter 4, 5 and 6 is also unraveled, which can be of further importance as the 
polymers to be used in the biological context require a strict definition.  
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Prologue 
The mechanism for the partial hydrolysis of PAOx and the resulting distribution of PEI units along the 
polymer chain was thoroughly examined in chapter 2. This revealed a similar block-like distribution of 
the PEI units in both partially hydrolysed PEtOx and PPrOx. In this chapter the kinetics of the hydrolysis 
of PPrOx will be examined and the effect of the PEI units upon the Tcp will be screened in different 
conditions. PEI is a well-known gene transfer agent and the copolymers of PPrOx-PEI will be examined 
for their DNA binding ability. It has been shown that polymers with a Tcp form well defined cationically 
charged particles at elevated temperatures that form polyplexes with DNA. These polyplex particles can 
act as a template for coating with poly(N-isopropylacrylamide) via free radical polymerization resulting 
in stable polyplexes. 
 
3.1 Introduction 
Gene therapy is a modern approach for treating diseases in which biological molecules, such as nucleic 
acids (i.e., plasmid DNA, antisense oligonucleotides, therapeutic RNAs, and siRNA), are used as active 
components. These molecules are delivered to the nucleus of diseased cells, where they change the gene 
expression of the cell. A key element in gene therapy is the delivery of nucleic acids. This delivery is 
achieved using a carrier because the naked nucleic acid would be biodegraded before reaching its target 
and it wouldn’t be taken up by cells. The carrier plays a crucial role in the delivery and expression of DNA 
in the cell because it prevents the degradation of the nucleic acid by nucleases in the blood. In addition, 
the desired cell can be targeted and penetrated.1 Once internalized, a number of barriers and obstacles, 
such as escape from the endolysosomal pathway, trafficking through the cytosol and gaining nuclear 
entry,2 must be overcome. 
Two types of carriers can be used: viral and non-viral. The viral carriers are highly efficient and can 
deliver nucleic acids to a specific cell type. However, they tend to make the DNA modification of the guest 
permanent, inducing mutagenic and immunogenic responses.3 The non-viral carriers consist of lipids, 
peptides or polymers. These are more advantageous than the viral carriers because they are safer and 
cheaper and exhibit a high loading capacity. In addition, these carriers can be produced in large quantities. 
The main disadvantage of non-viral carriers is the lower efficiency of nucleic acids delivery to cells, 
especially to the nucleus.3,4 Polymethacrylates,5 carbohydrate-based polymers5,6 and poly(L-lysine)7,8 are 
often used in this context but the most extensively studied systems include both branched (b-PEI) and 
linear polyethylenimines (L-PEI). b-PEI can be synthesized via acid catalyzed ring-opening polymerisation 
of aziridine,1 while L-PEI can be prepared by acidic or basic hydrolysis of poly(2-alkyl-2-oxazoline)s 
(PAOx), such as poly(2-ethyl-2-oxazoline) (PEtOx) or poly(2-methyl-2-oxazoline) (PMeOx).9 The PEI 
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polymers carry a positive charge on the amino functionalities (primary, secondary and tertiary for b-PEI 
and only secondary for L-PEI) that can interact with the negatively charged nucleic acid to form 
polyelectrolyte complexes known as polyplexes. For the design of new carriers, the toxicity must be 
reduced, and specific cell types must be targeted to create a more efficient vector. Therefore, the choice 
of a biocompatible, chemically versatile polymer such as PAOx is logical.10–12 The biggest advantage of 
PAOx is its high chemical versatility, which allows the introduction of chemical functionalities via the end 
groups, side chain or post-polymerisation modification.13–17 Previous studies have demonstrated that full 
hydrolysis is not mandatory, and copolymers containing the original polymer moieties (i.e., PEtOx and 
PEI) can be synthesized in a controlled manner.18,10 This approach is advantageous due to a combination 
of the nucleic acid interacting moieties and other moieties that preserve most of the properties of the 
original polymer.  
The precursors for L-PEIs, namely PAOx represent polymers that are synthesized via cationic ring-
opening polymerisation (CROP) and exhibit huge potential for biomedical applications. In the 
development of carriers many other factors besides the nucleic acid binding ability are important. These 
factors include providing colloidal stability, long-circulation time, introduction of ligands targeting 
specific cells, reduced (or absence of) cytotoxicity and immunogenicity as well as improved 
biocompatibility. The PAOx polymers exhibit most of these properties. In addition to the chemical 
advantages, the PAOx family possesses interesting solution behavior. For example, PMeOx is water 
soluble, and by adding an extra carbon to the side chain resulting in PEtOx, a lower critical solution 
temperature (LCST) of 65 °C can be achieved depending on the chain length and concentration.19,20 Upon 
addition of another carbon (i.e. poly(2-n-propyl-2-oxazoline) (PPrOx)), the LCST shifts to 25 °C.19,21 Above 
the specific LCST, the polymer chains undergo reorganization due to dehydration, which under specific 
conditions can lead to the formation of colloidally stable nanosized particles that are referred to as 
mesoglobules.22 The combination of PEI moieties (nucleic acid binding properties) and biologically 
tolerant moieties exhibiting LCST properties into a single copolymer chain may be a promising approach 
for the design of effective and biocompatible carriers for delivery of oligo- and polynucleotides as recently 
shown by Vlassi and Pispas for amphiphilic copolymers obtained by partial hydrolysis of 2-methyl-2-
oxazoline/2-phenyl-2-oxazoline gradient copolymers.23 
In this study, a series of random copolymers of n-propyl-2-oxazoline and ethylenimine was synthesized 
by partial acidic hydrolysis of PPrOx and the resulting materials were fully characterized. Polyplexes with 
DNA in a wide range of amino to phosphate group (N/P) ratios were prepared and their structure, stability, 
and cytotoxicity were studied under various experimental conditions. Some of the polyplexes were 
stabilized by the formation of a cross-linked polymer shell on their surface that acted as a physical barrier 
keeping the initial particles tight and preventing substantial swelling and eventual disintegration.   
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3.2 Materials and methods 
3.2.1 Instrumentations 
Size-exclusion chromatography (SEC). SEC was performed on an Agilent HPLC with a 1260 refractive 
index detector (RID) using dimethylacetamide containing 50 mM LiCl as an eluent at a flow rate of 0.6 
mL.min-1. Polymethylmethacrylate (PMMA) standards were used to calculate the molar mass values. The 
column set consisted of two PLgel 5 µm mixed D columns at 40 °C and a similar guard column (Agilent) 
in series. The chromatograms were analyzed using the Agilent Chemstation software with the GPC 
module. The copolymers obtained from hydrolysis were analyzed by size-exclusion chromatography 
(HFIP-SEC) using an Agilent HPLC that was equipped with a 1260 refractive index detector (RID). The 
eluent was hexafluoro-2-isopropanol (HFIP) containing 20 mM sodium trifluoroacetate at a flow rate of 
0.426 mL.min-1. PMMA standards were used to calculate the molar mass values. The column set consisted 
of two PSS PFG 100Ǻ gel 5 µm mixed D columns and a similar guard column (Agilent) at 35 °C in series. 
The chromatograms were analyzed using the Agilent Chemstation software with the GPC module. 
Nuclear magnetic resonance (NMR). The 1H NMR and 13C NMR spectra were recorded in CDCl3 or 
DMSO-d6 on a Bruker Avance 300 MHz or 500 MHz spectrometer. Diffusion-ordered NMR spectroscopy 
(DOSY). The DOSY measurements were performed on a Bruker Avance II+ 600 NMR spectrometer, 
equipped with a 5 mm dual 1H/31P Diff30 probe and a 40 A gradient amplifier, providing a maximum 
gradient strength of 11.8 T.m-1. The experiments were performed at 25 and 37 °C, below and above cloud 
point temperature (TCP) respectively. The DOSY spectra were acquired with the Diff suite package 
integrated in Topspin 3.2 by using a double-stimulated echo pulse sequence to compensate for possible 
convection during the measurements. The diffusion delay (Δ) was set to 50 ms (the relatively short value 
of the diffusion time was chosen to avoid loss of magnetization due to fast relaxation typical for large 
particles), sine shaped gradient pulses (δ) of 1.5 ms were applied. A gradient ramp of 24 linearly distributed 
gradient amplitude values was used. The starting and final gradient amplitudes were adjusted to ensure 
optimal signal attenuation, typically from 24 to 419 G.cm-1 for the measurements at 37 °C and from 16 to 
300 G.cm-1 for the experiments at 25 °C. All spectra were recorded without sample spinning with 16k time-
domain data points in the t2 dimension, 128 transients for each gradient increment, and a relaxation delay 
of 2 s. The DOSY spectra were measured using the following heating protocol: The sample temperature 
was equilibrated directly in the magnet using the water-cooling system of the Diff30 probe (BCU-20 
variable temperature unit) to set and maintain the selected temperature (25 or 37 °C). First the 
experiments at 25 °C were performed and then the temperature was set at 37 °C for the measurements 
above the TCP. The selected temperature was achieved and stabilized within max 20 min after setting the 
value (according to the reading of the BCU temperature unit). Since the quality of DOSY spectra is very 
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sensitive to any temperature drift or instabilities the experiments were started one hour after setting the 
temperature to ensure complete temperature stabilization within the sample volume. The spectra were 
processed with an exponential window function (line broadening factor 5), 32k data points in the F2 
dimension, and 256 data points in the diffusion dimension, by using the fitting routine integrated in 
TopSpin 3.2 package. The diffusion coefficients were calculated by fitting the sum of the columns along 
the chemical shift of each signal in the DOSY spectrum with a variant of Stejskal-Tanner equation adapted 
for the particular pulse sequence used. Additional processing using CONTIN algorithm was also applied. 
Dynamic and electrophoretic light scattering. To determine the TCP of the polymers, dynamic light 
scattering (DLS) measurements were performed in disposable cuvettes at a concentration of 10 mg.mL -1 
unless otherwise noted. The heating rate was 2 °C.min-1 with an equilibration time of 300 s starting at 10 
°C and ending at 80 °C. The TCP was taken as the onset of polymer aggregation using both the volume and 
intensity plots. 
The hydrodynamic radii (Rh)of the polyplexes were determined at 65, 37 and 25 ºC on a Zetasizer Nano-
ZS instrument (Malvern Instruments) that was equipped with a He-Ne laser (λ = 633 nm) and a non-
invasive backscatter system, allowing for measurement of the scattered light at a scattering angle of 173º 
according the Stokes-Einstein equation: 
Rh = kT/(6πηD) 
where k is the Boltzmann constant, η is the solvent viscosity at temperature T in Kelvin and D is the 
diffusion coefficient. Each measurement was performed in triplicate.  
The ζ potentials of the polyplexes were calculated from the obtained electrophoretic mobility at 37 and 
25 ºC using the Smoluchowski equation: 
ζ = 4πηυ/ε 
where η is the solvent viscosity, υ is the electrophoretic mobility, and ε is the dielectric constant of the 
solvent. 
 
3.2.2 Materials 
HCl, NaOH, dichloromethane, N-isopropylacrylamide (NIPAM), N,N-methylenebis(acrylamide) (BIS), 
2,2'-azobis(2-methylpropionamidine) dihydrochloride and polyethylenimine (Mw = 25000 Da) were 
obtained from Sigma-Aldrich and used as received. Salmon sperm DNA (D-1626, 2000 bp, corresponding 
to a molar mass of 1.32x106 Da) were also obtained from Sigma-Aldrich. PPrOx with different degrees of 
polymerisation (DPs) [i.e., PPrOx75 (Mn 1.3x104 Da, Đ=1.04), PPrOx160 (Mn 1.7x104 Da, Đ=1.2), PPrOx200 (Mn 
1.9x104 Da, Đ=1.4)] were synthesized according to a previously reported procedure.24 DPs values were 
based on the monomer feed and NMR data, whereas Mn and Đ were determined by SEC (see below). All 
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of the polymerisation mixtures were prepared in a Vigor glove box and the polymerisation were performed 
at 140 °C for 32 min, except for PPrOx75, which was synthesized at 85 °C for 7 hours. To prepare the 
polyplexes, a 100 μg.mL-1 stock solution in ultrapure water (> 18 MΩ.cm) was used.  
Cell lines and culture conditions 
The HL-60 (acute promyelocyte leukemia) and RPMI-8226 (multiple myeloma) cell lines were supplied 
by DSMZ GmbH, Germany. The urinary bladder carcinoma EJ was obtained from American Type Cell 
Culture, USA. In general, the cells were cultured in a controlled environment (i.e., 37 °C in 5% CO2 
humidified atmosphere). The cell lines were maintained in RPMI 1640 supplemented with 2 mM L-
glutamine and 10% fetal calf serum. These cell lines were also subcultured twice weekly to maintain 
continuous logarithmic growth. The EJ cells were used prior to the seventh passage. 
 
3.2.3 Procedures 
Kinetics of hydrolysis of poly(n-propyl-2-oxazoline). 
A stock solution of PPrOx75 (Mn 1.3x104, corresponding to DP 75, Ɖ = 1.04) was prepared by dissolving 3 
g in 50 mL of a 6 M HCl solution. 15 mL of the polymer stock solution was added to closed microwave vials 
and heated to 100 °C (internal temperature) in dry sin blocks. At various time intervals, a sample was 
removed and neutralized by the addition of a NaOH solution to calculate the degree of hydrolysis based 
on 1H NMR spectroscopic analysis. 1H NMR (300 MHz, δ in ppm, CDCl3): 1-1.2 (3 H,CH2-CH3), (2 H,CH2-
CH3); 2.3-2.5 (2H,CH2-CH2-CH3); 2.6-2.8 (4 H,CH2-NH); 3.2-3.5 (4 H,CH2NCH2). The integral ratios of the 
peaks at 2.6-2.8 ppm and 3.2-3.5 ppm were utilized to calculate the degree of hydrolysis. 
Preparation of the PPrOx-PEI copolymers. 
 3 g of PPrOx with various DPs (DP 75, 160, or 200) were dissolved in 50 mL of a 6 M HCl solution and 
subjected to hydrolysis for certain periods of time to obtain the desired degree of hydrolysis according to 
the kinetic study. The solutions were neutralized with NaOH and freeze-dried. The copolymers were 
extracted with CH2Cl2, and after removing the solvent, water was added. A dry powder was obtained after 
freeze-drying. The codes, DPs, PEI contents, total molecular weight and dispersity of the resulting 
copolymers are provided in Table 1. 
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Table 1. Molecular weight characterization data and PEI contents of PPrOx-PEI copolymers obtained 
by acidic hydrolysis of PPrOx homopolymers of different degrees of polymerisation. 
Code DPa PEI,b 
% 
Mn,c 
Da 
Ɖc 
PPrOx71-PEI4 75 5 10 100 1.4 
PPrOx68-PEI7 75 10 12 500 1.2 
PPrOx149-PEI11 160 7 21 200 1.3 
PPrOx146-PEI14 160 8.5 18 900 1.3 
PPrOx186-PEI14 200 7 24 600 1.4 
PPrOx182-PEI18 200 9 34 000 1.2 
a based on monomer feed and 1H NMR; b based on  1H NMR; c obtained by SEC 
 
Formation of polyplexes. The polyplexes were formed by dropwise addition of appropriate amounts of 
DNA (100 µg.mL-1) into an aqueous solution of the copolymer (0.5 mg.mL-1) at 65 °C under vigorous 
stirring. The polyplexes were prepared in amine to phosphate group ratios (N/P) in the 0.5-10 range. 
Coating of polyplex nanoparticles. To form a cross-linked polymer shell around the polyplex particles, 
seeded radical polymerisation of NIPAM was employed. The cross-linking reaction was carried out in 
aqueous media under mild conditions according to a previously published procedure.25,26 NIPAM (5 
mmol.L-1) and BIS cross-linker (0.26 mmol.L-1) were dissolved in water, and the mixture was added to the 
polyplex dispersion at 65 °C under a nitrogen atmosphere with vigorous stirring. After 30 min, 2,2'-
azobis(2-methylpropionamidine) dihydrochloride (1 mmol.L-1) was introduced to initiate the 
copolymerisation of NIPAM and BIS. The cross-linking reaction was allowed to proceed at 65 °C for 5 h. 
Cytotoxicity assay. The cytotoxicity of the tested polymers and their polyplexes with DNA was assessed 
using the MTT-dye reduction assay. This method is based on the ability of vital cells to metabolize a yellow 
tetrazolium salt to the violet formazan product, which is spectrophotometrically quantified. The assay 
was performed according to a previously described protocol27 with slight modifications.28 Exponentially 
growing cells were plated in 96-well sterile plates at a density of 104 cells/well in 100 μL of medium and 
incubated for 24 h. Then, the tested polymers or polyplexes were applied to the cells in a concentration 
range of 5-40 μg.mL-1 or 2.5 -14 μg.mL-1, respectively, for 72 h. For each concentration, a set of 8 wells was 
used. After a 72 h of continuous exposure, 10 μL aliquots of the MTT solution (5 mg.mL-1) were added to 
each well, and the plates were incubated for additional 4 h at 37 °C in a humidified 5 % CO2 atmosphere. 
The produced formazan crystals were solubilized by addition of HCOOH (5 %) acidified isopropanol. The 
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MTT-formazan absorbance was determined on a microprocessor-controlled multiplate reader (Labexim 
LMR-1). 
 
3.3 Results and discussion 
3.3.1 Hydrolysis of PPrOx 
The hydrolysis or PPrOx was investigated under acidic conditions in 6 M HCl at 100 °C. The hydrolysis 
kinetics was determined by taking samples at different times and the degree of hydrolysis (i.e. the 
copolymer compositions) of these samples was determined via 1H NMR spectroscopy from the signals at 
2.6-2.8 ppm and 3.2-3.5 ppm (Figure 3-1). It was observed that during the initial stage of the reaction, white 
milky dispersions were formed that sometimes contained macroscopic flocks, which can be ascribed to 
performing the reaction at a temperature well above the TCP of the starting PPrOx. During hydrolysis, the 
side chains of PPrOx are cleaved, resulting in the formation of ethylenimine units while butyric acid is 
released. The appearance of a signal corresponding to the methylene protons adjacent to NH at 2.8 ppm 
(Figure 3-1) as well as its increase in intensity with reaction time quantitatively confirmed the progress of 
hydrolysis. 
 
Figure 3-1 1H NMR spectra of the initial PPrOx (black line) and the resulting PPrOx-PEI copolymer with 10 % PEI 
content (red line). 
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 The conversion, which is expressed as the degree of hydrolysis as a function of reaction time, is shown 
in Figure 3-2. The hydrolysis is slow during the initial stage of the reaction, which is most likely due to the 
hydrophobicity of the polymer at temperatures above its TCP of 25 °C. Nonetheless, even under these 
reaction conditions, H3O+ can slowly reach the side chains and cleave them off. With the slow progress of 
the hydrolysis in the initial stage, the polymer chains become more soluble, which accelerates the 
hydrolysis (Figure 3-2, linear increase of conversion). The conversion reached a plateau at about 90 % after 
ca. 2 hours. In comparison to the previously investigated hydrolysis of PEtOx, the hydrolysis of PPrOx is 
much slower ascribed to the higher hydrophobicity of PPrOx.11 The hydrolysis of PEtOx was already 50% 
after 40 minutes (DP 100) while the PPrOx (DP 75) barely reaches 20% hydrolysis.  
 
Figure 3-2 Degree of hydrolysis (%)of PPrOx75 as a function of the reaction time. Each point was measured in 
triplicate. 
 
It is important to note that after hydrolysis the copolymers maintained their narrow Ɖ (Figure 3-3), 
which implied that the polymer backbone was not cleaved during the reaction and well-defined PPrOx-
PEI copolymers were obtained. Minor variation in elution time during HFIP SEC can result from variation 
in HFIP water content obstructing hard conclusions on molar mass from SEC. Nonetheless, the SEC traces 
clearly show that the molar mass distribution remains intact during hydrolysis. 
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Figure 3-3 SEC traces in HFIP of selected samples taken at different time intervals (min) during the process of 
hydrolysis. 
 
3.3.2 Effect of PEI-units on Tcp of PAOx-PEI 
The phase separation of an aqueous solution of PPrOx upon crossing the TCP is driven by entropic 
dehydration of the side chains leading to release of the hydrating water molecules to the bulk water. Upon 
hydrolysis of PPrOx, an amine functionality is introduced into the backbone, which can influence the 
LCST properties of the resulting copolymers. A set of copolymers based on PPrOx75 with PEI contents 
ranging from 3 to 65 % were synthesized based on the determined hydrolysis kinetics. The TCP of these 
copolymers was determined using DLS under various experimental conditions: in water, at different pH, 
and in presence of bovine serum albumin (BSA) and KSCN. DLS was utilized to determine the TCP as 
turbidimetry was found to be inaccurate possibly due to sticking of the copolymer material to the glass as 
well as formation of low scattering small aggregates. The TCP was taken as the onset of polymer 
aggregation from DLS. The results are summarized in Table 2.  
In water, the TCP of PPrOx75 was found to be 24°C. Upon increasing the PEI content to 16 %, a rather 
small increase of TCP was observed with maximal 8 °C increase up to a TCP of 32 °C. This rather small 
increase in TCP may be ascribed to only partial protonation of the PEI units in water as well as potential 
shielding of the (charged) PEI units by the rather hydrophobic PPrOx units. Suh et al.29 demonstrated that 
about 77-85 % of the amines in PEI were unprotonated at neutral pH. The 16% showed that around 30% 
is of the CH2 is located in PEI, this means if we assume that we have block with three PEI units this means 
that 90% of the PEI is located in a block distribution. Further increasing the PEI content led to the 
observation of a plateau in TCP around 50 °C for a PEI content of 35 to 65 %. In chapter 2 we discussed that 
the polymers show a block-like distribution of PEI units along the chain. This means that it would be 
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difficult to protonate all of the amines and in the block not all of them are protonated. This also means 
that the charge present is enough to induce repulsion between the chains. Because the pH value of the 
solution plays an important role in the protonation of the PEI units, the TCP of the copolymers was also 
determined at pH of 5 and 11 where the PEI units are expected to be fully protonated and deprotonated, 
respectively. Unexpectedly, the TCP results at both pH values are the same confirming that the PEI units 
are rather shielded and do not have a strong influence on the solubility behavior of the PPrOx-PEI 
copolymers. Instead, the minor decrease in TCP at pH 5 and 11 may be ascribed to salting out effects. The 
next step involved the addition of a strong “salting-in” salt, namely KSCN that is known in the Hofmeister 
series to increase the solubility of non-polar molecules and decrease the order in the water shell. The 
addition of this salt resulted as expected in a significant increase in TCP as previously also shown for 
PPrOx.29 The general trend that more PEI units increase the TCP was retained in this series. Finally, the 
effect of the presence of a negatively charged protein, namely BSA, was studied. By adding the BSA the 
positive charges were shielded and this could potentially have an effect on the TCP. This means that there 
is a strong interaction with the negatively charged protein. The TCP of PPrOx-PEI copolymers with a 
hydrolysis degree lower than 16 was not affected by the presence of BSA. The PPrOx-PEI copolymers with 
higher PEI content revealed a significant increase in TCP indicating that the polymer interacts with BSA, 
which suppresses aggregation providing a first indication that these copolymers may be used for the 
formation of polyplexes with negatively charged nucleic acids.  
 
Table 2. TCP values (°C) for a series of PPrOx-PEI copolymers with increasing PEI content from 0 to 65 
% and total DP of 75. The copolymer concentration was 10 mg.mL-1. The TCP values were determined as 
the onset of aggregation from DLS.  
% PEI Water BSAa pH 11 pH 5 KSCNb 
0 24.0 22.0 21.0 24.0 40.0 
3 24.0 24.0 22.0 21.0 47.5 
5 30.0 30.0 24.0 21.0 42.5 
11 30.0 30.0 24.0 23.0 45.0 
16 32.0 34.0 24.0 26.0 50.0 
35 55.0 60.0 40.0 39.0 57.5 
58 50.0 69.0 48.0 48.0 67.5 
65 48.0 - 49.0 48.0 65.0 
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3.3.3 DOSY and ζ-potential measurements of 
PPrOx-PEI 
As mentioned in the previous section, upon the introduction of the ethyleneimine functionality, the 
partially hydrolysed copolymers preserved their thermoresponsive behavior. Next, the effect of the 
temperature induced phase transition of the PPrOx-PEI copolymers, shown in Table 3, on the 
physicochemical properties was investigated to evaluate their potential to interact with DNA. The 
copolymers in this set exhibit various total DPs (from 75 to 200) and are characterized by their PEI 
contents (i.e., 5 – 10 % range). The increasing PEI content shifted the transition (TCP) to temperatures that 
were substantially higher than the physiological temperature, as mentioned in the previous section. In 
addition, a substantial increase in the cytotoxicity can be anticipated for the copolymers with a higher PEI 
content. Therefore, the latter were not further studied.  
 
Table 3. ζ-potential of a series of PPrOx-PEI copolymers in aqueous solution measured at 25 and 37 °C. 
 
Copolymer ζ-potential (mV)  
25 °C 37 °C 
PPrOx71-PEI4 -2.6 ± 5.3 25.5 ± 6.5 
PPrOx68-PEI7 -6.3 ± 3.1 31.8 ± 8.4 
PPrOx149-PEI11 -5.0 ± 4.4 19.6 ± 5.6 
PPrOx146-PEI14 -6.1 ± 4.7 34.2 ± 6.7 
PPrOx182-PEI18 -6.1 ± 4.2 19.0 ± 6.9 
 
DOSY has been developed as a valuable tool for complex mixture analysis. The DOSY spectra typically 
represent a two-dimensional matrix that correlates the chemical shifts of the signals (the horizontal scale) 
with the diffusion coefficients (the vertical scale). The method exploits the differences in the diffusion 
coefficients, which are related to particle sizes, to spectroscopically discriminate between components in 
a solution mixture. Figure 3-4 shows the DOSY spectra of a 1 mg.mL-1 solution of the PPrOx68-PEI7 
copolymer (corresponding to 10% PEI content) recorded at 25 and 37 °C, which is below and above the 
TCP, respectively. At 25 °C, the signals are very well resolved, and their chemical shifts are correlated with 
one population of particles with a diffusion coefficient of 6.0 x 10-11 m2.s-1 (Figure 3-4a), corresponding to 
a hydrodynamic radius of approximately 3.3 nm representing molecularly dissolved copolymer chains. 
The signals changed drastically at 37 °C (Figure 3-4b) and their hyperfine structure disappeared, which 
  
 
92 
 
CHAPTER 3 
may be due to reduced mobility resulting from formation of large aggregates, presumably mesoglobules. 
Indeed, the DOSY spectrum measured at 37 °C shows the existence of a second population of slow moving 
particles with a diffusion coefficient of approximately 0.5 x 10-11 m2.s-1, corresponding to a hydrodynamic 
radius of ≈ 50 nm, when assuming spherical shape. The additional treatment of the diffusion profiles with 
CONTIN (Figure 3-4b) indicated the presence of even larger particles with broad size distribution (170–
260 nm), which are most likely clusters of mesoglobules.  
 
Figure 3-4 DOSY spectra of a 1 mg.mL-1 solution of PPrOx68-PEI7 recorded at 25 (a) and 37 (b) °C. 
 
Dynamic light scattering, which is an independent method for determining the particle size, confirmed 
the formation of large (Rh up to 120 nm) particles (mesoglobules) upon heating above the transition 
temperature. The differences in the mesoglobule size may be due to the different heating protocols, which 
are known to greatly influence their size and size distribution.30,31 Thus, the fast heating (temperature 
jump) leads to fast phase separation and formation of small kinetically frozen mesoglobules while the 
slow (gradual) heating allows the growth of the particles. 
Very interesting results were obtained from the electrophoretic light scattering (Table 3). At 25 °C, when 
the copolymers were molecularly dissolved, the ζ-potential was close to zero/slightly negative, which is in 
agreement with the small number of ethylenimine units, only part of which are charged.32 The, 
insignificant in magnitude, negative values of the ζ-potential most probably derive from special 
arrangement of the hydration layer around the copolymers and strongly suggest that the charged 
ethylenimine units are shielded by the PPrOx moieties so that the copolymers at those conditions behave 
as non-ionic species. At 37 °C, however, the ζ-potential became strongly positive, implying that 
aggregation induced relocation of the positive charges to the outermost surface of the mesoglobules 
occurred simultaneously with the polymer phase transition. The rearrangement is schematically 
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represented in Figure 3-5 and could be considered beneficial since it would increase the accessibility of 
the positive charges and, in turn, favor the interactions with DNA and formation of better defined 
polyplexes. Besides the relocalization effect, we can speculate on lowering of pKa due to the collapse of 
PPrOx and more effective protection of the amino groups as reported elsewhere for other systems.33–35 
 
Figure 3-5 Schematic representation of the formation of mesoglobules from PPrOx-PEI copolymers in aqueous 
solution as well as the proposed rearrangement of the positive charges. 
 
3.3.4 Complexation of PPrOx-PEI with DNA 
The picture, derived from the previous section, illustrates that well-defined nanosized particles 
(mesoglobules) are formed at elevated (invariably above the TCP) temperatures that are composed of a 
large hydrophobic core of collapsed PPrOx and a thin positively charged shell with amino groups 
accessible for complexation with oppositely charged nucleic acids. This structure of the charged 
mesoglobules mimicks the structure of the globular proteins to a great extent. One can anticipate that 
with a further increase of temperature those features would become more pronounced, i.e., the core would 
become more tight and compact due to further dehydration and the positively charged groups would 
become more accessible, which would favor the polyplex formation. Therefore, the complexation with 
DNA was performed at temperatures well above the LCST of the PPrOx-PEI copolymers by drop-wise 
addition of an aqueous solution of DNA to a heated to 65 °C copolymer dispersion under vigorous stirring. 
Polyplexes were obtained at N/P ratios in the 0.5 – 10 range. At 65 °C, the polyplex particles were 
relatively small with hydrodynamic radii as determined by DLS typically less than 100 nm (Figure 3-6). 
The three studied copolymers contained the same amount of PEI (8.5 – 10 %) but a different total DP. 
However, no noticeable effect of the DP on the particle size was observed with the exception of the 
copolymer with the lowest DP, which exhibited a slight increase in Rh, to approximately 200 nm only at 
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the highest N/P ratios (Figure 3-6a). Lowering the temperature to 25 °C had a dramatic effect on the 
particle sizes because a 5- to 10-fold increase in Rh at a N/P ≥ 2 was observed (Figure 3-6). The increase 
was significantly smaller at N/P < 2 and the size of the resulting particles was still appropriate for 
intravascular administration. After a further increase in temperature to the physiological value of 37 °C, 
the behavior of the systems did not change and the Rh vs. N/P curve patterns generally followed those at 
25 °C.  
 
 
Figure 3-6 Influence of the N/P ratio on the hydrodynamic radii (Rh) of the polyplexes obtained with the PPrOx68-
PEI7 (a), PPrOx146-PEI14 (b), and PPrOx182-PEI18 (c) copolymers. The polyplexes were prepared at 65 °C, then cooled to 
25 °C and heated again to the physiologically relevant 37 °C. The hydrodynamic radii were determined by DLS. 
 
Upon decreasing temperature to 25 °C, disintegration of the PPrOx core and transition to a molecularly 
dissolved state were initiated. However, the DNA remained bound to the PEI moieties and at N/P ratios 
≥ 2, the DNA acted as a physical cross-linking agent. As a result, enormously swollen microgel particles 
that tended to further aggregate due to the low ζ-potential (Figure 3-7) were formed. The rearrangement 
is schematically represented in Figure 3-8. At lower N/P ratios (< 2), the role of DNA, which was in excess, 
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was no longer as a cross-linking agent. Instead, the layer that it formed on the surface of the mesoglobules 
by binding to the PEI moieties probably provided a barrier function similar to that of a membrane, which 
strongly reduced the mobility of the PPrOx moieties and prevented the latter from leaving the initial 
polyplex particles. Furthermore, the strongly negative ζ-potential (Figure 3-7) contributed to the colloidal 
stability of the particles and inhibited aggregation. The overall size of the particles increased only slightly, 
which can be ascribed to swelling of the PPrOx core. The rearrangement that occurred upon cooling 
affected only the PPrOx cores, which transformed from dense and compact to swollen and loose. 
The expected restoration process of the initial structure of the polyplex particles at N/P ≥ 2 did not take 
place upon heating to 37 °C, though this temperature was above the TCP. The values of the ζ-potential were 
restored (Figure 3-7), but the Rh values were not (Figure 3-6). To explain this result, it is important to 
recall the restricted mobility of the copolymer chains that are fixed to the large DNA molecules via 
numerous cross-linking centers/junctions (Figure 3-8). This limited freedom prevented the re-formation 
of the initial structures. Instead, small in volume but large in number PPrOx domains, interconnected via 
DNA, were presumably formed (Figure 3-8). With this rearrangement, the PEI moieties that were not 
involved in interactions with DNA (note that at N/P ≥ 2, the copolymer is in excess) preferentially 
migrated to the surface of the microgel particles, whereas DNA remained mainly in their interior, which 
explains the restoration of the ζ-potential values. 
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Figure 3-7 Variations of ζ-potential of polyplexes formed from PPrOx68-PEI7 (a), PPrOx146-PEI14 (b), and 
PPrOx182-PEI18 (c) copolymers with the N/P ratio at 25 and 37 °C. 
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Figure 3-8 General scheme of the rearrangements of the structures formed from PPrOx-PEI copolymers and DNA at 
N/P ≥ 2 due to temperature variations. Up: formation of mesoglobules and polyplex particles at elevated temperatures. 
Down: schematic representation of part of the interior of the enormously swollen polyplex particles at lower 
temperatures and their rearrangement upon heating from 25 to 37 °C. Interparticle aggregation may also contribute 
to dimensional changes. Structures are not drawn to scale. 
 
3.3.5 Coating of the polyplex particles 
In summary, the results discussed in the previous section indicate that upon cooling from 65 to 25 °C 
followed by heating to a physiologically relevant temperature, the polyplex nanoparticles at N/P ≥ 2 
underwent unfavorable rearrangement, which was associated with a tremendous increase in the size and 
formation of microgel particles. The particles at N/P < 2 typically preserved their initial dimensions. 
However, these particles were negatively charged, which might also influence unfavorably the interactions 
with cell membranes and, in turn, the cellular uptake. To avoid undesirable rearrangement into large 
microgel particles, the initial polyplex nanoparticles were stabilized by coating them with a cross-linked 
polymeric shell. A similar approach has recently been employed to prepare polymeric nanocapsules36 and 
cover complexes of DNA and cationic copolymers.25,26,37 This method employs heterophase radical 
copolymerisation that occurs on the surface of the (polyplex) particles. The resulting shell acts as an 
envelope (i.e., a physical barrier) that provides mechanical strength and keeps the initial particles tight, 
preventing substantial swelling and eventual disintegration. In addition, stealth properties, targeting, and 
membrane functions can be imparted to the more sophisticated constructions.30 
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The polyplex nanoparticles that were prepared from the PPrOx182-PEI18 copolymer at N/P = 4 were 
coated via heterophase (seeded) copolymerisation of Poly(N-isopropylacrylamide) NIPAM and NN-
methylenbisacrylamide (BIS). The latter acted as a cross-linking agent and the polymerisation was 
initiated by 2,2'-azobis(2-methylpropionamidine) dihydrochloride. Note that this is a model system for 
proof of concept and for future continuation of this work towards gene delivery a degradable crosslinker 
will be introduced. 
The construction of the coating was performed immediately after formation of the polyplex 
nanoparticles at 65 °C. The monomer and initiator amounts as well as the polyplex concentration were 
selected to obtain a shell thickness of approximately 30 nm. The consecutive steps for shell formation and 
cooling to 25 °C as well as the corresponding variations in hydrodynamic radii are shown in Figure 3-9. 
The construction of the shell was associated with a slight increase in Rh from 93 to 125 nm. The shell 
thickness was calculated from the difference between the hydrodynamic radii of the initial polyplex and 
the coated polyplex particles. In particular, the shell thickness for the system based on PPrOx182-PEI18 was 
32 nm, which was in very good agreement with the theoretical value. This result indicates precise and 
effective control during the coating procedure. Upon cooling to 25 °C, the coated polyplex particles slightly 
increased in size. As previously suggested,38 the shell, which is based on PNIPAM, acts as water-permeable 
elastic and flexible protective outer layer, possessing properties of a thermoresponsive hydrogel that 
allows for swelling upon cooling and deswelling (shrinking) upon heating. Note that the LCST of PNIPAM 
is 32 °C and upon cooling from 65 to 25 °C this critical temperature is crossed. A 50 % increase in the 
particle dimensions was observed for the systems based on PPrOx182-PEI18 (Figure 3-7). The increase was 
even smaller (below 22 %) for the systems based on copolymers with lower degrees of polymerisation 
(data not shown). Assuming that the shells were constructed following the same procedure, which implied 
the same cross-linking density, one may conclude that not only the PNIPAM shell but the copolymer 
molar mass has a substantial role in the swelling process. Nevertheless, the size increase of the coated 
particles upon cooling may be considered insignificant compared to the enormous (5- to 10-fold) increase 
in the size of non-coated polyplex particles (see above). This approach involving coating of the polyplex 
particles was successful in terms of retaining their colloidal stability and preserving the initial 
physicochemical parameters, especially the hydrodynamic dimensions. Other benefits include reduction 
of the strongly positive (or negative) values of the ζ-potential, which prevents salt-induced aggregation, 
reduces the protein and cell interactions that lead to extension of the plasma circulation time, modulates 
the interactions with the cell surface and cellular compartments, and reduces cytotoxicity. Whereas the 
former are subjects of forthcoming publications, the cytotoxicity evaluation of the copolymers, polyplexes 
and coated polyplexes is presented in the next section. 
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Figure 3-9 Schematic presentation of the approach for coating polyplex nanoparticles and their behavior upon cooling 
(upper panel). Size and size distribution variations of initial polyplex and coated polyplex, based on PPrOx182-PEI18 
copolymer at N/P = 4 at different temperatures (lower panel). Expansion of both PNIPAM shell and polyplex 
contribute to the dimensional changes 
 
3.3.6 Cytotoxicity evaluation 
The lack of toxicity is an important prerequisite for the excipients used in preparation of drug or gene 
delivery systems. However, one of the major limitations against broad application of PEI is its prominent 
cytotoxicity. Therefore, a basic cytotoxicity evaluation of the copolymers and their counterpart polyplexes 
was performed using a panel of human cell lines with different cell type and origin (RPMI-8226, HL-60, 
and EJ). The corresponding concentration-response curves are shown in Figure 3-10. As evident from the 
results, the tested copolymers exhibited strong concentration-dependent cytotoxic effects, causing almost 
total eradication of viable cells at the highest concentration levels. For the sake of comprehensiveness we 
also tested the cytotoxicity potential of the reference PEI. Despite of the shown inhibitory effect on the 
cell proliferation, the tested copolymers are less toxic as compared to PEI which has an IC50 values of 10.7 
μM (Figure 3-10d). The toxicity increase could be caused by the fact that all positive charges are on the 
outside of the mesoglobule and thus in direct contact with the organism. 
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Figure 3-10 (a-c) Cytotoxicity of a series of PPrOx-PEI copolymers determined by the MTT-dye reduction assay after 
72 h of continuous exposure towards a panel of human cell lines. Each data point represents the arithmetic mean ± 
SD of 8 separate experiments. (d) IC50 values of selected PPrOx-PEI copolymers and referent PEI towards HL-60. 
 
Considering the proposed utility of tested copolymers for gene delivery vectors, we sought to determine 
the cytotoxic potential of their non-coated and PNIPAM-coated polyplexes after 72 h exposure (Figure 3-
9). In contrast to the cytotoxicity of the free copolymers, the polyplexes are characterized with far less 
prominent inhibitory effects on cell viability (cf. Figure 3-8 a-c with left panel of Figure 3-9). Even at the 
highest concentrations the inhibitory effect on cell viability was not more than 30 % as compared to the 
untreated control. This lower cytotoxicity of the polyplexes is probably due to shielding the positive 
charges of PEI resulting from the complexation with the DNA. The coating of the polyplexes with PNIPAM 
contributed to further loss of cytotoxic effects (Figure 3-9) and rendered them practically devoid of 
cytotoxicity. The favorable effect is better pronounced for HL-60 and RPMI-8226. Obviously, the 
additional diffusion steric barrier afforded by the coating hampered the accessibility of the toxic cationic 
surface groups of the PPrOx-PEI to the biological targets, mediating their cytotoxicity.  
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Figure 3-11 Cytotoxicity of non-coated (a – c, left panel) and the corresponding PNIPAM-coated (d – e, right panel) 
polyplexes at N/P = 4, determined by the MTT-dye reduction assay after 72-h continuous exposure. Each data point 
represents the arithmetic mean ± SD of 8 separate experiments 
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3.3.7 Transfection experiments 
After the formation the polyplexes of DNA with PPrOx182-PEI18, the (non-coated) particles were tested 
in an in vitro cell transfection experiment. The test was performed on two human cell lines, non-malignant 
HEK-293 (human kidney embryonal cells) and malignant REH (acute leukemia), by using flow cytometry. 
By using cationic polymers genetic information is introduced into the cell whereby a fluorescent protein 
is expressed, such that the flow cytometer can detect these cells. The b-PEI was used as a reference 
transfection agent. The non-coated polyplexes showed a 65% transfection efficiency as compared to the 
b-PEI. The particles with the PNIPAM shell had only 45%.  
 
Figure 3-12 Transfection efficiency of non-coated and coated PPrOx-PEI polyplexes at N/P 4 expressed as % relative 
to fluorescence of b-PEI-polyplexes taken as 100%. 
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3.4 Conclusions  
 
PPrOx-PEI copolymers were prepared by acidic hydrolysis of PPrOx at 100 °C in 6 M HCl. Kinetic studies 
revealed a slow initial phase of hydrolysis and a plateau at around 90 % conversion. The hydrolysis of 
PPrOx was a substantially slower process compared to that of PEtOx due to the higher hydrophobicity of 
PPrOx. The partial hydrolysis kinetics and procedure was then applied for the preparation of a series of 
PPrOx-PEI copolymers yielding well-defined copolymers. 
The introduction of PEI moieties distributed along the PPrOx chain gradually increased the TCP in water 
from 24 °C for the PPrOx75 to 32 °C for PPrOx-PEI with 16% PEI. Copolymers with 35% to 65% PEI all had 
a TCP around 50 °C. The TCP values were found to mildly decrease when the solution pH was adjusted to 
either 5 or 11 indicating that the protonation state of the PEI moieties has little influence, ascribed to their 
shielding by the PPrOx moieties. Finally, the TCP shifted to higher temperatures upon addition of KSCN 
due to the salting-in effect and by specific interaction with BSA as indicated by the clear dependence of 
the effect of BSA on the PEI content of the copolymers. 
At elevated (above TCP) temperatures, the DOSY NMR and electrophoretic light scattering results 
revealed formation of well-defined nanosized particles (mesoglobules) composed of a PPrOx core and a 
thin shell with numerous positively charged amino groups that are accessible for complexation with 
oppositely charged nucleic acids. A series of copolymers that varied in their total degree of polymerisation 
and PEI content (i.e., 5–10 % range) was evaluated as DNA delivery carriers. Polyplex particles with Rh 
typically less than 100 nm were obtained at N/P ratios in the 0.5 – 10 range at 65 °C. Upon lowering the 
temperature to 25 °C (below TCP) followed by an increase to a physiologically relevant temperature (i.e., 
37 °C, above TCP), the polyplex particles at N/P < 2 underwent minor changes in their dimensions ascribed 
to the formation of a surface layer of DNA, which was in excess, that acted as a barrier and prevented 
swelling and disintegration of the initial particles. The polyplex particles at N/P ≥ 2 dramatically 
rearranged upon cooling below the TCP into strongly swollen microgel particles, in which the PPrOx core 
disintegrated and the individual copolymer chains were proposedly fixed to the DNA molecules via 
numerous junctions with ethylenimine units (Figure 3-8). Additional rearrangement consisting of the 
formation of numerous small PPrOx domains that were interconnected via DNA (Figure 3-8) occurred 
upon heating to 37 °C. However, the initial arrangement of the particles was not restored. This 
rearrangement of the polyplexes upon cooling could be overcome by coating of the initial polyplex 
nanoparticles with a cross-linked polymeric shell. The resulting outer layer acted as a physical barrier that 
prevented strong swelling and disintegration of the initial particles upon cooling.  
The bioassay clearly showed that the complexation and then in turn the outer coating each afforded for 
progressive loss of cytotoxicity as compared to the free PPrOx-PEI copolymers. Thus, besides the steric 
  
 
104 
 
CHAPTER 3 
stabilization, the outer coating is associated with a potential bypass of the safety issues of polyplexes as 
non-viral vectors for gene delivery. 
This chapter showed that besides PEtOx and PMeOx, the PPrOx is another valuable candidate as 
precursor for L-PEI. The partial hydrolysis of PPrOx, which was used in chapter 2 for the confirmation of 
the block like acidic hydrolysis, was further investigated to determine the hydrolysis kinetics. This opens 
up a new polymer toolbox that allows the preparation of biocompatible thermoresponsive polymers. The 
partially hydrolysed PPrOx-PEI polymers contain amines, which can be used as a reactive handle to couple 
bioactive molecules. The use in gene transfection is just one possible application that opens up new 
opportunities for thermoresponsive polymers in gene delivery. The chemical modifications proposed in 
the following chapters can of course also be applied on these PPrOx-PEI copolymers to make functional 
derivatives. 
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Prologue 
Next to its DNA binding ability the L-PEI units can act as a reaction platform to introduce new 
functionalities. This gives the possibility to make different types of copolymers without the burden of new 
monomer synthesis. In this chapter the modification of PEI units in either a pure L-PEI polymer or in a 
PEtOx-PEI copolymer, yielding a copolymer of L-PEI and a copolymer of PEtOx respectively. The reaction 
we explored was the reaction between an amine and CO2 resulting in a carbamate. This fluorescent 
zwitterion is introduced on L-PEI or PEtOx, obtaining either a fluorescent L-PEI as a potential gene 
transfection agent and a fluorescent biocompatible polymer as such expanding the chemical toolbox of both 
polymers. 
4.1 Introduction 
Poly(2-alkyl-2-oxazoline)s (PAOx) are a class of polymers with many applications in the biomedical field 
due to their excellent biocompatibility.1–3 The polymers can be seen as a competitor for the current gold 
standard PEG.4 Both polymers have similar behavior in biological media,5 although the PAOx polymer 
class is superior when it comes to chemical versatility6. Chemical functionalities on the PAOx polymer 
can be introduced through end groups6, through functional monomers6–8 or via post-polymerisation 
modification.9 The main example of post-polymerisation modification of PAOx is the (partial) hydrolysis 
of PAOx into linear poly(ethylene imine) L-PEI.10 The L-PEI is the key reference in gene transfection 
experiments.11,12 The amines on the backbone of L-PEI can not only be used as a charge carrier but also for 
a broad range of reactions to introduce chemical functionalities along the backbone.13 These reactions can 
be applied on the fully hydrolysed L-PEI and on the partially hydrolysed PAOx-L-PEI.14,15 As such the post-
polymerisation modification can be used to introduce different kind of functionalities, which broaden the 
application field of the PAOx polymer class and broaden the chemical toolbox. The introduced 
functionalities are often bioactive molecules but it is also possible to prepare fluorescent polymers.  
Remarkably there are not a lot of fluorescent poly(2-alkyl-2-oxazoline)s published.16–18 The first  example 
was reported by Kanazaki et al16 and showed the coupling of a indiocyanine green molecule to a partially 
hydrolysed PEtOx. The group of Ana Aguiar-Ricardo synthesized PAOx polymers in scCO2 and observed 
that they exhibited a blue fluorescence, which originates from the carbamic acid that was formed during 
the initiation.19 This origin of fluorescence was proven by comparing it to the small model molecule tris(2-
aminoethyl) carbamic acid.20 These carbamic acid containing PEtOx were further used as a tag for 
bacterial cell membranes, when the PAOx was end capped with quaternary amines.21–23 The initiator based 
method is advantageous because it allows to orthogonally alter the side chain and terminator end. The 
same group also showed the development of a dendrimeric theranostic based on polyurea and a 
fluorescent poly(2-methyl-2-oxazoline) (PMeOx) and PEtOx. As model drug, paclitaxel was loaded into 
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the dendrimer. However, this polymer only contains one carbamate per polymer chain limiting the 
achievable fluorescence intensity. A combination of the biocompatible PEtOx or PMeOx with fluorescent 
carbamate groups in the side chains would make a powerful tool in fluorescent imaging.  
Fluorescent imaging is crucial for the understanding of dynamic biological processes and detection and 
diagnosis of diseases. The chromophore visualizes the site of interest without being invasive hence not 
interfering.24 The fluorescent chromophores can have an organic, inorganic or hybrid nature.25,26 
Fluorescent organic molecules24 are often bulky proteins27–30 such as GFP31 or conjugated dyes e.g. 
rhodamines32. These organic molecules often show low sensitivity due to low absorption and photo 
bleaching. Quantum dots33,34 are an example of fluorescent inorganic materials, besides other inorganic 
particles such as metal nanoparticles or silica nanoparticles.24,33,35,36 Some of the organic and inorganic 
dyes suffer from inherent toxicity, which is problematic in a biological context.29,34,37,38 The overall 
biological properties of fluorescent materials can be improved by combining them with biocompatible 
polymers. Polymers can act as a stabilizer and ensure better solubility of fluorescent materials while also 
expanding the chemical modification potential. Which can be used to incorporate selective targeting, or 
coupling of bioactive molecules. Thereby theranostic polymers can also be developed by coupling drugs 
or reactive molecules to the fluorescent polymer.37 The polymer needs to be non-toxic while both short 
and long term protecting the chromophore from the harsh biological environment preventing leakage 
and degradation for which PAOx are very promising. Higher intensities are achieved by multiple 
fluorescent dye loading, to increase the local concentration and thereby resulting in brighter signals.  
Different methods can be applied for the synthesis of fluorescent polymers, either through 
polymerisation or a post-polymerisation modification.37,39 During the polymerisation a fluorescent moiety 
can be used as an initiator40 or terminator or covalently bound to a monomer that is polymerised.39 The 
post-polymerisation modification method uses reactive groups on the polymer to couple the fluorescent 
dye on one or both of the terminal groups41 or the side chains.42,43 Besides fluorescently labelled polymers, 
intrinsically fluorescent polymers can also be used for imaging, mostly conjugated polymers.44–47 
Intrinsically fluorescent polymers that lack extended π-conjugated systems are rare, but can be obtained 
when the electron hole (LUMO) and excited electron (HOMO) are in close proximity, both electronically 
and spatially. In the case of amino containing dendrimers the coexistence of carboxylic acids and tertiary 
amines have been reported to induce fluorescence.48–50 The fluorescence intensity increased upon 
oxidation of the amine groups.49–53 In some cases the protonation is important which was shown when 
poly(amido amine) (PAMA) dendrimers containing urea bonds had intrinsic pH dependent 
fluorescence.48 The role of the polymer branching on the recombination of the electron with its hole was 
examined by comparison of branched and linear poly(ethylene imine) (b-PEI and L-PEI) were compared, 
both showing blue emission.54 The complex with oxygen and the electron lone pair of the amine plays a 
crucial role as it induces an electron hole recombination process which causes the emission.54 This was 
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demonstrated by an increase in fluorescence upon oxidation. Note that the fluorescence was measured in 
methanol as L-PEI in its free base form, is not soluble in water. b-PEI, which is water soluble, shows 
increased fluorescence after reaction with CO2. The origin of the fluorescence of PEI is the formation of 
conjugated system when the lone electron pair of the nitrogen forms a conjugated system with the 
deprotonated carbamate.55 The last examples showed that it could be possible to synthesise PEI with a 
fluorescent label by the reaction with CO2. 
The primary amines in b-PEI can react with ambient CO256 leading to the formation of zwitterionic 
carbamates.57,58 CO2 is at first sight a simple linear non polar molecule, however with complex chemistry. 
Due to the charge distribution the central carbon atom is prone to nucleophilic attack.57,59 The attack of 
a amine, Scheme 4-1, yields a carbamate that is immediate deprotonated by non-reacted amines. This acid 
base equilibrium results in the formation of a stable zwitterion as shown in Scheme 4-1.55,57,59,60 As a 
consequence half of the amines react with the CO2 while the other half acts as a base and is protonated.61 
The nature of the amine is crucial as secondary amines react much slower with CO2 than primary amines 
due to enhanced steric hindrance.62 This reaction is reversible, whereby the amine is formed and CO2 is 
released in the reversed reaction.23 
 
 
Scheme 4-1 Formation of the zwitterionic carbamate from a secondary amine (one step process, 
equilibrium).62,63 The nucleophilic attack of the first amine onto the carbon of CO2 forms a carbamate, 
the second amine acts as a base and deprotonates the carbamate resulting in the zwitterionic 
carbamate. 
 
This reversible reaction could be advantageous in industrial applications to filter CO2 out of waste 
streams via the formation of carbamates. Therefore b-PEI and L-PEI have been applied in CO2 scrubbers.64 
However, upon reversible cycling, heating of the material, a loss in CO2 capture ability was observed, 
which has been ascribed to the irreversible formation of cyclic imidazolidinone. This reaction proceeds 
slower than the carbamate formation but can be accelerated at elevated temperatures (Figure 4-1, 
bottom).65 When two amines are in close proximity they form a cyclic urea while locking the CO2 on the 
diamine. The humidity of the gas stream plays a crucial role for this side reaction because wet gas was 
proposed to suppress the cyclic urea formation as during the ring closure water is released.64,66  
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Figure 4-1: Side reactions in amine-containing CO2 adsorbents: The reversible reaction between two primary amine 
forms an urea (top), the reaction of a secondary amine and CO2 is impossible due to steric hindrance(middle), the 
reaction of two connected secondary amines with CO2 forms a cyclic urea (bottom) 64 
 
By combining amine containing polymers and CO2, the formation of the carbamate functionality can 
lead to fluorescent polymers. The high amine concentration in L-PEI is of high interest for this reaction, 
because it could lead to fluorescent L-PEI as a gene transfection vector.11,12 Due to the nature of the reaction 
with CO2 only a part of amines will be functionalised. The first amine will react with the CO2 while the 
second amine will act as a base by deprotonating the carbamate. The combination of the fluorescent label 
and the qualities of L-PEI in gene transfection, will lead to a fluorescent non-viral vector. Next to the fully 
hydrolysed polymers, the partial hydrolysed PAOx polymers can be applied. The PAOx-PEI is a reaction 
platform and can be seen as a chemical handle for the introduction of different kind of functionalities. 
The amines of the PAOx-PEI polymers can react with CO2 to form carbamates. This enables the formation 
of intrinsically fluorescent PAOx containing polymers showing ‘stealth behavior upon injection in the 
body.67 The earlier reports showed that the more reactive primary amine of b-PEI reacted with ambient 
CO2 and that only at elevated temperatures the secondary amines of L-PEI react with CO2. The latter is 
caused by the steric hindrance induced by the secondary amines.  
To overcome the lower reactivity of the secondary amine of L-PEI, scCO2 was used for the modification 
of L-PEI in this study. This could increase the reaction rate and due to the non-solvent character no 
solubility problems should arise. Earlier reports showed that ambient CO2  reacts with the primary amines 
in b-PEI, however not with the secondary amines.56 As illustrated in Scheme 4-2, the reaction between the 
amine and scCO2 is anticipated to reversibly form deprotonated carbamates and protonated amines. 
However we have to keep in  mind that the irreversible formation of cyclic urea could also be possible, 
which could induce cross linking. Therefore, lower temperatures will be investigated and as well as the 
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presence of water to suppress cyclic urea formation. The reaction of the L-PEI with scCO2 was investigated 
for different reaction times to study the progress of the reaction and determine the optimal exposure time. 
 
Scheme 4-2 Reaction of the L-PEI with scCO2 forming carbamates. The scheme (from top to bottom) shows 
the hydrolysis of the PEtOx into a fully hydrolysed L-PEI. During the reaction of L-PEI with scCO2, carbamates 
are formed by the nucleophilic attack of the amine of the L-PEI on the CO2, the neighbouring amine on the PEI 
acts as a base yielding the carbamate zwitterion. Cyclic urea can be irreversibly formed thereby water is released. 
The formation of this bond leads to crosslinking (red square). 
 
The second part of this chapter focuses on the reaction of a PEtOx-PEI copolymer with scCO2. This 
polymer was synthesised by the partial acidic hydrolysis of PEtOx, yielding a polymer with a block-like 
distribution of blocks of L-PEI present along the backbone, which was shown in chapter 2. The amines of 
the PEI parts can react with the scCO2 yielding the carbamates (Scheme 4-3). The remaining PEtOx 
remains unmodified and will yield a biocompatible polymer. This methodology gives the opportunity to 
obtain multiple carbamate units on one polymer chain proposed leading to a higher fluorescence 
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intensity. This is quite different from the earlier reported PEtOx containing carbamates end-groups 
prepared in scCO2. (Figure 4-2). As shown in Figure 4.2 these polymers with a single carbamate end-group 
could already be used as a tag for the cell wall. We will obtain a polymer with a much higher carbamate 
loading hence a much higher fluorescence potentially allowing their use for fluorescence imaging at much 
lower concentration. 
 
 
Scheme 4-3 Reaction of the PAOx-PEI with scCO2 forming carbamates. This scheme (from top to bottom) 
shows the partial hydrolysis of the PEtOx into PEtOx-PEI polymer. During the reaction with scCO2, carbamates 
are formed by the nucleophilic attack of the amine on the CO2, the neighbouring amine on the PEI acts as a 
base to deprotonate the formed carbamate. 
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Figure 4-2 Fluoresence labelling of S. Aureus using carbamate containing oligo(2-methyl-2-oxazoline) terminated with 
N,N-dimethyldodecylamine. Bacterial cells visualized by phase contrast (left panels) and cells visualized by 
fluorescence microscopy using DAPI filters (right panels). (A) cells in the absence of oligomer and cells in the presence 
of oligomer with low carbamic acid (B)and high end group functionalisation degree, (C).20 
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4.2 Materials and methods 
4.2.1 Instrumentations 
Size exclusion chromatography (SEC) was performed using an Agilent HPLC equipped with a 1260 
refractive index detector (RID) and UV-VIS detector with detector set on 375 nm. Using 1,1,1,3,3,3-
hexafluoro-2-isopropanol (HFIP) containing 20 mM sodium trifluoroacetate as eluent, which was dried 
with molecular sieves (3 Å). The flow rate was 0.53 mL/min (HFIP-SEC). Polymethylmethacrylate (PMMA) 
standards were used to calculate the molar mass values. The column set consisted of two PSS PFG 300*8Ǻ 
gel 5 µm MIXED-D columns and a similar guard column (PSS) in series with a molar mass range from 100-
1 000 000 at 35 °C. Chromatograms were analyzed with Agilent Chemstation software using the GPC add-
on. The hydrolysis reactions were done in a single mode microwave Biotage initiator eight using 
temperature control (IR temperature sensor) (Biotage, Uppsala, Sweden). NMR measurements were done 
using a Bruker AVANCE II spectrometer operating at 400.12 MHz for 1H and at 100.61 MHz for 13C. All 
analysis were done with the Spinworks 4.2 Software and chemical shifts are given in ppm. The exposure 
of the polymers to supercritical CO2 was done in a house built autoclave, clamp sealed, Mk.III stainless 
steel autoclave. DSC measurements were performed on a Q2000 from TA Instruments from -50 to 200 
degrees and for the modulated DSC samples the temperature was modulated by ± 1°C every 60 s with an 
overall heating rate of 3 °C/minute. The fluorescence measurements were done in a Varian Cary Eclipse 
spectrophotometer equipped with a Cary temperature and stir control. 
 
4.2.2 Materials 
PEtOx with a degree of polymerisation (DP) of 400 was synthesized as reported elsewhere (Mn =40600 
; Ð = 1.06).68 Hydrogen chloride, sodium hydroxide and dichloromethane where obtained from Sigma-
Aldrich and used as received.  
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4.2.3 Procedures 
 
Partial hydrolysis of PEtOx to PEtOx307-PEI93 
PEtOx (2 g, DP 400) was dissolved in 7.5 mL of water under stirring. Then, 7.5 mL of a 36 wt% solution 
of concentrated HCl was added and the mixture was heated to 140 °C in the microwave for 40 min. After 
the hydrolysis, the volatiles were removed on a rotary evaporator. The polymer solution was basified to 
pH 10-11 by addition of a 2 M NaOH solution. The solution was then lyophilized and the solid was dissolved 
in dichloromethane while the salts remained as solids in the flask. Next, the organic phase was filtered 
and concentrated under reduced pressure to yield a solid white product. The integral ratio between the 
peaks at 2.56-2.8 ppm (PEI backbone) and 3.15-3.6 ppm (PEtOx backbone) in the 1H-NMR spectrum are 
used to calculate the degree of hydrolysis (23%). 
PEtOx307-PEI93: 1H NMR (CDCl3):  = 0.9 – 1.25 (m, 3H, 5); 2.1 – 2.50 (m, 2H, 4), 2.56 – 3.0 (m, 4H, 6); 
3.15 – 3.60 ppm (m, 4H, 2). 13C NMR (CDCl3):  = 9.4 (CH3, 5); 25.9 and 26.2 (CH2, 4); 43 – 51 (CH2, 6 and 
2); 175-173 ppm (C=O, 3). (Mn = 33980 g/mol; Ð = 1.1). 
 
Full hydrolysis of PEtOx400 to PEI400 
PEtOx (2 g, DP 400) was dissolved in 7.5 mL of water under stirring. Then, 7,5 mL of a 36 wt% solution 
of HCl (concentrated HCl) was added and the mixture was heated to 140 °C in the microwave for 3 hr. 
After the hydrolysis, the volatiles were removed on a rotary evaporator. The polymer solution was basified 
to a pH 10-11 by addition of NaOH pellets and stirring while heating until the polymer was dissolved. When 
the solution was cooled the polymer precipitated. After filtration the powder was lyophilized. A white 
powder was obtained. 
PEI400 (1&3)1H NMR (CD3OD):  = 2.7-28(s,CH2,6). 13C NMR (CD3OD):  = 9.4 (CH3, 5); 25.9 and 26.2 
(CH2, 4); 49.7 – 51 (CH2, 6); PEI-1 (Mn = 87000 g/mol; Ð = 1.13) and PEI-2(Mn = 84000 g/mol;Đ = 1.23) 
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Modification of the polymers with supercritical CO2 
The polymer, typical 100 mg, was transferred into a small glass vial that was placed in the autoclave. 
Secondly the autoclave was heated to 135°C, except PEI400 (24C), which was done at 40°C. The CO2 pressure 
was raised up to 27.58 MPa. After the desired reaction time the autoclave was vented. NMR samples were 
prepared by dissolving the polymer in D2O.  
Three start polymers, PEI-1 (DP 400); PEtOx-PEI-2 (DP 400) and PEI-3 (DP400) were used and were 
reacted simultaneous in the autoclave. The yield of the reaction between the amine of the polymer  and 
CO2 was calculated via 1H-NMR spectroscopy by using the values of integration of the CH2 (peak 
5&6&7)next to the formed carbamic acid functionality, divided by the total CH2 protons(peak 1-7) 
 
Data of the PEI-1(x) polymers 
PEI-1(0.5) 1H NMR (D2O):  = 2.7-2.8(m,CH2,1); 3.0 (m,CH2,2);3.01 (m,CH2,3);3.14 (CH2,m,4);3.24-3.35 
(CH2,s,5); 3,4. (CH2,m,6); 3.49(CH2,s,7) . 13C NMR (D2O):  = 44.77 (CH2, 7 and 1); 46.49(CH2,5); 46.85 
(CH2, 3);47.44 (CH2, 4); 160.34 (CO, 9); 163.6-164.40 (NCO)(Mn = 13700 g/mol; Ð = 1.3) 
PEI-1(1) 1H NMR (D2O):  = 2.7-2.8 (m,CH2,1); 3.0 (m, CH2,2); 3.01 (m, CH2, 3); 3.16 (CH2, m, 4);3.32-
3.35 (CH2, s, 5); 3,40. (CH2, m, 6); 3.48(CH2,s,7) . 13C NMR (D2O):  = 44.84 (CH2, 7 and 1); 46.43(CH2, 5); 
46.82 (CH2, 3);47.44 (CH2, 4); 160.34 (CO, 9); 163.6-164. (NCO)(Mn = 75000 g/mol Ð = 1.3) 
PEI-1(2) 1H NMR (D2O):  = 2.7-2.8 (m,CH2,1); 3.1 (m, CH2, 3);3.18 (CH2, m, 4);3.23-3.31 (CH2, s, 5); 3,42. 
(CH2, m, 6); 3.5 (CH2,s,7) . 13C NMR (D2O):  = 44.43 (CH2, 7); 44.68 (CH2, 1), 46.49(CH2,5); 46.92 (CH2, 
3);47.48 (CH2, 4); 160.26 (CO, 9); 163.6-164.19 (NCO) (Mn =47000 g/mol; Ð =1.76) 
PEI-1(2large) 1H NMR (D2O):  = 2.7-2.8 (m, CH2, 1); 3.1 (m, CH2, 3);3.18 (CH2, m, 4);3.23-3.31 (CH2, s, 
5); 3,42. (CH2, m, 6); 3.49(CH2, s, 7) . 13C NMR (D2O):  = 44.76 (CH2, 1&7), 46.49 (CH2,5); 46.92 (CH2, 
3);47.48 (CH2, 4); 160.26 (CO, 9); 163.6-164.19 (NCO) (Mn = 23295 g/mol; Ð = 1.65) 
PEI-1(24) 1H NMR (D2O):  = 2.7-2.8 (m, CH2, 1); 3.0 (m, CH2, 2);3.08 (m, CH2, 3);3.15 (CH2, m, 4);3.21-
3.31 (CH2, s, 5); 3,4. (CH2, m, 6); 3.49 (CH2, s, 7) . 13C NMR (D2O):  = 44.44 (CH2, 7); 44.76 (CH2, 1); 46.49 
(CH2, 5); 46.88 (CH2, 3);47.46 (CH2, 4); 160.34 (CO, 9); 163.6-164.19 (NCO) (Mn =28000 g/mol; Ð = 4.5) 
PEI-1(24C) 1H NMR (D2O):  = 2.7-2.8 (m,CH2,1); 3.0 (m,CH2,2);3.08 (m,CH2,3);3.16 (CH2,m,4);3.25-3.34 
(CH2,s,5); 3,4. (CH2,m,6); 3.49(CH2,s,7) . 13C NMR (D2O):  = 44.80 (CH2, 7 and 1); 46.48(CH2,5); 46.83 
(CH2, 3);47.51 (CH2, 4); 160.38 (CO,9); 163.6-164.40 (NCO)(Mn = 33000 g/mol; Ð = 1.55) 
PEI-1(48) 1H NMR (D2O):  = 2.7-2.8 (m, CH2, 1); 3.10 (m, CH2, 3); 3.14 (CH2, m, 4);3.28 (CH2, s, 5); 3.43. 
(CH2,m,6); 3.48(CH2,s,7) . 13C NMR (D2O):  = 42.42(CH2,6”); 43.01 (CH2,5); 44.90 (CH2, 7 and 1); 45.48 
(CH2,5); 46.83 (CH2, 3);47.51 (CH2, 4); 160.44 (CO, 9); 162.6 (NCO)-164. (NCO)(Mn =9105 g/mol; Ð = 11) 
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Table 1. Selected data of the PEI-1(x) copolymers obtained after reaction with scCO2 
 
* From 1H NMR spectroscopy. (* not determined) 
 
 
Data of the PEtOx-PEI-2(x) polymers 
PEtOx-PEI-2(0.16) ) 1H NMR (D2O):  = 0.9 – 1.25 (m, 3H, 5); 2.2 – 2.50 (m, 2H, 4), 2.65 – 2.88 (m, 4H, 
6); 3.20 – 3.60 ppm (m, 4H, 2,7,8). 13C NMR (D2O):  = 9.11 (CH3, 5); 25.99 (CH2, 4); 43 – 51 (CH2, 6,2,7 and 
8); 163.1 (NC=O,7 and 8),177 ppm (NC=O, 3). (SEC, not soluble in eluent) 
PEtOx-PEI-2(0.5) 1H NMR (D2O): = 0.9 – 1.10 (m, 3H, 5); 2.13 – 2.50 (m, 2H, 4), 2.73 – 2.90 (m, 4H, 6); 
3.20 – 3.73 ppm (m, 4H, 2,7,8). 13C NMR (D2O):  = 9.11 (CH3, 5); 25.99 (CH2, 4); 43 – 51 (CH2, 6,2,7 and 8); 
163.1 (NC=O,7 and 8),177 ppm (NC=O, 3). (Mn = 102000 g/mol; Ð = 1.30) 
PEtOx-PEI-2(1) 1H NMR (D2O): = 0.91 – 1.10 (m, 3H, 5); 2.20 – 2.48 (m, 2H, 4), 2.73 – 2.93 (m, 4H, 6); 
3.20 – 3.78 ppm (m, 4H, 2,7,8). 13C NMR (D2O):  = 8.9 (CH3, 5); 25.80 (CH2, 4); 42.4 – 48.04 (CH2, 6,2,7 
and 8); 160.4 (C=O);177 ppm (C=O, 3). (Mn = 35000 g/mol; Ð =1.36) 
PEtOx-PEI-2(2) 1H NMR (D2O): = 0.85 – 1.30 (m, 3H, 5); 2.13 – 2.50 (m, 2H, 4), 2.73 – 3.02 (m, 4H, 6); 
3.20 – 3.73 ppm (m, 4H, 2,7,8). 13C NMR (D2O):  = 9.11 (CH3, 5); 25.99 (CH2, 4); 42.4 – 47 (CH2, 6,2,7 and 
8); 160.4 (C=O); 163.1 (NC=O,7 and 8),177 ppm (C=O, 3). (Mn = 132000 g/mol; Ð = 1.18) 
Polymer  Reaction time (h) Amine conversion 
(%)* 
Tm (DSC) 
(°C) 
% loss (100-150°C) 
(TGA) 
PEI-1 0 0 68.8 / 
PEI-1(0.16) 10 min Insoluble* 68.3 4.8 
PEI-1(0.5) 0.5 36.9 65.2 32.4 
PEI-1(1) 1 36.5 65.2 32.2 
PEI-1(2) 2 39.9 53.2 40.5 
PEI-1(24) 24 41.6 40.7 28.4 
PEI-1(24C) 24 (40°C) 34.1 86.2 31.7 
PEI-1(48) 48 52.9 Tg (-21) 28.4 
PEI-
1(2Large) 
2 (0.5g) 
34.8 
63.7 36.0 
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PEtOx-PEI-2(2large) ) 1H NMR (D2O): = 0.85 – 1.10 (m, 3H, 5); 2.11 – 2.45 (m, 2H, 4), 2.74 – 2.95 (m, 
4H, 6); 3.20 – 3.80 ppm (m, 4H, 2,7,8). 13C NMR (D2O):  = 8.73 (CH3, 5); 25.4 (CH2, 4); 42.4 – 48 (CH2, 
6,2,7 and 8); 160.4 (C=O);177 ppm (C=O, 3). (SEC not recorded) 
PEtOx-PEI-2(24C) 1H NMR (D2O): = 0.90 – 1.18 (m, 3H, 5); 2.21 – 2.47 (m, 2H, 4), 2.65 – 3.07 (m, 4H, 
6); 3.20 – 3.80 ppm (m, 4H, 2,7,8). 13C NMR (D2O):  = 8.9 (CH3, 5); 25.6 (CH2, 4); 41.2 – 49 (CH2, 6,2,7 
and 8); 160.59 (C=O);177 ppm (C=O, 3). (SEC not recorded) 
PEtOx-PEI-2(24) ) 1H NMR (D2O): = 0.91 – 1.12 (m, 3H, 5); 2.12 – 2.47 (m, 2H, 4), 3.17 – 3.86 ppm (m, 
4H, 2,7,8). 13C NMR (D2O):  = 8.9 (CH3, 5); 25.6 (CH2, 4); 41.2 – 49 (CH2, 6,2,7 and 8); 160.59 (C=O);177 
ppm (C=O, 3). (Mn = 21753 g/mol; Ð = 2.82) 
PEtOx-PEI-2(48)1H NMR (D2O): = 0.93 – 1.15 (m, 3H, 5); 2.12 – 2.475(m, 2H, 4), 3.20 – 3.74 ppm (m, 
4H, 2,7,8). 13C NMR (D2O):  = 8.9 (CH3, 5); 25.4 (CH2, 4); 41.7 – 50.53 (CH2, 6,2,7 and 8); 160.59 (C=O);177 
ppm (C=O, 3). (Mn = 1791 g/mol; Ð = 8.03) 
 
Table 2 Selected data for PEtOx-PEI-2(x) obtained after reaction with scCO2; Note that amine 
conversion could not be determined due to overlapping signals 
 
Polymer  Reaction time 
(h) 
Tg (DSC) % loss (100-150°C) 
(TGA) 
PEtOx-PEI-2 0 35.8 / 
PEtOX-PEI-2(0.16) 10 min 24.5 3.5 
PEtOx-PEI-2(0.5) 0.5 64.8 (Tm) 9.1 
PEtOx-PEI-2(1) 1 67.4 7.3 
PEtOx-PEI-2(2) 2 70.7 (Tm) 9.4 
PEtOx-PEI-2(24) 24 59.1 (Tm) 8.0 
PEtOx-PEI-2(24C) 24/40°C 12.6 4.1 
PEtOx-PEI-2(48) 48 49.4 10.7 
PEtOx-PEI-2(2L) 2 (0.5g) 42.3 9.4 
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Data of the PEI-3(x) polymers 
PEI-3(0.5) 1H NMR (D2O):  = 2.80-2.93 (m, CH2, 1); 2.97 (m, CH2, 2); 3.01 (m, CH2, 3); 3.10 (CH2, m, 4); 
3.22-3.32 (CH2, s, 5); 3,37 (CH2, m, 6); 3.45 (CH2, s, 7) 13C NMR (D2O):  = 44.94 (CH2, 7 and 1);45.37 (CH2, 
7 and 1); 45.81 (CH2, 7 and 1) 46.40 (CH2,5); 46.65 (CH2, 3);47.399 (CH2, 4); 160.34 (CO, 9); 163.6-164.40 
(NCO) (SEC not recorded) 
PEI-3(1) 1H NMR (D2O):  = 2.75-2.95 (m, CH2, 1); 2.99 (m, CH2, 2); 3.03 (m, CH2, 3); 3.13 (CH2, m, 4); 
3.22-3.33 (CH2, s, 5); 3,40. (CH2, m, 6); 3.47 (CH2, s, 7) 13C NMR (D2O):  = 44.82 (CH2, 7 and 1); 45.22 
(CH2,7 and 1); 45.66 (CH2, 7 and 1) 46.43 (CH2, 5); 46.61 (CH2, 3); 47,43 (CH2, 4); 160.39 (CO,9); 163.6-
164.40 (NCO) (Mn = 66000 g/mol; Ð = 1.3) 
PEI-3(2)  1H NMR (D2O):  = 2.75-2.95 (m, CH2, 1); 2.96 (m, CH2, 2);3.03 (m, CH2, 3);3.10 (CH2, m, 4); 
3.22-3.33 (CH2, s, 5); 3,37. (CH2, m, 6); 3.45(CH2, s, 7) 13C NMR (D2O):  = 44.97 (CH2, 7 and 1); 45.40 
(CH2,7 and 1); 45.79 (CH2,7 and 1) 46.45 (CH2, 5); 46.76 (CH2, 3);47,42 (CH2, 4); 160.56 (CO, 9); 163.6-
164.45 (NCO) (SEC not recorded) 
PEI-3(24) 1H NMR (D2O):  = 2.78-2.98 (m, CH2, 1); 3.08 (m, CH2, 3);3.15 (CH2, m, 4);3.22-3.31 (CH2, s, 
5); 3,41. (CH2, m, 6); 3.48 (CH2, s, 7) 13C NMR (D2O):  =42.97 (CH2,not determined); 44.70 (CH2, 7 and 
1);45.41(CH2,7 and 1); 46.43(CH2,5); 46.88 (CH2, 3); 47,47 (CH2, 4); 160.28 (CO,9); 163.52-164.49 (NCO) 
(SEC not recorded) 
PEI-3(24C) 1H NMR (D2O):  = 2.86 (m, CH2, 1); 2.95 (m, CH2, 2); 3.29 (CH2, s, 5); 3,42. (CH2, m, 6&7); 
13C NMR (D2O):  = 44.09 (CH2, 7 and 1); 45.51 (CH2, 7&1); 46.59 (CH2, 5); 46.76 (CH2, 3);47,41 (CH2, 4); 
160.57 (CO, 9); 163.78-164.25 (NCO) (SEC not recorded) 
PEI-3(48)1H NMR (D2O):  = 2.80 (m, CH2, 1); 2.92 (m, CH2, 3); 3.27(CH2, s, 5); 3,40. (CH2, m, 6); 13C 
NMR (D2O):  =41.13 (CH2, 5’); 42.37 (CH2, 6),42.88 (CH2, 5); 45.29 (CH2, 6); 47,37 (CH2, 1); 160.28 (CO,9); 
162.59-164.49 (NCO)(Mn = 18000 g/mol; Ð = 2.1) 
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Table 3 selected data for PEI-3(x) obtained after reaction with sCO2 
Polymer  Reaction time 
(h) 
Amine 
conversion (%)* 
Tm (°C)(DSC) % loss (100-150°C) 
(TGA) 
PEI-3-(0) 0 0 68.3 / 
PEI-3(0.16) 10 min ns 55.9 30.9 
PEI-3(0.5) 0.5 36.8 35.7 31.3 
PEI-3(1) 1 32.1 63.1 35.3 
PEI-3(2) 2 31.6 56.5 30.9 
PEI-3(24) 24 44.4 45.3/Tg (35.0) 27.3 
PEI-3(24C) 24/40°C 23.5 61.8 10.9 
PEI-3(48) 48 55.0 -19.0 25 
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4.3 Results and discussion 
The work of Pan et al56 on the modification of b-PEI and L-PEI with ambient CO2 demonstrated that 
the more reactive primary amines on b-PEI reacts to form fluorescent carbamates. Moreover, fluorescent 
poly(2-oxazoline)s were synthesized in the group of Aguiar-Ricardo by using scCO2 as a polymerisation 
medium, whereby a fluorescent carbamate was introduced at the initiator site.22,23,69 Intrigued by those 
literature examples and the fluorescence of carbamate functional polymers, we have explored the 
modification of the secondary amine group of L-PEI and PEtOx-PEI with scCO2. This chapter is divided 
in two parts, in the first part we will focus on the reaction between L-PEI and scCO2, which will give us 
information about the reaction and help us to identify different species. Furthermore, the resulting 
fluorescent L-PEI may be interesting as intrinsically fluorescent gene transfection vector. Secondly, the 
treatment of a copolymer containing PEI and PEtOx with scCO2 will be investigated for the preparation 
of biocompatible fluorescent polymers. 
 
4.3.1 Polymer synthesis with L-PEI 
The L-PEI was obtained by the full hydrolysis of well-defined PEtOx (DP 400), which was used in 
Chapter 2. Two L-PEI polymers were used, referred to as PEI-1 and PEI-3. While the synthesis of both 
polymers was identical, PEI-1 was a freshly prepared sample while PEI-3 had been standing under ambient 
conditions for 2 months and attracted water from the air. As seen on the TGA (Figure 4-3 left), the PEI-3 
loses more weight during heating in the region of 100°C, an indication of the presence of water. The higher 
water peak in the 1H-NMR spectrum is another indication of the higher water content of PEI-3. This was 
further examined with modular DSC (Figure 4-3, right). The modulated method uses small steps of heating 
and equilibrating to distinguish polymer peaks from non-polymer peaks and can thus be used to identify 
solvent evaporation peaks. The solid lines of PEI-1 shows that no solvent is present as the reversible and 
non-reversible cycles are identical both showing the melting point of L-PEI. However for the PEI-3 (dashed 
lines) an extra peak appears in the non-reversible mode, which is not present in the reversible mode. This 
weight loss around 120°C is non reversible. This shows that this peak is not related to the polymer and is 
presumably caused by the evaporation of a solvent, in our case water. The main reason why wet and dry 
L-PEI were chosen for treatment with scCO2 was to observe if an influence of water could be recognized.64  
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Figure 4-3 TGA (left) and modulated DSC (right) of the starting polymers PEI-1 and PEI-3. 
 
Both L-PEI polymers were exposed to scCO2 in a closed autoclave at 135°C and with a pressure of 27.58 
MPa. The secondary amine is expected to react with scCO2 resulting in the formation of carbamates. The 
advantage of the scCO2 is that it has both liquid and gas properties enabling good penetration into the 
solid polymer. The reaction times were altered to monitor the progress of the reaction and to spot eventual 
side reactions. The first change in properties that was observed was the water solubility of the resulting 
samples as the starting product, the free base L-PEI is not water soluble at room temperature. Also the 
polymer became bright yellow and even brown for longer reaction times. The texture of the polymer 
changed from a soft and powder like for the staring materials to a hard and brittle product. The TGA of 
both the PEI-1 and PEI-3 after exposure to scCO2 for different times are shown in Figure 4-4. The starting 
polymers start to degrade around 370 °C and are fully degraded at 405°C. This degradation step is also 
present for the modified polymers, but they reveal a second degradation step between 100°C and 150°C. 
This mass loss is an indication of the release of CO2 from the formed carbamates, which happens around 
135°C.65 The PEI-1(0.16) that was reacted for only 10 min with scCO2 has a weight loss of 4.8% in this region. 
While the PEI-1(0.5) and PEI-1(2) have a weight loss of 32% and 40.5%, respectively, showing that the 
addition of CO2 on the polymer has significantly increased. We hypothesized that after 24h and 48h the 
weight loss would further increase. However, this is not the case as the weight loss of CO2 drops to ~30%. 
This observation indicates that the reversibility of the reaction is partially lost upon extended exposure 
times and that side reactions may occur that lock the CO2 on the polymer chain. 
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Figure 4-4 TGA of PEI400-1 (left) and PEI400-3 (right) before and after treatment with scCO2for different reaction 
times. 
 
The PEI-3(x) polymers, Figure 4-4(right), show a similar trend, although the maximum CO2 loading of 
35% is already reached after 1 h. The general weight loss is slightly decreased compared to PEI-1. The 
weight loss of the 10 min sample probably due to the water present. However in the PEI-3(x) samples it 
seems that the ring formation happens faster and in this case water helps the ring formation rather than 
blocking it. Nonetheless, for both polymers it is shown that after a short time, the loss of CO2 is maximised 
and with longer reaction times this loss decreases due to side reactions locking the carbamates on the 
chain. We obtained a maximum of 40% loading of CO2 while, as stated before, the maximum loading is 
50% on L-PEI due to the formation of a zwitterionic carbamate.  
To further evaluate the effect of scCO2 treatment on the residual polymer after heating and CO2 loss, 
differential scanning calorimetry (DSC) was performed. The first run, not shown, shows a transition 
around 135°C which is the irreversible release of CO2, as seen in TGA. Therefore, the second run was 
evaluated and since all CO2 should be removed during the first heating run the original L-PEI should be 
retained if only carbamates are formed. The pure L-PEI has a melting transition at 69,7 °C and for PEI-
1(0.16) there is almost no shift in Tm, meaning that the newly formed groups are indeed carbamates. With 
longer reaction times, a clear shift of the Tm is seen towards lower melting temperatures. For the 2h reacted 
polymer the Tm is 53°C indicating that the remaining polymer after removal of the carbamate is different 
than the original PEI and the crystallinity is disturbed. For the 24h reacted polymers, the DSC revealed a 
glass transition temperature (Tg), followed by a cold crystallization (exotherm) and a melting transition. 
The 48h reacted polymers no longer have a Tm, but only a Tg indicating the amorphous nature of these 
polymers. 
The TGA and DSC results prove that CO2 has been chemically bound to the PEI after treatment with 
scCO2 and is only partially released upon heating the samples. Moreover, the original L-PEI is not 
recovered for scCO2 longer exposure times and in particular the samples of 24 and 48h exposure indicated 
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that the carbamates have irreversibly reacted with L-PEI. Based on the literature it may be proposed that 
the cyclic urea side product is formed.64,65 
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Figure 4-5 DSC of PEI-1(x) (left) and PEI-3(x) (right) before and after treatment with scCO2 for different times. 
 
The 1H-NMR spectra of PEI-1(x) and PEI-3(x) after exposure to scCO2 for different times are shown in 
Figure 4-6, left. Notice that the 10 min sample is not added as this was found to be insoluble in 
conventional solvents such as CD3OD, CDCl3, D2O, D-DMSO. The single PEI-peak at 2.7-2.8 ppm has 
disappeared which is a proof of the reaction between the PEI and CO2 forming the carbamate and inducing 
a chemical shift of the CH2 protons. Hereby 3 domains are distinguished, the first domain is found in the 
region 2.8-3.60 ppm (peaks (1-4)) corresponding to CH2 protons next to a free amine, these are the 
unreacted PEI units. The second region contains a single peak (5) at 3.30 ppm. The last domains is located 
between 3.35-3.55 ppm and contains a both a shoulder (6) and a large peak (7). This domain corresponds 
with the CH2 groups next to an amide, probably the carbamate. Important to notice is the rise in intensity 
of peak (6) with longer reaction times. In PEI-1(48) this peak is as large as peak (7). The peaks of (6) and 
(5) overlap with longer reaction time. In PEI-1(0.5) this is a single peak but the 48h sample shows a large 
overlap between (5) and (6). The PEI-3(x) polymers are shown in Figure 4-6, right. The three domains can 
again be recognized, however peak (1) is larger and the peak (4) remains smaller. The main difference is 
that (6) seems to be enhanced and is incorporated in (7) rather than being present as a shoulder. The 48h 
sample shows that peak (1) is similar to the start PEI peak, peak (7) has disappeared and (6) is the single 
peak. This means that this polymer does not contain any carbamates and only the presumably isolated 
cyclic urea. In summary, the 1H-NMR spectra show that there are three types of CH2 groups formed, one 
related to PEI, one related to a possible carbamic acid and a third unassigned resonance. 
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Figure 4-6 Stack plot of the 1H-NMR spectra of PEI-1(x) and PEI-3(x) before and after exposure to scCO2 for different 
times; measured in D2O except for both start polymers that were measured in CD3OD. 
 
The 2D correlation spectroscopy {1H-1H} (COSY) was used to identify the relation between the different 
protons. The COSY of four different polymers was measured, namely PEI-1(0.5); PEI-1(2), PEI-1(48) and 
PEI-3(48). All PEI-1(x) polymers show one cross peak. Therefore, only the COSY spectrum of PEI-1(0.5) is 
shown in Figure 4-7. The rectangle shows the cross peak between the protons (4) and (7). Hence CH2 (4) 
is a direct neighbor of the CH2 (7), which is the CH2 next to the amide. This means that both methylene 
groups are neighbouring and because the CH2 (7) is located next to a carbamic acid, the CH2 (4) will be 
neighbouring an amine of PEI as indicated in Figure 4.7. The COSY of PEI-3(48) will be discussed further 
on because this polymer has a different functionality. 
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Figure 4-7 COSY spectrum of PEI-1(0.5) in D2O. The red rectangle shows the cross peak between protons (7) and (4). 
The chemical structure shows the correct assignment. 
 
To further understand the 1H and 13C-NMR spectra and the corresponding polymer structures, a more 
detailed study was performed on three different polymers PEI-1(0.5); PEI-1(2) and PEI-1(48). The 13C-NMR 
spectrum of the PEI-1(0.5) is shown below in Figure 4-8 revealing a range of peaks in the region of 42-50 
ppm (CH2-domain) and above 160 ppm (C=O domain). These extra signals are not present in L-PEI and 
indicate that the CO2 is bound on the amines of the L-PEI. The peak at 160 ppm is intriguing as similar 
observations were reported in an earlier publication.56 This paper claimed that this peak corresponds to 
the deprotonated carbamic acid. The HMBC analysis described further will however show this is incorrect. 
Next to our experimental prove, literature also provides some arguments that contradict this assignment. 
First, all peaks are broad indicative of polymer signals, except for the signal at 160 ppm. Secondly 
carbonates are well studied specie by 13C-NMR spectroscopy and a broad range of publications indicate 
that the 160,1 ppm signal belongs to the CO32-/HCO3-.70–73 The carbonate is formed when the carbamate is 
hydrolysed and produces the bicarbonate and the free amine. This is shown in the reaction below.70 
𝑅2𝑁𝐶𝑂𝑂
− + 𝐻2O ⇄ 𝐻𝐶𝑂3
− + 𝑅2𝑁𝐻 
 
The carbonate is formed due to the solvation of CO2 in water were the amine acts as a base leading to  
following equilibrium were B is a base. This explains the presence of the sharp peak at 160 ppm in Figure 
4-8. 
𝐶𝑂2 + 2𝐻2𝑂 ⇄ 𝐻𝐶𝑂3
− + 𝐻3𝑂
+ 
𝐻𝐶𝑂3
− + 𝐵𝐻 ⇄ 𝐶𝑂3
2− + 𝐵𝐻2
+ 
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Figure 4-8 13C-NMR spectrum of PEI-1(0.5h) in D2O, The inset shows the zoom of the CH2 region(42-50) ppm. 
 
The assignment of the  peaks located between 40-50 ppm on the 13C-NMR will tell us which type of CH2 
groups are present. Therefore an identification of the carbon peaks and the corresponding protons is done 
via the 2D NMR technique, {1H-13C}, heteronuclear single quantum correlations spectroscopy (HSQC). For 
the PEI-1(0.5) the HSQC spectrum is shown in Figure 4-9, allowing identification of the protons and the 
corresponding carbon atoms. Carbons (1) and (7) have overlap and cannot be distinguish via this 
technique. The carbon connected to H (2) is not visible and does not form a cross peak on the HSQC, 
probably caused by the lower abundance of C (2), similar conclusions can be drawn for C (6). Table 4 lists 
the corresponding coordinates of the cross peaks.  
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Figure 4-9 HSQC spectrum of PEI-1(0.5) in D2O 
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Table 4 Cross-peaks present in the HSQC spectrum of PEI-1(0.5); f1(13C-NMR), f2(1HNMR) 
 
CH2 f1(ppm) f2(ppm) 
1 44.9 2.87 
2 / / 
3 46.8 3.07 
4 47.6 3.13 
5 46.4 3.28 
6 / 3.40 
7 44.9 3.47 
 
By identifying the neighboring groups of the CH2 groups, the chemical environment will be unraveled. 
This can be done via heteronuclear multiple bond correlation (HMBC) spectroscopy. We split the HMBC 
spectrum in two parts to have a better overview, the first part will focus on the 40-50 ppm region (CH2) 
(Figure 4-10) while the second part focus on 155-165 region (quaternary carbons) (Figure 4-11). The cross 
peaks correlate specific carbon atoms and protons within 2-4 bonds. Table 5 lists the cross peaks and 
corresponding coordinates. The cross peaks designated with a number are cross peaks that were also 
present in HSQC spectrum, Table 4. This means that the protons are connected to carbons with a similar 
chemical environment. The cross peaks (a) and (b) show that CH2(3) and CH2(1) are connected, however 
on COSY (Figure 4-7) no cross peak is observed. This implies that there is an amine group in between 
both CH2 groups. We propose an amine group in the middle as both CH2 groups are located in the PEI 
region and no connection can be found with a carbonyl group. The chemical shift is induced by the change 
in chemical environment between CH2(3) and CH2(1), proposed structure is given in Figure 4-10. Cross 
peaks (c) and (e) confirm the conclusion obtained from the COSY spectrum, by linking (7) and (4) as 
neighboring CH2 groups; the proposed structure can be found in Figure 4-7. The last cross peak is (d), 
which cannot be assigned due to the overlap of carbons (7) and (1). This means that either C(7) or C(1) are 
connected to H(5).  
The 155-170 region, Figure 4-11, shows the correlation of the quaternary carbons with only two protons 
H(7) and H(5). This confirms that these peaks are the carbamates of the CH2 groups next to an amide like 
bond, CH2 (7) in Figure 4-7. The CH2 (5) is connected to a amide bond, however the nature of the carbonyl 
is still unclear (Figure 4-11).The second carbonyl group (160 ppm) does not connect with any protons in 
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the proximity of three to four bonds. This confirms our assignment of this sharp CO32- signal as no protons 
are connected.  
Table 5 Cross peaks present in the HMBC spectrum of PEI-1(0.5). 
Cross 
peak f1(ppm) C f2(ppm) H 
1 44.97 1 2.87 1 
a 46.84 3 2.87 1 
2 45.75 ? 2.98 2 
b 44.64 1 3.06 3 
c 44.74 7 3.14 4 
4 47.6 4 3.13 4 
5 46.4 5 3.28 5 
d 44.8 7/1 3.29 5 
7 44.7 7 3.49 7 
e 47.5 4 3.5 7 
f 163.9 8 3.28 5 
g 164 8 3.48 7 
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Figure 4-10 Zoom of the HMBC spectrum of PEI-1(0.5) (region 40-51 ppm). The structure below shows a part of the 
backbone of the modified polymer. CH2 (1) is connected with CH2 (3) within two bonds.(D2O) 
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Figure 4-11 Zoom of the HMBC spectrum of PEI-1(0.5) (region 160-150ppm) (D2O) 
To evaluate and understand the polymer structure for the other polymers, a similar NMR analysis was 
done on the PEI-1(2). As shown in the stack plot in Figure 4-6, peak H(4) and H(6) are slightly increased 
in PEI-1(2) compared to PEI-1(0.5). As previously mentioned the COSY spectrum of these polymers does 
not provide extra information. The HSQC is shown in Figure 4-12. A few extra details appear as cross-
peaks (1) and (7) in PEI-1(2) are slightly separated. The cross peak of H(6) and C(6) is visible and appears 
at 45.6 ppm and 3.40 ppm. In the stacked plot (Figure 4-6) H(6) is a shoulder of the H(7), which increases 
with longer reaction times. In the HMBC spectrum of PEI-1(2) (Figure 4-13) we see similar correlations as 
for PEI-1(0.5). The cross peaks can be found in Table 7, which however do not provide extra information 
for the CH2 area. CH2(1) and CH2(3) have a cross peak (a) which was identified in Figure 4-10, CH2(7) and 
CH2(4) have two cross peaks (b) and (d) which was identified to be in Figure 4-7. C(7/1) and CH2(5) have 
a cross peak (c), which does not provide further information as C(1) and C(7) are inseparable. The region 
of the quaternary carbons provides more valuable information. The quaternary carbon (8) does not only 
have cross-peaks with (5) and (7) ((e) and (f)) but also shows an extra cross-peak (g) with H(6). This means 
that the CH2(6) is in close contact with a carbonyl functionality. Via the DSC and TGA we showed that 
the amount of presumably cyclic urea is increasing with reaction. This is confirmed by the stacked plot 
where H(6) steadily grows upon time confirming that the CH2(6) is most likely located within the 
irreversibly formed cyclic urea. 
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Figure 4-12 The HSQC spectrum of PEI-1(2) in D20 
Table 6 HSQC cross peaks present in the spectrum PEI-1(2) 
CH2 f1(ppm) f2(ppm) 
1 44.77 2.87 
2 / / 
3 46.9 3.07 
4 47.6 3.14 
5 46.5 3.29 
6 45.6 3.40 
7 44.9 3.47 
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Figure 4-13 HMBC spectrum of PEI-1(2) (D2O). The structure shows that CH2(6) is located in the cyclic urea. 
 
Table 7 Cross peaks present in the HMBC spectrum of PEI-1(2) 
Cross peak f1(ppm) C f2(ppm) H 
1 44.68 1 2.87 1 
a 46.91 3 2.87 1 
b 44.69 7 3.15 4 
4 47.66 4 3.15 4 
5 46.48 5 3.28 5 
c 44.82 7/1 3.30 5 
7 44.77 7 3.50 7 
d 47.61 4 3.5 7 
e 163.76 8 3.28 5 
f 164 8 3.49 7 
g 164 8 3.40 6 
 
The polymer which was exposed to scCO2 for 48h was also examined in further detail as this could 
provide further information about the ring formation. As the TGA showed a decreased in CO2 loss around 
130°C this polymer should contain more irreversibly formed ring structures. This was confirmed by the 
second run of the DSC, that indicates that the polymer after heating to remove the carbamates is no longer 
pure L-PEI. The 1H-NMR spectrum of PEI-1(48) shows that the peaks H(6) and H(7) merge into one large 
domain. On the HSQC spectrum (Figure 4-14) the new appearing peaks on the 13C-NMR spectrum are 
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assigned. The spectrum shows that the signal of C(1) shifted around 1 ppm on the 13C-NMR spectrum so 
it’s no longer overlapping with C(7). Peaks C(5), C(6) and C(7) remain at the same location, although a 
few new peaks appear too. There is an extra peak C(5’), which has its carbon at 42.55 ppm, in between 
C(6’) and C(6”). This is a clear indication that the polymer contains different chemical environments 
compared to L-PEI and PEI-1(2). The HMBC cross peaks are listed in Table 9. Again CH2(3) and CH2(1)are 
connected as well as CH2(7) and CH2(4). Due to the deconvolution of C(1) and C(7), it is revealed that 
CH2(5) and CH2(1) have a cross peak. This helps to unravel the problem we had with the PEI-1(0.5) as both 
(7) and (1) were located at the same chemical shift in the 13C-NMR spectrum. Peaks (6”) and (5) are also 
correlated which could indicate that all kinds of micro domains have arisen. This means that all kind of 
domains with different neighbouring groups are formed, amines located next a carbamate or ring. 
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Figure 4-14 HSQC spectrum of PEI-1(48) in D2O. 
Table 8 Cross peaks in the HSQC spectrum of the PEI-1(48). 
CH2 f1(ppm) f2(ppm) 
1 45.52 2.91 
2 / / 
3 46.60 3.05 
4 47.68 3.15 
5 46.30 3.30 
5’ 42.55 3.26 
6” 42.81 3.43 
6’ 42.46 3.34 
6 45.36 3.35 
7 44.87 3.48 
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Table 9 Cross peaks in the HMBC spectrum of PEI-1(48) 
Cross peak f1(ppm) C f2(ppm) H 
1 44.53 1?? 2.83 1 
a 46.73 3 2.84 1 
b 44.83 7 3.10 4 
4 47.66 4 3.15 4 
5 46.28 5 3.24 5 
c 42.99 6” 3.20 5 
d 44.82 1 3.30 5 
7 44.83 7 3.45 7 
e 47.54 4 3.44 7 
f 163.65 8 3.24 5 
g 163.84 8 3.29 5 
h 164 8 3.44 7 
I 162.72 ? 3.20 5 
 
When observing the stack plot of PEI-3(x) a similar behaviour is seen as in the PEI-1(x) polymers, except 
for the PEI-3(48). This polymer gives us an unique opportunity as it contains the highest fraction of cyclic 
urea rings. The shoulder H(6) is dominant and the H(7) peak seems to have disappeared. The H(4) peak 
has also disappeared again showing the relation between these two peaks. The peak of the CH2 correlated 
with PEI, shows a double distribution H(1&2). The manifold of peaks that was previously present in the 
other polymer samples has vanished. We further investigated the PEI-3(48) via different NMR techniques. 
Already on the COSY spectrum, Figure 4-15, a remarkably difference is observed. The previous COSY 
spectra only showed one cross peak between peaks H(4) and H(7), while the PEI-3(48) polymer showed a 
cross peak connecting H(1) and H(5). 
1
2
56
a
 
Figure 4-15 1H-1H COSY spectrum of PEI-3(48) in D2O. 
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Figure 4-16 HSQC spectrum of PEI-3(48) in D2O. 
 
Table 10 Cross peaks in the HSQC spectrum of PEI-3(48). 
CH2 f1(ppm) f2(ppm
) 
1 46.55 2.80 
2 47.93 2.92 
5 42.68 3.25 
5’ 41.12 3.27 
6 42.65 3.40 
6 45.43 3.40 
 
The identification of the carbon atoms with the corresponding protons is found on the HSQC spectrum, 
Figure 4-16 and Table 10. Remark that for H(6) and H(5) two types of carbons can be found C(6&6’) and 
C(5&5’) respectively. This may be caused by two neighbouring cyclic urea, however this cannot be 
concluded from the present data. The HMBC spectrum of PEI3-(48), Figure 4-16, gives us valuable 
information about the interaction with the urea ring. It shows that both H(7) and H(4) are correlated as 
they both disappeared from the 1H-spectrum. It was already shown that CH2(7) was correlated to an amide 
bond. In this polymer no significant carbamates were present, only ring structures. Furthermore, peaks 
(5) and (1) are also part of the same family. Focusing on (5) we know that is in close contact with a carbonyl 
functionality, found on the previous HMBC spectrum as it shows a cross peak with a Cq. However the 
absence of the carbamic acid on this polymer shows that there is also a correlation between CH2(1) and 
CH2(5) which was confirmed on the COSY spectrum. The HMBC spectrum clearly shows that CH2(6) and 
CH2(5) are in proximity. This means that the CH2(5) is located next to the ring, Figure 4-17. 
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Figure 4-17 HMBC spectrum of the PEI-3(48) in D2O. Structure showing the urea ring and the assigned peaks. 
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Table 11 Cross peaks observed in the HMBC PEI-3(48) 
Cross 
peak f1(ppm) C f2(ppm) H 
a 42.86 5 2.78 1 
1 46.77 1 2.80 1 
b 45.73 5/6 2.93 2 
C 43.01 5/6 3.24 5 
d 43.10 5/6 3.25 5 
5’ 41.53 5’ 3.27 5‘ 
e 43.10 5/6 3.27 5’ 
f 45.47 6 3.27 5’ 
6 43.04 6 3.42 6 
g 47.41 2 3.39 6 
H 162.95 Cq 3.25 5 
I 162.58 Cq 3.28 5’ 
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Figure 4-18 13C-NMR spectra stack plots of the PEI-1(x) (left) and PEI-3(x) (right) in D2O. 
 
All peaks in both the 1H-NMR and 13C-NMR spectra have now been identified and the assigned peaks 
and structures are summarized in Figure 4-19. The first group of peaks indeed has no contact with a 
carbonyl functionality and can be appointed as the CH2 zone next to PEI, this includes the peaks from (1)-
(4). The peak corresponding with (1) is probably the CH2  group next to the amine, in an amine rich 
environment. The peak CH2(4) is located next to peak CH2(7) in the HMBC and COSY spectra and when 
(7) disappeared peak (4) also vanished. We can therefore assume that this is the PEI unit in a carbamate 
rich environment as it shows no correlation with other CH2 groups of PEI. In the second CH2 zone the 
peaks (5), (6) and (7) are located corresponding to CH2 groups, next to a carbonyl functionality. This is 
the carbamate zone. During the reaction with scCO2 (6) is steadily growing so it is proposed that this is 
the CH2 of the cyclic urea. Hence (7) is the CH2 group next to the carbamate. For CH2(5) the assignment 
is complex as it is connected with a carbonyl of an amide and it is in contact with CH2(1). This can be the 
CH2 next to the ring structure while still in contact with the CH2 group of PEI. As the carbamate can’t 
exist as stable species, the formation of a zwitterion plays an important role. Therefore, it may be 
speculated that all the NH groups located next to the carbamate functions have a positive charge, which 
alters the chemical shift as observed in peak (4). This is different for the urea ring as here no charge is 
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formed during the ring formation as the reaction happens through a dehydration reaction of the 
carbamates (Scheme 4-2). When water is present, the zwitterion can be destroyed by removing the H+ 
from the amine. This amine can react with the carbamate forming the ring as the nucleophile is restored. 
The TGA shows the decreased release of CO2 upon longer reaction times indicating that the formation of 
the cyclic urea is quite slow. The change in Tm shows that the original PEI has disappeared and more and 
more rings are formed, which lowers the melting temperature and eventually leads to an amorphous 
polymer with. These polymers also lost the softness and became brittle.  
 
Figure 4-19 Overview of the different structures that are formed during scCO2 treatment of L-PEI. Top: the 
zwitterionic carbamate is formed at the beginning in the reaction. Middle: formation of a cyclic urea, locking the 
carbamate on the backbone . Bottom: formation of a urea bond and as such cross linking between different polymer 
chains 
 
 
In summary it can be concluded that the secondary amine on the L-PEI can react with the scCO2 to 
form carbamates as indicated by the weight loss on the TGA. However after 2hr reaction time a decrease 
in weight loss on the TGA meaning that less CO2 is released while the scCO2 reaction time was longer. 
This decrease in weight loss is explained by the DSC, which shows that after longer reaction time the 
melting temperature of the L-PEI is lost indicating that the carbamate bonds are irreversible locked onto 
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the polymer backbone and the reversibility is lost by the formation of cyclic urea structures. The NMR 
studies confirms this hypothesis by showing that the present CH2 groups can have different chemical 
environments. As shown in Figure 4-19 (top) at the beginning of the reaction the formation of a zwitterion 
occurs. Herewith only two CH2 are recognized as either the PEI is converted into a carbamate(7) or 
protonated(4) (Figure 4-19 top). Already in the first moments of the reactions a second structure is formed 
that locks the carbamate by forming the cyclic urea bond. Here two CH2 groups can be recognized, either 
(6) which is located in the ring or (5) which is located next to the ring, (Figure 4-19 middle). A last structure 
is proposed by the formation of a urea bond by cross linking two chains.(Figure 4-19, bottom). 
The reaction mechanism to form the cyclic urea could also occur between multiple chains leading to 
chain coupling. The formed ring and the crosslinking bond have a similar chemical environment and 
therefore NMR cannot be used to see a distinction. Therefore SEC analysis was performed in HFIP, which 
is an excellent solvent for PEI like polymers. Caution still has to be taken, because the introduction of 
charges can induces more column interaction which may affect the measurement. This was indeed shown 
an the  SEC traces are inconclusive 
Due to the presence of the carbamate groups the formed polymers are fluorescent, which is induced by 
the close contact of the HOMO and the LUMO within one bond enabling delocalization of the excited 
electron. The fluorescence spectra of the polymers are shown Figure 4-20. Note that the polymers with 
the cyclic urea are still fluorescent and only a small shift towards lower wavelength is observed. In the 
case of the cyclic urea a different HOMO and LUMO is activated and thus different entities are exited. 
Figure 4-21 shows the difference between the absorption and the emission spectra of the 2h exposed 
polymer. The maximum of the absorbance spectrum can be found at 260 nm and for the fluorescence this 
is 470 nm, resulting in a Stoke shift of 210 nm. Which is of great importance as the larger the shift between 
both the better it is for fluorescence.  
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Figure 4-20 Fluorescence spectra of PEI-1(x) in water 
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Figure 4-21. The comparison between the absorption and the emission of PEI-1(2large) in water. 
The carbamate bond is a reversible bond and by heating the CO2 is released. To confirm the formation 
of the cyclic urea the polymer was heated above 200°C to remove all carbamates. During this heat 
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treatment that was performed in a close reaction vessel, there was a clear pressure build-up by release of 
the CO2, that ejected the septum of the microwave vial. The stacked plots of the 1H NMR spectra (Figure 
4-22)of the polymers before and after heat treatment clearly show the pure L-PEI is not regained, it was 
previously also shown by DSC. However, it is evident that peak H(6) is present confirming the earlier 
conclusion that this is the CH2 group of the cyclic urea. Similar conclusions can be drawn for peak (1) as 
this resembles the PEI-3(48). The broad peaks containing H(5) and H(6) probably have a lot of different 
small domains with different environments of L-PEI in between, which causes all kind of different 
chemical shifts and the corresponding peak broadening. Interestingly, the resulting polymer after heat 
treatment and removal of the carbamates still showed fluorescence indicating that the formed cyclic urea 
is also fluorescent, (Figure 4-23) for which the origin is unclear. The comparison to dendritic polyureas 
may give a hint, even though in literature no real consensus has been reached to explain such type of 
fluorescence. It was already shown that PAMAM urea dendrimers show intrinsic fluorescence, that is pH 
dependent48 which is ascribed to the combination of the urea and the positive charged end groups.74 In 
the case of the cyclic urea rings we have a similar system. First of all the polymer contains the needed urea 
ring and second of all the PEI units, that are still present can be protonated. An important observation is 
that the initial L-PEI is not water soluble and after scCO2 treatment followed by heating i.e. by addition 
of the ring structure, a water soluble PEI is formed. This solubility most likely results from suppression of 
the crystallisation by the cyclic urea groups that also lead to intrinsic fluorescence of this L-PEI analogue. 
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Figure 4-22 1H NMR spectra of PEI1-(2) (left) and (PEI-1(48) (right) before and after heat treatment at 200 oC (oven); 
all measured in D2O. 
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Figure 4-23 Fluorescence spectra of PEI-1(48) before and after heating in oven. 
 
To see whether it was possible to do the modification of L-PEI with scCO2 at lower temperatures, both 
PEI-1 and PEI-3 were also reacted with scCO2 at 40°C for 24h and 27.58 MPa pressure. The difference 
between both PEI-1(24c) and PEI-3(24c) is shown Figure 4-24. The amount of CO2 bound to the L-PEI is 
34% and 24% respectively, calculated based on the 1H-NMR spectra. TGA confirms this as it shows a higher 
weight loss for PEI-1(24c) compared to PEI-3(48) (Figure 4-24). 
The DSC data of both polymers shows a distinct difference as the PEI-(24c) has a Tm of 86°C and the 
PEI-3(24c) has two melting points at 62.4 °C and 83.1°C in the second run. This can indicate that a part of 
the polymer sample still contains unmodified L-PEI units while another part is similar to the PEI-1(24). 
This reaction temperature of 40°C is well below the Tm of the starting polymers which means that the 
polymer is in a solid state. It may therefore be speculated that the high reaction temperature melts the 
polymer and all parts are easily accessible for reaction. For the low temperature modification, the porosity 
of the polymer sample influences the contact with scCO2. The PEI-3 was indeed a more dense solid and 
had a more brittle appearance. The HFIP SEC shows that between the low and high temperature exposure 
to scCO2 there is a clear difference as the low temperature treatment leads to much higher molar mass 
indicating significant interaction in coupling. The origin of this difference may lay in solubility, (Figure 4-
25).  
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Figure 4-24 TGA of the PEI-1(24c) and PEI-3(24c) (left); DSC of the PEI-1(24c) and PEI-3(48c) (right) 
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Figure 4-25 Normalized HFIP SEC-UV signal (375nm) PEI-1, PEI-1(24) and PEI-1(24c) 
 
The 1H NMR spectra overlay, Figure 4-26, indicates that the PEI-1(24C) reacted at 40°C shows similar 
peaks as the PEI-1(24). Indicating that this polymer has both the ring, the functionalized part and the PEI, 
hence the temperature does influence the ring formation. The PEI-3(24c) spectrum is similar to the PEI-
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3(48) spectrum. This indicates that the formation of the ring happens at lower temperature and is merely 
influenced by the water content. This is opposite to literature reports that state that the presence of water 
blocks the formation of the rings as during the formation of the ring H2O is released and the reaction is 
slowed down in presence of water.75 However, in our case we have a catalytic amount of water present 
which can act as a charge carrier and promotes ring formation by the formation of H3O+.56 This removes 
the charge from the protonated amine and enhances the nucleophilic attack of the lone pair of the amine 
onto the carbamate.  
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Figure 4-26 overlay of the 1H-NMR spectra of PEI-1(24c) and PEI-3(48c)(D2O) 
 
4.3.2 PEtOx-PEI functionalisation 
In the second part of this work, we investigated whether it could be possible to make a fluorescent 
biocompatible polymer in scCO2. Therefore, PEtOx307-PEI93 was prepared by partial hydrolysis of PEtOx400 
and the resulting PEtOx-PEI copolymers was exposed to scCO2 for different times at 135°C. It is important 
to state that the PEtOx-PEI has a block like distribution of PEI units along the chain as demonstrated in 
Chapter 2. The TGA degradation profile shows similarities with the PEI modified with scCO2, because a 
weight loss is observed in between 100 and 150°C indicative of CO2 loss due to formation of the carbamates. 
The polymers have a max weight loss after 2h and the max loading of 10% is much smaller compared to 
the L-PEI because less secondary amine groups are available. Also a 25% loading can never be achieved 
due to the formation of the zwitterion with a positive charge on the amine. After 48 h and 24h there is a 
decrease in weight loss indicating the locking of the carbamate in cyclic urea groups, which is facilitated 
due to the block-like distribution of the L-PEI units. The DSC is difficult to interpret as we have a polymer 
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with different domains. All of the polymers are however still amorphous after scCO2 treatment although 
some shifts are observable. 
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Figure 4-27 TGA of the PEtOx-PEI-2(x)(left) and DSC of the PEtOx-PEI-2(x)(right) 
 
The 1H-NMR spectra in Figure 4-28 shows that upon reaction the PEI peak at 2.8 ppm has vanished and 
that there is a shoulder in the backbone peak of 3.5 ppm. These results are similar to those previously 
discussed for the PEI indicating that there is formation of carbamates and possible rings upon exposure 
of PEtOx-PEI to scCO2. 
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Figure 4-28 Stacked plot of the 1H NMR spectra of PEtOx-PEI-(x) in D2O 
 
 The 13C-NMR had a very poor signal to noise ratio and it was difficult to interpret whether there was a 
formation of a carbamic acid due to the lack of carbonyl signal at 163 ppm. The HSQC also had too much 
noise and could not be interpret. Luckily the HMBC resolved the problem and an interesting conclusion 
could be drawn. In Figure 4-29 the HMBC spectrum is shown. As expected, there is a correlation between 
the CH3 (C) signal at 1 ppm and the CH2 (B) signal of the PEtOx at 2.4 ppm. There are extra cross peaks 
appearing in the region between 120-140 ppm, corresponding to dissolved CO2. This is possible as the 
samples were not freshly prepared and there is a possible release of CO2 due to the reversed reaction. The 
interesting part is seen in the CH2 region of the backbone of PEtOx and the formed carbamates, both can 
be found around 3.6 ppm in the 1H-spectrum. Different than the L-PEI carbamate the Cq signal of these 
polymers is located around 174 ppm. This indicates that the CH2 groups next to the carbamate are in close 
contact with the PEtOx chain, hence the similar chemical shift. This indicates that the formed PEI blocks 
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as discussed earlier are rather small, as may be expected for this rather low degree of hydrolysis. A similar 
conclusion can be drawn from the PEtOx-PEI-2(48). The zoom of the HMBC spectrum is shown in Figure 
4-30 and here it is clear that the shoulder also has a Cq contact. There is not enough data to draw 
conclusions as the 13C-NMR is not well measured after multiple attempts. 
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Figure 4-29 HMBC spectrum of the PEtOx-PEI-2(0.5) (D2O). 
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Figure 4-30 Zoom of the HMBC spectrum of PEtOx-PEI-2(48)(D2O) 
 
 
Figure 4-31 Polymer structure of modified PEtOx-PEI 
 
The structure of the new polymers is shown in Figure 4-31. Different CH2 groups can be found. The first 
type is the (D) which is the CH2 group next to the original PEtOx unit. The (5-7) peaks are found next to 
the carbamate. The (1) signals is the same as in the L-PEI polymer and is located next to an protonated 
amine, as maybe assumed that all of the non-reacted amines are protonated. From the obtained data no 
conclusion can be drawn from possible ring formation.  
The main goal was to make a fluorescent biomaterial on the PEtOx-PEI platform and the fluorescent 
spectrum (Figure 4-32) shows that the obtained materials are indeed fluorescent. The same shift as with 
the PEI-1 with longer reaction times towards a lower excitation value is observed, ascribed to the formation 
of urea groups.   
  
 
154 
 
CHAPTER 4 
400 450 500 550 600
0
200
400
600
800
1000
In
te
n
s
it
y
 (
a
u
)
wavelength (nm)
 0,5h
 1h
 2h
 24h
 48h
Figure 4-32 Fluorescence spectra of the PEtOx-PEI(x) 
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4.4 Conclusions  
 
The goals of modifying the L-PEI with scCO2 was successful leading to new fluorescent copolymers. 
Depending on the reaction time, two structures were formed. The first structure contained the 
deprotonated carbamate and a protonated amine. Due to a side reaction a second cyclic urea structure 
was formed. With longer reaction time this ring structure became more pronounced. There is also a 
possible cross linking reaction which may occur via the same mechanism. It was also shown that after 
removal of the carbamates the ring structure was preserved and this ring structure also showed intrinsic 
fluorescence. In the second part a PEtOx-PEI polymer was modified with sCO2 resulting in fluorescent 
PEtOx. The formed carbamates do show a different value for the Cq as this was shifted towards a larger 
value. This is caused by the different chemical environment and the block like distribution of L-PEI units 
that makes it possible to have a PEtOx and the carbamate in close proximity. This interesting platform of 
course has to be further tested for further biomedical applications. First of all it has to be checked whether 
the amorphous functionalized PEI can be used in gene transfection yielding fluorescent polyplexes or even 
if the zwitterionic form is less toxic due to the neutralization of the positive charge. The PEtOx-PEI 
copolymer should be tested on toxicity and on the ability to be use the intrinsic fluorescence for 
microscopy visualization. 
This chapter fits in the broader picture of post modification of L-PEI and PEtOx-PEI herewith expanding 
the chemical toolbox. It was indeed useful to see whether fluorescent materials could be made. This 
enables new types of polymers with a fluorescent tag. As the polymers are shown to be stable further 
examination is needed towards applications. 
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Prologue 
PAOx polymers have excellent biocompatible properties and upon injection there is no immune response 
of the hosting organism. As discussed in the introduction these qualities are similar to PEG, the gold 
standard of biocompatible polymers. The advanced chemical versatility makes PAOx polymers superior to 
PEG. In this chapter different linkers are explored for the modification of PAOx, which can be used to couple 
bioactive molecules onto the polymer platform. To couple these linkers onto the polymer a post 
polymerisation approach was chosen where first the polymer was partially hydrolysed. It is known from 
chapter 2 that this proceeds in a block like fashion. The nucleophilic properties of the amine of the PEI units 
is used to couple a methyl ester group via four different linkers based on amide (oxazoline), tertiary amine, 
isocyanate and thioisocyanate. It is demonstrated that the methyl ester functionality can be converted into 
an amide via a direct amidation reaction with a wide range of (functional) amines. This model reaction can 
be used for future reactions with bioactive compounds containing amines. 
 
5.1 Introduction 
The story of poly(2-oxazoline)s started in 1966 when 4 independent research groups reported the 
cationic ring opening polymerisation (CROP) of 2-aryl-2-oxazolines and 2-alkyl-2-oxazolines, such as 2-
phenyl-2-oxazoline and 2-methyl-2-oxazoline.1–4 After this discovery, the CROP of 2-oxazolines has gained 
significant interest. Well-defined poly(2-alkyl/aryl-2-oxazoline)s (PAOx) can be obtained if the 
polymerisations are done under nucleophile free conditions to avoid side reactions such as chain transfer 
and termination.5,6 After the flourishing of PAOx in the seventies and eighties, research interest was 
retracting in the nineties. Since the dawn of the new millennium, PAOx are quickly gaining interest again, 
as researchers have discovered their high potential for biomedical applications.7–10 In addition, a 
microwave assisted polymerisation protocol was introduced about ten years ago to drastically reduce 
polymerisation times from days and hours to minutes.11,12 The livingness of the CROP allows the 
preparation of defined PAOx with full control over polymer architectures including blocks,13,14 gradients15 
and star-shaped structure16. Furthermore the properties of PAOx are highly tunable by variation of the 
side-chain R group as well as by copolymerisation of different monomers.17–19  
The current interest in PAOx is more and more shifting towards biomedical applications stimulated by 
the high biocompatibility and stealth behaviour, which is especially documented for poly(2-methyl-2-
oxazoline) (PMeOx) and poly(2-ethyl-2-oxazoline) (PEtOx).7,20 In fact, they can arguably compete or even 
outperform the gold standards of the field, namely poly(ethylene glycol) and poly(N-
hydroxypropylmethacrylamide).21–24 For use of PAOx in biomedical applications, it is important to have 
easy and straightforward functionalization methodologies, either for conjugation of the polymers to 
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biological entities or substrates or to attach drug molecules, labels or targeting moieties. Up to three 
orthogonal functionalities can be (simultaneously) introduced in PAOx through initiation, termination 
and incorporation of functional monomers.18,25 The choice of functional monomers is however limited to 
groups that are non-nucleophilic as any nucleophile will interfere with the polymerisation process.  
A major advantage of PAOx over PEG is the possibility to introduce functionalities in the side chains by 
simple copolymerisation of a functional monomer with a non-functional monomer. However, many 
functional groups need to be protected during the CROP to avoid interference with the polymerisation 
conditions, as has been reported for monomers with acid,12,19,26 alcohol,19 amine,12 thiol19 and aldehyde19,27,28 
functionalities. An important exception are monomers containing double and triple bonds that are not 
affected by the living CROP. The direct introduction of internal and terminal double bonds as well as 
terminal triple bonds into PAOx has been demonstrated.14,27,29,30 These polymers could further be utilized 
for efficient post-polymerisation modification by thiol-ene,25,31,32 thiol-yne32 and copper(I) catalysed azide-
alkyne cycloaddion (CuAAC),31,32 so called click reactions33. 
In this work, we report a novel straightforward post-polymerisation modification strategy for PAOx, 
which allows the incorporation of a wide range of side-chain functionalities by direct amidation of the 
side chain methyl ester groups with different amines as shown in Figure 5-1. The PAOx building blocks 
containing side-chain methyl ester groups can either be prepared by partial hydrolysis of PAOx followed 
by introduction of the methyl ester functionality by reaction with methyl succinyl chloride or other methyl 
ester containing electrophilic reagents or by copolymerisation of a non-functional 2-oxazoline monomer 
with 2-methoxycarbonylethyl-2-oxazoline.4,34 Within this chapter we will demonstrate the versatility of 
this new synthetic methodology. The newly formed methyl ester containing groups can be modified into 
an amide via the direct amidation reaction. 
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Scheme 5-1 Schematic representation of the partial hydrolysis of a poly(2-oxazoline) followed by 
modification with methyl succinyl chloride, methyl-isocyanopropanate, methyl-thiocyanopropanate, 
methyl bromoacetate . The direct synthesis of the methyl ester containing PAOx by copolymerisation is also 
included in the scheme as alternative route.34 The grey sphere is the initiator part and the grey rectangle the 
termination agent part. 
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Figure 5-1 Direct amidation of the methylester containing groups 
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5.2 Materials and methods 
5.2.1 Materials and Instrumentations 
Poly(2-ethyl-2-oxazoline) (PEtOx; DP = 100, Mn 9700, PDI 1.13; measured on SEC with DMA as eluent) 
was synthesized following a literature protocol.11 Hydrogen chloride, sodium hydroxide, dichloromethane, 
aminomethane, aminoethane, 1-aminopropane, dimethylamine, hydrazine, glycine, Leucine methyl ester, 
1,3 aminopropanol, allylamine, 1-amino-3-butyn, allylamine, N,N’-dimethyl-1,2-ethylene diamine, 1,2 
ethylene diamine, methyl succinyl chloride and amino ethanol were obtained from Sigma Aldrich and 
used as received. 1H NMR and 13C NMR spectra were recorded in CDCl3 or in DMSO on a Bruker Avance 
300 MHz or 500 MHz spectrometer. Size exclusion chromatography (SEC) was performed on a Agilent 
HPLC with a 1260 refractive index detector (RID) using dimethylacetamide containing 50 mM LiCl as 
eluent at a flow rate of 0.6 mL/min. Polymethylmethacrylate (PMMA) standards were used to calculate 
the molar mass values and the column set consisted of two PLgel 5 µm mixed D columns at 40°C and a 
similar guard column (Agilent) in series. Chromatograms were analyzed using Agilent Chemstation 
software with the GPC add on. The polymers obtained after amidation were analyzed by size exclusion 
chromatography (HFIP-SEC) using a Agilent HPLC with a 1260 refractive index detector (RID) with eluent 
of hexafluoro-2-isopropanol (HFIP) containing 20 mM Sodium trifluoroacetate at a flow rate of 0.3 
mL/min. PMMA standards were used to calculate the molar mass values and the column set consisted of 
two PSS PFG 100Ǻ gel 5 µm mixed D columns and a similar guard column (Agilent) at 35°C in series 
Chromatograms were analyzed using Agilent Chemstation software with the GPC add on. The FT-IR was 
performed on a Perkin Elmer 1000 FTIR spectrum meter with PIKE HATR module. All of the 
polymerisation were done in a Vigor glovebox. Matrix assisted laser desorption/ionization time of flight 
mass spectroscopy (MALDI-TOF MS) was performed on an Applied Biosystems Voyager De STR MALDI-
TOF mass spectrometer equipped with 2 m linear and 3 m reflector flight tubes, and a 355 nm Blue Lion 
Biotech Marathon solid state laser (3.5 ns pulse). All mass spectra were obtained with an accelerating 
potential of 20 kV in positive ion mode and in reflector mode. 2-(4'-hydroxybenzeneazo)benzoic acid 
(HABA) (20 mg/mL in acetone) was used as matrix. Polymer samples were dissolved in acetone 2mg/mL 
analyte solutions were prepared by mixing 10 µl matrix and 5 µl polymer samples. 
Samples were applied using the dried droplet method. 
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5.2.2 Procedures 
Partial hydrolysis of PEtOx.  
The PEtOx (10 g) was dissolved in 50 mL of water with heating and stirring until everything was 
dissolved. Then 50 mL of 36% solution of HCl was added and the mixture was heated to 73°C (internal 
temperature) for 200 min. After the volatiles were removed on a rotary evaporator, the polymer was 
dissolved in water and the solution was basified to pH 10-11 using a NaOH solution. The solution was then 
lyophilized and the solid was dissolved in dichloromethane. The organic phase was washed with brine 
and then concentrated in vacuum to yield the PEtOx-PEI as a solid white product (7 g; 77% yield). 1H-
NMR (300 MHz, δ in ppm, CDCl3): 1-1.2 (3 H,CH2-CH3); 2.3-2.5 (4H,CH2-CH3); 2.6-2.8 (4 H,CH2-NH); 3.2-3.5 
(4 H,CH2NCH2). The integral ratios between the peaks at 2.6-2.8 ppm and 3.2-3.5 ppm were utilized to 
calculate the degree of hydrolysis to be 18%. 
 
Modification of PEtOx-PEI with methyl succinyl chloride. 
7 g of the PEtOX-PEI (18%) was several times washed with toluene for the removal of any water. 
Subsequently, the polymer was dissolved in dry dichloromethane (6 mL/g of polymer) and the mixture 
was cooled to 0°C. Methyl succinyl chloride (4.5 mLmL, 3.65 mmol, 2eq.) was added to this solution of 
PEtOx-PEI followed by drop wise addition of triethylamine (2 eq, 0.3 mL). The mixture was stirred for 24 
h after which the reaction mixture was directly precipitated in cold ether. The precipitated polymer was 
isolated by filtration and dried under vacuum to yield the PEtOx copolymer with methyl ester side chains 
(PEtOx-MestOx) in 84% yield (7.5 g). 1H-NMR (300 MHz, δ in ppm, CDCl3): 1-1.2 (3 H,CH2-CH3); 2.3-2.5 
(4H,CH2-CH3); 2.6-2.8 (4 H,CH2-NH); 3.2-3.5 (4 H,CH2N-CH2); 3.7 (3 H,O-CH3). SEC-data Mw 1.76 104; Mn 
1.67 104 g/mol and Ɖ 1.1. The IR spectrum showed following peaks (cm-1): 1731 (CH3-O, ester ) 1630 (all 
amides).  
 
Modification of PEtOx-PEI with methyl thio(isocyanate).  
Methyl-isocyanatopropanoate (3 eq, 290 mg, 2.25 mmol) or methyl-(thio) isocyanatopropanoate (3eq., 
33 mg, 2.25 mmol) was added toghether with the polymer (0.5 g) in a microwave vial. The reaction was 
carried out in the microwave for 5 min. at 150°C. Purification was done by preparative SEC (PD10). 
1H-NMR(300 MHz, δ in ppm, CDCl3): 1-1.2 (3 H,CH2CH3); 2.3-2.5 (4H,CH2-CH3); 2.6-2.8 (4 H,CH2-CH2); 
3.2-3.5 (4 H,CH2NCH2); 3.7 (3 H,O-CH3). 4.7 ppm (1 H, CH2NH-CO-NH); 3.9 (1 H, CH2NH-CS-NH)  
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Modification of PEtOx-PEI with methyl bromoacetate.  
3 g of the PEtOX-PEI (15%) was dissolved in 30 mLmL if acetonitrile. Subsequently, 0.3 g K2CO3 and 
methyl bromoacetate (200µl, .0.0018 mol,10eq) were added to this solution. The mixture was refluxed for 
12 h. After evaporation of the solvent DCM was added and the solution was filtered. A cold precipitation 
in ether was done to remove all residual reactants. After precipitation the samples was lyophilised. 1H-
NMR(300 MHz, δ in ppm, CD3OD): 1-1.2 (3 H,CH2CH3); 2.3-2.5 (2H,CH2-CH3); 2.6-2.8 (4 H,CH2-CH2); 3.2-3.5 
(4 H,CH2NCH2); 3.7 (3 H,O-CH3). 
 
Amine coupling method 1: (aminomethane, aminoethane, 1-aminopropane, 
hydrazine).  
The PEtOx-PMestOx copolymer/PEtOx-Poly((thio)ureum)methylester/PEtOx-Poly(amine acetate) 
(300 mg) was directly dissolved in an excess of amine (~6 mL). The reaction was stirred for 2 days at 70°C 
after which the solution was evaporated to dryness. Purification was done using preparative SEC, PD 10 
column with water ass eluent, to yield the modified polymers in near-quantitative yields. 
 
Amine coupling method 2: (amino ethanol, amino propanol, allylamine, amino-
3-butyne, N, N dimethylethylene diamine).  
The PEtOx-PMestOx (300 mg, 4.6 * 10-4 mol) copolymer was dissolved in 6 mL of acetonitrile; for amines 
that are not soluble in acetonitrile the solvent was changed to DMF. In the case where the amines where 
part of on an amino acid, such as glycine or Leucine, water with a pH of 9 was used to ensure that all 
amines where deprotonated. A concentrated solution of amine (3 equivalents to the methyl ester) was 
then added and the reaction mixture was stirred for 1 day at 40 °C. After evaporation of the solution under 
reduced pressure, the remaining polymer was purified by preparative SEC, PD 10 column with water as 
eluent yielding the modified polymers in near-quantitative yields.  
 
Polymerisation of the methyl ester functionalized monomer (MestOx) DP 20.  
The MestOx monomer was synthesised as described earlier.34 The polymerisation was carried out in a 
20 mL microwave vial. The methyl tosylate (0.34 mL; 0.002 mol) was dissolved in a solution containing 
MestOx monomer (7 g; 0.04 mol) and 8 mL of acetonitrile obtaining a 3 M polymer solution. The reaction 
mixture was prepared in the glovebox ensuring an oxygen and water free environment. The 
polymerisation was performed by heating the mixture for 2.35 minutes to 140 oC in the microwave. After 
polymerisation the reaction was terminated by addition of 1 mL of a 1 M solution KOH in methanol. The 
acetonitrile was then removed via reduced pressure and the polymer was dissolved in dichloromethane 
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and precipitated in cold diethyl ether (10-fold excess). The polymer was then dissolved in water and freeze 
dried to obtain a white powder (3.311 g; yield 65%). 1H-NMR (500 MHz, δ in ppm, D2O): ;2.5-2.7(4H , CO-
CH2-CH2-CO-OCH); 3.2-3.5 (4 H,CH2N-CH2); 3.7 (3 H,O-CH3). SEC-data Mw 6600; Mn 5800 g/mol and Ɖ 
1.12. 
5.3 Results and discussion 
5.3.1 Synthesis of PEtOx-MestOx via hydrolysis and 
modification of PEtOx 
To evaluate the newly proposed post-polymerisation modification platform of PAOx copolymers with 
methyl ester side chains with amines (Figure 5-1), a well-defined PEtOx was first prepared as starting 
material, whereby the narrow dispersity (Ɖ) will facilitate the evaluation of the products after each 
reaction step by SEC. Therefore, a large batch (10 g) of PEtOx with a DP of 100 was prepared using the 
previously optimized microwave assisted polymerisation protocol yielding well-defined PEtOx with a Ɖ 
of 1.1 determined by SEC with DMA as eluent.11  
Next, the well-defined PEtOx was hydrolysed in controlled acidic conditions and based on the 
previously established hydrolysis kinetics, a good control can be achieved over the hydrolysis rate.35 As 
shown in chapter 2 there is a block like distribution of the PEI units along the backbone. This hydrolysis 
reaction allows for an easy control over the amount of secondary amines in PEtOx-PEI and, thus, provides 
control over the amount of methyl ester functional groups that can be attached to the main chain. To aim 
for a hydrolysis degree around 20% the hydrolysis was performed in ~6.8 N hydrochloric acid at 73°C for 
200 min. The degree of hydrolysis was determined by 1H-NMR spectroscopy. The integral ratio of signals 
corresponding to the backbone of PEtOx at δ 3.5 ppm and the backbone of PEI at δ 2.8 ppm was used to 
calculate the degree of hydrolysis, as shown in Figure 5-2. It is shown that 18% of the PEtOx units were 
hydrolysed yielding a PEtOx82-PEI18 copolymer. Purification of this PEtOx-PEI was done by first drying 
the reaction mixture on a rotary evaporator to remove the water, propionic acid and excess of hydrochloric 
acid. Subsequently the polymer is dissolved in a small amount of water and the pH is adjusted to pH 10-11 
with NaOH, to deprotonate the PEI units, followed by lyophilization. The resulting white powder is 
subsequently dissolved in dichloromethane and extracted with brine and water to remove the traces of 
propionate as well as the NaOH. The final purified polymer is collected by evaporation of the 
dichloromethane. This partially hydrolysed copolymer can no longer be analysed by SEC in DMA due to 
too strong interactions between the amine groups and the column material leading to tailing of the signal 
and with higher hydrolysis degrees even to complete sticking of the polymer to the column. Therefore, 
SEC of PEtOx-PEI was measured with hexafluoroisopropanol (HFIP) as eluent,36 revealing a Mn of 1.5 x 104 
Da and Ɖ of 1.3. The broadening of size distribution can be ascribed to the SEC system and column set as 
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the PEtOx starting polymer revealed a Mn of 7.6 x 103 Da and a Ɖ of 1.4 on this SEC system with HFIP. The 
counterintuitive increase in Mn upon removal of 18% of the side chains is in line with previous observations 
and can be ascribed to the larger hydrodynamic volume of the partially hydrolysed copolymer in HFIP, 
presumably due to better hydrogen bonding of the HFIP to the polymer chains. 
The prepared PEtOx-PEI represents a well-defined reaction platform containing the biocompatible 
PEtOx as main structure together with the nucleophilic secondary amine units from the PEI. A wide 
variety of modification reactions of such partially hydrolysed polymers have already been reported in 
literature.37 In this work, the PEtOx-PEI copolymer was first reacted with methyl succinylchloride to 
reintroduce a side chain amide group similar to the native PAOx structure containing a latent methyl 
ester functionality yielding PEtOx82MestOx18. The 1H-NMR spectrum of PEtOx-MestOx revealed the 
disappearance of the PEI backbone resonances at 2.6 ppm as well as the appearance of the methyl ester 
peak at 3.7 ppm demonstrating the success of the modification reaction. Furthermore, the IR spectrum 
also revealed the representative methyl ester carbonyl vibration at 1730 cm-1. The SEC trace of PEtOx-
PMestOx in HFIP also revealed a decrease in Mn caused by the change in hydrodynamic volume while the 
Ɖ remained the same (Ɖ  = 1.3). Overlays of the SEC traces and 1H NMR spectra of PEtOx, PEtOx-PEI and 
PEtOx-MestOx are shown in Figure 5-2 to illustrate the successful modifications.
17 18 19 20 21 22 5,0 4,5 4,0 3,5 3,0 2,5 2,0 1,5 1,0 0,5
5,0 4,5 4,0 3,5 3,0 2,5 2,0 1,5 1,0 0,5
5,0 4,5 4,0 3,5 3,0 2,5 2,0 1,5 1,0 0,5
5
3
3
2
2
1&5
1
4
3
1
freq (ppm)
2
PEtOx-PEI
PEtOx
PEtOx-PMestOx
7
6
time (min.)
 PEtOx
 PEtOx-PMestOx
 PEtOx-PEI
 
Figure 5-2. Overlay of the SEC traces in HFIP (Left) and 1H NMR spectra of PEtOx, PEtOx-PEI and PEtOx-MestOx in 
CDCl3. 
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As mentioned in the introduction PEtOx-MestOx can also be obtained by direct copolymerisation of 2-
ethyl-2-oxazoline (EtOx) and 2-methoxycarboxyethyl-2-oxazoline (MestOx). Although the direct 
polymerisation seems to be a more straightforward method compared to the here presented two-step 
hydrolysis-modification method, it should be noted that EtOx is available in bulk quantities while MestOx 
has to be custom synthesized in a two-step synthetic protocol when starting from methyl succinyl chloride 
with 57% overall yield, including double purification by distillation.34 In this perspective, the 
demonstrated hydrolysis-modification method may actually be more cost-effective and time-efficient 
than the direct polymerisation method. Moreover, the hydrolysis-modification route is also more versatile 
as different reactive linkers, such as methyl bromopropionate, methyl acrylate or methyl 
iso(thio)cyanatopropionate may be used to install similar methyl ester side chains as will be discussed in 
the following section.38 
 
5.3.2 Synthesis of methyl ester functional PEtOx via 
reaction of PEtOx-PEI with (thio)urea or methyl 
bromo acetate 
A similar synthesis as above is proposed for the synthesis of a PAOx polymer containing either a urea 
or thio urea bond in the side chain. The reaction between isocyanates and partially hydrolysed PAOx was 
already explored for the synthesis of hydrogels with a PMeOx-PEI polymer.39 Here a reaction between 
methyl-3-isocyanatopropanoate or methyl-3-thioisocyanatopropanoate with PEtOx-PEI is performed by 
heating in the microwave at 150°C with no catalyst.40 The 1H-NMR spectra before and after the reaction 
are shown in Figure 5-3 revealing that the PEI peak at 2.8 ppm has disappeared showing the coupling of 
the iso(thio)cyanate onto the backbone of the polymer. A pronounced new peak is seen at 3.7 ppm which 
indicates the formation of a methyl ester side chain. As we know from the previous part this shows a 
successful coupling to the backbone. By this method two types of polymer are coupled, urea and thio urea 
both bearing the methyl ester that can be used for further modification. 
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Figure 5-3 NMR overlay of the (thio)urea modified copolymers. Bottom (PEtOx-PEI(15%)), middle PEtOx-Poly(urea 
methyl ester), top PEtOx-Poly(thiourea methyl ester). 
 
A final modification strategy to introduce the methyl ester side chains in PEtOx-PEI that was explored 
is by reaction with methyl bromoacetate. Hereby, the amine of PEI attacks methyl bromo acetate and 
forms a tertiary amine with the methyl ester on the side chain. The reaction is performed under reflux 
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conditions and is pushed by the formation of KBr, which precipitates in the acetonitrile. The 1H-NMR 
spectrum shows that the reaction was successful, although the reaction was not complete as there are still 
PEI units left as the signal left at 2.8 ppm has not disappeared from the 1H-spectrum, (Figure 5-4). 
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
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3
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2
1 3
Figure 5-4 1HNMR spectrum (CD3OD) of the PEtOx-Poly(amino methyl acetate) 
 
5.3.3 Post-polymerisation modification of PEtOx-
MestOx by direct amidation 
After establishing a robust procedure for the preparation of PEtOx-MestOx, we focused our attention 
to the amidation of the methyl ester side chains. Even though it is commonly accepted that a direct 
amidation is not feasible under mild conditions, we did try this out by stirring the PEtOx-MestOx 
copolymer for two days in neat n-propylamine at 70 oC. 1H NMR spectroscopic analysis of the resulting 
polymer after precipitation revealed that the methyl ester resonance at 3.7 ppm disappeared and a new 
amide signal appeared at 7.9 ppm indicating successful amidation. The disappearance of the methylester 
peaks proves that there is a full conversion from an ester to an amide. In addition, FT-IR also confirmed 
the successful amidation by disappearance of the methyl ester band at 1730 cm-1 and appearance of a new 
band at 1531 cm-1 representative for the NH bending in a secondary amide group. Furthermore, SEC 
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analysis in DMA revealed an increase in Mn from 9.7 x 103 Da for PEtOx to 11 x 103 for PEtOx-MestOx to 
17.8 x 103 Da for the n-propyl modified polymer. Importantly, the Ð remained constant at 1.1 indicating 
that no side reactions take place. Even though it is not fully clear why the direct mild amidation of PEtOx-
MestOx is possible, it may be speculated that this is due to the very high concentration and large excess 
of amine groups, possibly in combination with a neighbouring group effect in which the amide groups 
attached to the PAOx backbone participate in the reaction mechanism by stabilization of the transition 
state via the formation of H-bonds. 
Inspired by the success of this first direct amidation reaction, we continued to explore the scope of this 
post-polymerisation modification reaction for PEtOx-MestOx. Several other readily available and cheap 
amines, namely aminomethane, aminoethane and hydrazine-hydrate, were utilized using the same 
Method 1, whereby the reaction is performed in a solution of the amine. 1H NMR spectroscopy, FT-IR and 
SEC again revealed the success of these direct amidation reactions (Table 1). The hydrazine modified 
polymer is especially interesting as it contains hydrazide side-chains that may be further utilized for 
conjugation of ketone containing molecules via a pH-degradable hydrazone linker.41 In a next step, a series 
of more complex functional amines was explored for direct amidation of PEtOx-MestOx. As these amines 
are more expensive and often occur as viscous liquids, the reaction conditions were modified resulting in 
Method 2. In this second method, the polymer is dissolved in acetonitrile and three equivalents of the 
amine are added. The resulting solution is stirred at 40 oC overnight. Only if the amine is not soluble in 
acetonitrile, the reaction was performed in a similar manner in DMF, which was the case for allylamine 
and 1-amino-3-butyne. In the case of amino acids such as leucine ester and glycine a deprotonation was 
needed. Therefore basic water was used as a reaction medium. The different tested amines are listed in 
Table 1 and successful direct amidation was found based on 1H NMR and FT-IR spectroscopy as well as 
SEC for dimethylamine, leucine methyl ester, glycine, 1,2-aminoethanol and 1,3-aminopropanol, 
allylamine, 1-amino-3-butyne, N,N-dimethyl-1,2-ethylenediamine and 1,2-ethylenediamine. As such, we 
could include a wide variety of functional groups in the side chains of PAOx based on the same PEtOx-
MestOx reactive platform. It is important to note, that the reaction with 1,2-ethylenediamine led to a 
minor increase of Ð and a decrease in Mn. This observation can be ascribed to tailing of the SEC trace due 
to interaction of the free amine group with the column materials. There is no evidence of double molar 
mass shoulders indicating that no cross-linking took place. A series of representative 1H NMR spectra, FT-
IR spectra and SEC traces of the PEtOx-MestOx and some products after amidation are shown in Figure 
5-5, 5-6 and 5-7, respectively. The 1H-NMR spectra clearly show that the peak at 3.7 ppm of the methyl 
ester group in PEtOx-PMestOx disappears upon amidation. There is also a notable change of signal 6, 
which after reaction with the amine moves closer to, and partially overlap with the peak around 2.2 ppm. 
These peaks merge together because of the similarity between the side chain of the PEtOx and the side 
chain of the succinyl. FT-IR clearly shows the disappearance of the band at 1730 cm-1 of the methyl ester 
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carbonyl and reveals the appearance of a new band in the region between 1530-1560 cm -1a finger print of 
the NH bending. Finally, SEC analysis clearly shows that the polymer molar mass distributions have very 
similar shape before and after amidation demonstrating that no polymer coupling occurred. 
4000 3600 3200 2800 2400 2000 1600 1200 800
4
(cm
-1
)
1
N-H stretch
4
%T
2
1
N-H stretch
4
NH
+
stretch
 
Figure 5-5: FT-IR data starting from the top with the PEtOx-MestOx and below two examples of polymers after the 
direct amidation 
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Table 1: Overview of the direct amidation of PEtOx-MestOx with various amines. 
 
R1-group Chemical shift 
amide proton(ppm)1 
Mn (kDa)2 Ɖ2 Method3 
aminomethane  6.4 17.7 1.1 1 
aminoethane  6.5 17.7 1.1 1 
1-amino 
propane 
 7.9 17.8 1.1 1 
N-metylmethaanamine 
 
6.3 17.8 1.1 2(water) 
hydrazine monohydrate  9 17.7 1.1 1 
leucine methylester 
 
nd
 4 18 1.1 2(basic water) 
glycine 
 
nd
 4 18 1.1 2(basic water) 
2-aminoethanol  nd
 4 22 1.1 2(acetonitrile) 
3-amino-1-propeen  nd
 4 16.5 1.1 2(DMF) 
1-amino-3-butyne 
 
7.8 16.7 1.1 2(DMF) 
N,N'-dimethyl-1,2-
ethyleen diamine 
 
8.2 16.6 1.1 2(DMF) 
1,2 ethylene diamine 
 
nd
 4 14 1.3 1 
1 Chemical shift in 1H-NMR spectra recorded in CDCl3. 
2 Calculated from SEC analysis with DMA as eluent and PMMA as calibration. 
3 Method 1: amine is used as reaction solution; method 2: The amidation reaction is done in another solvent 
specified between brackets.  
4 Not distinguishable as the 1H-NMR-spectra were recorded in DMSO and the NH peak could not be seen. 
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Figure 5-6: Overlay of the 1H-NMR spectra of PEtOx-MestOx and four products after direct amidation with different 
amines.  
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Figure 5-7: Overlay of normalized SEC (HFIP) traces of PEtOx-PMestOx and four examples of amidated polymers 
functionalized with hydrazine, allyl amine, 1-amino-3-butyne, cystamine 
 
To show that the direct amidation is also possible on homopolymers, PMestOx with DP 20 was 
synthesized by CROP of MestOx using methyl tosylate as initiator. This resulting polymer was analyzed 
by 1H-NMR spectroscopy, MALDI-TOF MS and SEC revealing the formation of a defined polymer with a 
low polydispersity (Ɖ=1.13; Figure 5-6). This polymer was subsequently modified with 1-aminopropane via 
method 1 (bulk method) by dissolving the polymer in 1-aminopropane and stirring overnight at 37°C. The 
MALDI-TOF mass spectrum of the resulting polymer clearly shows that there is a shift in mass in 
comparison to the begin product (Figure 5-6). MALDI-TOF MS of the PMestOx revealed the expected 
spacing of 157 m/z corresponding to the MestOx monomer while after reaction the spacing increased to 
184.24 m/z corresponding to the amidopropane side chain. Furthermore, the exact mass of 3197 m/z for 
PMestOx corresponds to a polymer with 20 repeat units and methyl and OH end-groups charged with a 
sodium cation. After the amidation reaction, the exact mass of 3738 is found corresponding to the amido-
propane functionalized polymer with methyl and OH end-groups and charged with a sodium cation. 
These results confirm a clean amidation of all methyl ester side chains. The 1H-NMR spectra also 
demonstrate that the methyl ester groups disappeared after amidation while 3 new peaks appeared 
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corresponding to the propyl side chains (signals 4-6 in Figure 5-7). Finally, SEC confirmed an increase in 
hydrodynamic volume after the amidation reaction while the Ɖ mildly increased from 1.13 to 1.17, albeit no 
clear shoulders are observable (Figure 5-8). 
 
Figure 5-8  Overview of the 1H-NMR data in D2O (top left), MALDI-TOF MS (right) and SEC (DMA as eluent; bottom 
left) analysis of the pure PMestOx with 20 repeating units before and after amidation with 1-aminopropane. The 
bottom 1H NMR and MALDI TOF mass spectra show PMestOx and the top spectra show the polymer after amidation 
with propylamine. 
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Figure 5-9 Conversion of the PEtOx-poly(urea) methyl ester with ethylamine 
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Figure 5-10 Conversion of the PEtOx-poly(thiourea) methyl ester with ethylamine 
 
The versatility of the methyl ester conversion was introduced by combining the amines with the methyl 
esters formed out the (thio)urea reaction. This enlarges the system versatility. It also shows that the 
methyl ester located on the side chain is a potent reactive group and the reactivity is independent of the 
linker. 
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Figure 5-11 Converted quaternary amine changed with hydrazine. 
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5.4 Conclusion  
 
We successfully showed a novel modification procedure to expand the chemical toolbox for poly(2-
oxazoline)s PEtOx. Starting from the controlled hydrolysis of well-defined PEtOx a copolymer is obtained 
with a specific amount of amine units to control the number of functional groups that can be incorporated. 
These amine units are subsequently reacted with methyl succinyl chloride restoring the poly(2-oxazoline) 
side chain structure while installing a methyl ester functionality. Even though such methyl ester 
functionalized copolymers can also be obtained via a direct polymerisation method, the post 
polymerisation modification route is, arguably, more cost effective and less time consuming. The synthesis 
of three different methyl ester containing linkers was also demonstrated, based on urea, thiourea and a 
tertiaire amine, showing the further versatility of the PEtOx-PEI platform. 
The copoly(2-oxazoline)s containing methyl ester side chains methyl ester group is demonstrated to 
undergo a direct amidation reaction, enabling the installation of a wide-range of side chain amide groups 
and functionalities. An important feature is that these reactions efficiently proceed without a catalyst, 
proposedly due to activation by neighbouring amide groups. Furthermore, we also demonstrated the 
synthesis of a PMestOx homopolymer with 20 repeat units by direct CROP of MestOx. The direct 
amidation of this model polymer with 1-aminopropane clearly revealed that all methyl ester side-chains 
can be modified. 
We are confident that this direct amidation side-chain modification approach will be an important 
extension of the PAOx toolbox that will lead to the development of novel applications of these polymers. 
By using the PAOx-PEI platform in these post-polymerisation modification reactions we have accessed 
four new types of polymers with reactive and functional side chains. These four different structures can 
be further developed to couple drug or bioactive molecules in future work. This novel methodology shows 
that the chemical versatility of the PAOx polymer family is large. 
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Prologue 
This chapter is an example of the post-polymerisation modification on the PAOx-PEI platform. By using 
this platform we can couple carbohydrates on to this platform. These carbohydrates can act as a model in 
the further development of more complicated carbohydrates. As carbohydrates play an important role in 
all kinds of biological processes this coupling could introduce a useful functionality. It gives the 
opportunity to introduce new and more complex structures. 
 
6.1 Introduction 
Carbohydrates are a crucial part of living organisms and function as structural components, energy 
sources, and in cellular communication and recognition.1,2 As glycoconjugates, carbohydrates can be 
integrated with proteins (glycoproteins) or with lipids (glycolipids). Galactin is an example of a 
carbohydrate binding protein, which interacts with polylactosamines on the cell surface and is crucial in 
cellular activation, differentiation and survival. An example of a glycoconjugate is hyaluronan, a 
polysaccharide that is highly abundant in the extracellular compartment of cartilage and synovial fluid 
and which induces cell adhesion by binding to various proteins.3 The carbohydrates interact through weak 
forces with low selectivity, such as hydrogen bonds, chelation, electrostatic and hydrophobic 
interactions.4,5 In nature, these low-affinity interactions occur between multiple, oligomeric binding 
site/pockets for monomeric/oligomeric sugar units. The binding becomes stronger due to multivalency,5 
which also generates reversible interactions that differentiate multivalency from covalent interactions6 
and generally results in stronger binding, as observed in lectin7. A great way to mimic these 
glycoconjugates is fabricating carbohydrate-containing polymers or glycopolymers; unlike glycoproteins, 
glycopolymers can be easily produced on a large scale.8–13 This process of biomimicry uses a simplified 
system, which facilitates the understanding of biological systems without the burden of difficult 
syntheses. 
To obtain these polymers, two strategies can be followed: the first consists a polymerisation of a 
carbohydrate-containing monomer, whereas the second consists of a post-polymerisation-modification 
in which the carbohydrate is coupled to a preformed polymer. In the case of the carbohydrate-containing 
monomer, the combination of a hydrophilic sugar component and a hydrophobic backbone often gives 
solubility problems due to the large differences in polarity. Therefore, living radical polymerisation and 
free radical polymerisation are often applied in solvent mixtures such as methanol:water or water:DMF.14 
Some examples of the direct polymerisation of unprotected sugar-containing monomers include the 
reversible addition-fragmentation chain transfer (RAFT) polymerisation of methacrylates,15–17 atom-
transfer radical polymerisation (ATRP) of poly(oligoethylene glycol) methacrylate18 and single electron 
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transfer living radical polymerisation (SET-LRP).19,20 The ring opening polymerisation of substituted N-
carboxyanhydride yields a large range of polypeptides depending on the (protected) carbohydrate.13 
Nonetheless, protecting groups must be introduced to the carbohydrate, which requires the use of a 
deprotection step. 
The second approach for the preparation of glycopolymers is the post-polymerisation modification of a 
reactive polymer with a sugar. In this approach, the sugar units do not intervene in the polymerisation, 
which provides more control and requires no subsequent deprotection step. An azide group is often used 
to click the sugar onto the polymer.16,21–23 The use of thiol-ene and NHS-esters to couple sugar units onto 
a polymer chain have also been described.13,14 Moreover, reductive amination has been used to couple 
sugars to amine-containing polymers.13,24–27 
For further biomedical applications, the choice of polymer is crucial because this determines, to a large 
extent, the properties and biocompatibility of the material. Ideal candidates have high water solubility, 
do not interact with the immune system, show no toxic effects, and are well defined and easily accessible. 
Therefore, poly(2-oxazoline)s (PAOx) were chosen in this work not only for their biocompatibility28–30 but 
also for the easy introduction of functionalities.29,31–33 These polymers are readily accessible by cationic 
ring opening polymerisations (CROP), which enables different architectures and functionalities. Earlier 
publications have already shown the preparation of glyco-PAOx using carbohydrate initiators, which 
resulted in chain-end functionalized PAOx.34,35 Furthermore, poly(2-methyl-2-oxazoline) and other PAOx 
have been grafted onto the polysaccharide chitin yielding graft copolymers.36,37 The first report on the 
CROP of a protected sugar-functionalized 2-oxazoline monomer was by Takasu,38 who copolymerised a 
sulfur-modified galactosyl containing a 2-oxazoline monomer with 2-methyl-2-oxazoline and with 2-
benzyl-2-oxazoline. The second publication by Schubert reported the copolymerisation of a 2-oxazoline 
monomer with a protected sugar with 2-ethyl-2-oxazoline or 2-decenyl-2-oxazoline.39 The main 
disadvantage of this copolymerisation route, however, is that the carbohydrates interfere with the CROP, 
necessitating protection of the hydroxyl groups of the sugar and deprotection after the polymerisation. 
Therefore, the post-polymerisation modification route is preferred for the preparation of these types of 
glyco-PAOx polymers. For example, Diehl et al40 reported the glycosylation of PAOx via thiol-ene 
chemistry in which the double bond was located on the side chain of the polymer; related polymers have 
been reported by the same and other research groups.41–45 This route enables the synthesis of well-defined 
polymers with a variety of functionalities, although the synthesis of a functional 2-oxazoline monomer is 
required for the thiol-ene mediated introduction of the carbohydrates. 
Therefore, in this work, an alternative post-polymerisation modification route starting from a well-
defined poly(2-ethyl-2-oxazoline) (PEtOx) homopolymer is proposed. The PEtOx was easily converted 
into a copolymer of PEtOx-PEI with a controllable percentage of PEI via acidic hydrolysis.46–48 The 
resulting copolymer contained the biocompatible PEtOx and a secondary reactive amine that was 
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subsequently used to couple the carbohydrate. In this step the amount of PEI in the partially hydrolysed 
PEtOx controlled the number of carbohydrates that could be incorporated. A major advantage of this 
modification of the PEtOx-PEI copolymer is that a biocompatible polymer was obtained. During the 
polymerisation of PEtOx, there is the possibility of further tailoring the end groups with functional 
terminators/initiators31 to enable the introduction of specific targeting groups or labels. The targeting 
groups could deliver polymers in specific tissue or organs. Also labels or traces can be coupled so the 
polymers can be used as tracking devices. As shown in earlier reports, sugar moieties can be coupled to 
primary amines through reductive amination; this approach has been used to introduce sugar moieties 
into hyperbranched PEI.24–26 However, such direct modification of the linear PEI (co)polymer has not been 
reported to date, and it is not directly clear whether the efficient modification via reductive amination is 
possible on the more sterically hindered secondary amine groups.  
Here, we report the preparation of defined PEtOx-PEI copolymers and the subsequent coupling of 
carbohydrates via the aldehyde of the linear form to yield an imine linkage, which was then reduced to a 
tertiary amine group in situ, so-called reductive amination (Scheme 1). The carbohydrates may increase 
bioavailability or even render a higher rate of accumulation in, for example, tumors due to the higher 
nutrient intake of cancer cells. This also could be the start of a new field of polymers where PEtOx and 
specific oligosaccharides are combined. The success of coupling the sugar onto copolymers with different 
amounts of PEI was investigated via size exclusion chromatography (SEC) and 1H and 13C NMR 
spectroscopy. The temperature-dependent solution behavior of the resulting glyco-PAOx was also 
investigated using dynamic light scattering (DLS). Finally, we demonstrated the biological affinity of the 
obtained glycopolymers by studying their interaction with Concanavalin A via DLS.39 
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Scheme 1 Synthetic approach for synthesizing PEtOx(100-x)-PEIx-Glc and PEtOx(100-x)-PEIx-Mal. Reaction 
conditions: i) acid hydrolysis (6 M HCl) at 73°C; ii) excess Glc (10eq) or Mal (20 eq) and excess BH3*Py (8 M) in 
sodium borate buffer (0.1 M) at 50°C for 7 days. The amount of x can be found in Table 1 of the SI. The upper 
box shows the formation of an imine via nucleophilic attack; the imine is subsequently reduced to an amine 
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6.2 Materials and methods 
PEtOx with a degree of polymerisation (DP) of 100 was synthesized as reported earlier (Mn = 9700 
kg/mol; Ð = 1.13).49,50 Hydrogen chloride, sodium hydroxide, dichloromethane, Concanavalin A (ConA) 
(Canavalia ensiformis, 25.5 kDa per monomer), maltose monohydrate, anhydrous glucose and borane-
pyridine complex (BH3*Py) were purchased from Sigma-Aldrich and were used without further 
purification. Dialysis membranes with a molecular weight cut-off of 1000 g/mol were purchased from Roth 
(Germany). 
Dynamic light scattering (DLS) was recorded on a Zeta Sizer Nano device (Malvern) using disposable 
polystyrene latex cuvettes. The concentration of the polymers was 5 mg/mL in MilliQ water. Unless 
otherwise mentioned, all samples were filtrated and sonicated before measurements were taken. Size 
exclusion chromatography (SEC) was performed using an Agilent HPLC equipped with a 1260 refractive 
index detector (RID) with 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) containing 20 mM sodium 
trifluoroacetate as the eluent at a flow rate of 0.3 mL/min (HFIP-SEC). Polymethylmethacrylate (PMMA) 
standards were used to calculate the molar mass values. The column set consisted of two PSS PFG 100Ǻ 
gel 5 µm MIXED-D columns and a similar guard column (Agilent) in series at 35°C. Chromatograms were 
analyzed in Agilent Chemstation software using the GPC add-on.  
The NMR measurements were carried out on a Bruker DRX 500 NMR spectrometer operating at 500.13 
MHz for 1H and at 125.75 MHz for 13C. All samples were measured in D2O. Sodium 3-(trimethylsilyl)-3,3,2,2-
tetradeuteropropionate was added for internal calibration ( (13C) = 0 ppm;  (1H) = 0 ppm). The signal 
assignments were done by combination of 1D and 2D NMR experiments using the standard pulse 
sequences provided by Bruker. All chemical shifts are given in ppm. 
 
Partial hydrolysis of PEtOx for the synthesis of PEtOx(100-x)-PEIx 
PEtOx was fully dissolved in 50 mL of water with heating and stirring. Then, 50 mL of a 36 wt% solution 
of HCl (concentrated HCl) was added and the mixture was heated to 73°C or 100°C for a defined period of 
time, which was adjusted to obtain the desired amount of partial hydrolysis of PEtOx to PEtOx-PEI based 
on the hydrolysis kinetics described in an earlier work by our group46: PEtOx96-PEI4 (25 min, 73 °C); 
PEtOx93-PEI7 (35 min, 73 °C); PEtOx89-PEI11 (50 min, 73 °C); PEtOx85-PEI15 (180 min, 73 °C); PEtOx73-PEI27 
(50 min, 100 °C); and PEtOx60-PEI40 (120 min, 100 °C).46,47 After the hydrolysis, the volatiles were removed 
on a rotary evaporator. The polymer was basified to pH 10-11 by the addition of a NaOH solution. The 
solution was then lyophilized, and the solid was dissolved in dichloromethane. The organic phase was 
washed with brine and then concentrated under reduced pressure to yield a solid, white product. The 
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integral ratio between the peaks at 2.6-2.8 ppm (PEI backbone) and 3.2-3.5 ppm (PEtOx backbone) in the 
1H-NMR spectra were used to calculate the degree of hydrolysis. 
PEtOx96-PEI4: 1H NMR (D2O):  (ppm) = 0.9 – 1.25 (m, 3H, d); 2.1 – 2.55 (m, 2H, c), 2.6 – 3.0 (m, 4H, b); 
3.15 – 3.95 (m, 4H, a). 13C NMR (D2O): (ppm) = (D2O):  (ppm) = 11.98 (CH3, d); 28.6 and 28.9 (CH2, c); 
50.0 – 52.0 (CH2, a and b); 180.2 (C=O, e). Mn = 10000 kg/mol; Ð = 1.13). 
PEtOx93-PEI7: 1H NMR (D2O):  (ppm) = 0.9 – 1.25 (m, 3H, d); 2.1 – 2.55 (m, 2H, c), 2.6 – 3.0 (m, 4H, b); 
3.15 – 3.95 (m, 4H, a). 13C NMR (D2O):  = (D2O):  (ppm) = 11.98 (CH3, d); 28.6 and 28.9 (CH2, c); 50.0 – 
52.0 (CH2, a and b); 180.2  (C=O, e). Mn = 11000 kg/mol; Ð = 1.11). 
PEtOx89-PEI11: 1H NMR (D2O):  (ppm) = 0.9 – 1.25 (m, 3H, d); 2.1 – 2.55 (m, 2H, c), 2.6 – 3.0 (m, 4H, b); 
3.15 – 3.95 (m, 4H, a). 13C NMR (D2O):  = (D2O):  (ppm) = 11.98 (CH3, d); 28.6 and 28.9 (CH2, c); 50.0 – 
52.0 (CH2, a and b); 180.2 (C=O, e). Mn = 12000 kg/mol; Ð = 1.11). 
PEtOx88-PEI12: 1H NMR (D2O):  (ppm) = 0.9 – 1.25 (m, 3H, d); 2.1 – 2.55 (m, 2H, c), 2.6 – 3.0 (m, 4H, b); 
3.15 – 3.95 (m, 4H, a). 13C NMR (D2O):  = (D2O):  (ppm) = 11.98 (CH3, d); 28.6 and 28.9 (CH2, c); 50.0 – 
52.0 (CH2, a and b); 180.2  (C=O, e). Mn = 12500 kg/mol; Ð = 1.15). 
PEtOx85-PEI15: 1H NMR (D2O):  (ppm) = 0.9 – 1.25 (m, 3H, d); 2.1 – 2.55 (m, 2H, c), 2.6 – 3.0 (m, 4H, b); 
3.15 – 3.95 (m, 4H, a). 13C NMR (D2O):  = (D2O):  (ppm) = 11.98 (CH3, d); 28.6 and 28.9 (CH2, c); 50.0 – 
52.0 (CH2, a and b); 180.2 (C=O, e). Mn =12000 kg/mol; Ð = 1.13). 
PEtOx73-PEI27: 1H NMR (D2O):  (ppm) =1.07 (s, 3H, d); 2.15 – 2.55 (m, 2H, c); 2.55 – 2.95 (m, 4H, b); 2.95 
– 4.0 (m, 4H, a). 13C NMR (D2O):  = (D2O):  (ppm) = 11.98 (CH3, d); 28.6 and 28.9 (CH2, c); 50.0 – 52.0 
(CH2, a and b); 180.2  (C=O, e). Mn = 15000 kg/mol; Ð = 1.10). 
PEtOx60-PEI40: 1H NMR (D2O):  (ppm) = 0.85 – 1.15 (m, 3H, d and A); 2.1 – 2.25 (q, 2H, A); 2.25 – 2.5 (m, 
2H, c); 2.5 – 3.0 (4H, b); 3.0 – 4.0 (m, 4H, a). 13C NMR (D2O):  (ppm) = 11.98 (CH3, d); 13.1 (CH3, A); 28.6 
and 28.9 (CH2, c); 33.5 (CH2, A); 45.0 – 52.0 (CH2, a and b); 180.2 (C=O, e); 187.6 (C=O, A). Mn = 25000 
kg/mol; Ð = 1.2). Signals assigned with A belong to the residual propionic acid formed during the partial 
hydrolysis of PEtOx. 
 
General procedure for the synthesis of maltose- or glucose-modified PEtOx(100-x)-
PEIx 
The precursor PEtOx(100-x)-PEIx (x = mol percent of hydrolysed EtOx unit in PEtOx into the PEI unit), 
maltose monohydrate (360.31 g/mol) or anhydrous glucose (180.16 g/mol) and borane-pyridine complex 
(BH3*Py, 8 M) was dissolved in a sodium borate buffer (0.1 M). The solution was stirred at 50 °C for 7 days. 
The crude product was purified by dialysis (1000 MWCO) against deionized water for 2 days. A solid 
product was obtained by freeze drying. Further information about the molar ratios used between the 
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precursor and other chemicals are presented in Table 1. The yields of these materials were between 40 and 
80%. 
 
Table 1. Molar ratio of components for the synthesis of PEtOx-PEI(x)-Carbohydrate (x = 4, 7, 
11, 15, 27, 40). 
  
 Precursor 
eq. [PEI: x mol] [mg] 
Carbohydrate 
eq. [mol] [g] 
BH3*Py [8 M] 
eq. [mol] [ml] 
borate 
buffer 
[ml] 
Mn Đ 
PEtOx-PEI4-Mal PEtOx-
PEI4 
1 
1.9 x 10-4 
200 
20 
3.8 x 10-3 
1.37 
20 
3.8 x 10-3 
0.48 
10 14400 1.4 
PEtOx-PEI7-Mal PEtOx-
PEI7 
1 
3.3 x 10-4 
200 
20 
6.7 x 10-3 
2.41 
20 
6.7 x 10-3 
0.84 
10 14000 1.3 
PEtOx-PEI11-Mal PEtOx-
PEI11 
1 
5.3 x 10-4 
200 
20 
10.7 x 10-3 
3.85 
20 
10.7 x 10-3 
1.34 
10 15600 1.2 
PEtOx-PEI15-Mal PEtOx-
PEI15 
1 
5.8 x 10-4 
200 
20 
11.6 x 10-3 
4.176 
20 
11.6 x 10-3 
1.45 
15 14000 1.4 
PEtOx-PEI27-Mal PEtOx-
PEI27 
1 
12.5 x 10-4 
200 
20 
25.1 x 10-3 
9.044 
20 
25.1 x 10-3 
3.14 
10 17900 1.2 
PEtOx-PEI40-Mal PEtOx-
PEI40 
1 
18.6 x 10-4 
200 
20 
37.2 x 10-3 
13.4 
20 
37.2 x 10-3 
4.7 
15 
 
15000 1.4 
PEtOx-PEI12-Glc PEtOx-
PEI12 
1 
4.3 x 10-4 
150 
10 
4.3 x 10-3 
0.782 
10 
4.3 x 10-3 
0.54 
10 17000 1.4 
PEtOx-PEI27-Glc PEtOx-
PEI27 
1 
9.4 x 10-4 
150 
10 
9.4.1 x 10-3 
1.695 
10 
9.4.1 x 10-3 
1.18 
10 21600 1.4 
PEtOx-PEI40-Glc PEtOx-
PEI40 
1 
18.6 x 10-4 
150 
10 
18.6 x 10-3 
3.35 
10 
18.6 x 10-3 
2.40 
15 18700 1.3 
 
PEtOx88-PEI12 -Glc: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 – 
50.0 (CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). SEC 
data: Mn = 17000 kg/mol; Ð = 1.4. 
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PEtOx85-PEI15 -Glc: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45  (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 
– 50.0 (CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). 
SEC data: Mn = 19500 kg/mol; Ð = 1.2. 
PEtOx73-PEI27-Glc: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 – 
50.0 (CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2  (C=O, e). 
SEC data Mn = 21600 kg/mol; Ð = 1.4. 
PEtOx60-PEI40-Glc: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.05 – 2.52 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.8 (CH2, c); 45.0 – 
50.0 (CH2, a); 52.0 – 56.0 (CH2, b); 59.2 (CH2, 1´); 65.6 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). SEC 
data: Mn = 18700 kg/mol; Ð = 1.3. 
PEtOx96-PEI4-Mal: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 – 
50.0 (CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). SEC 
data: Mn = 14400; Ð = 1.4. 
PEtOx93-PEI7-Mal:1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 4H, 
1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 – 50.0 
(CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). SEC data: 
Mn = 14000 kg/mol; Ð = 1.3. 
PEtOx89-PEI11-Mal: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 – 
50.0 (CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). SEC 
data: Mn = 15600 kg/mol; Ð = 1.2. 
PEtOx88-PEI12-Mal: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 – 
50.0 (CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). SEC 
data: Mn = 14000 kg/mol; Ð = 1.4. 
PEtOx85-PEI15-Mal: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.0 – 2.55 (m, 2H, c); 2.55 – 3.2 (m, 
4H, 1´ + b); 3.2 – 4.45 (m, a + 2´-6´). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 28.9 (CH2, c); 45.0 – 
50.0 (CH2, a); 52.0 – 57.0 (CH2, b); 59.3 (CH2, 1´); 65.7 (CH2, 6´); 73.0 – 81.0 (CH, 2´-5´); 180.2 (C=O, e). SEC 
data: Mn = 17900 kg/mol; Ð = 1.2. 
PEtOx73-PEI27-Mal: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.25 – 2.55 (m, 2H, c); 2.55 – 3.0 (m, 
4H, 1´ + b); 3.3 – 4.1 (m, 2-6 + 2´-6´); 4.9 – 5.45  (s, 1H, 1). 13C NMR (D2O):  (ppm) = 11.98 (CH3, d); 28.6 
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and 28.9 (CH2, c); 45.0 – 50.0 (CH2, a); 53.0 – 56.5 (CH2, b); 59.8 (CH2, 1´); 63.3 (CH2, 6); 65.1 and 65.6 (CH2, 
6´); 71.8 (CH, 2´); 72.2 (CH, 4); 74.5 (CH, 2, 3´); 75.3 (CH, 5); 75.5 (CH, 5´); 75.8 (CH, 3); 83.3 (CH, 4´); 103.5 
(CH, 1); 180.2 (C=O, e). SEC data: Mn = 15000 kg/mol; Ð = 1.4. 
PEtOx60-PEI40-Mal: 1H NMR (D2O):  (ppm) = 0.8 – 1.3 (m, 3H, d); 2.25 – 2.55 (m, 2H, c); 2.55 – 3.3 (m, 
4H, 1´ + b); 3.3 – 4.5 (m, 2-6 + 2´-6´); 4.8 – 5.45 (s, 1H, 1). 13C NMR (D2O):  (ppm) = 11.9 (CH3, d); 28.6 and 
28.9 (CH2, c); 45.0 – 50.0 (CH2, a); 51.0 – 56.0 (CH2, b); 59.8 (CH2, 1´); 63.2 (CH2, 6); 65.1 and 65.6 (CH2, 6´); 
71.6 (CH, 2´); 72.2 (CH, 4); 74.4 (CH, 2, 3´); 75.3 and 75.8 (CH, 3, 5, 5´); 84.6 and 85.2 (CH, 4´); 103.4 (CH, 
1); 180.2 (C=O, e). SEC data: Mn = 18700 kg/mol; Ð = 1.3. 
 
General procedure for the DLS measurements with ConA 
The concentration of the sugar-grafted PEtOx(100-x)PEIx copolymers was kept constant at 0.4 mmol/L in 
phosphate buffered saline (PBS). The polymer was weighed (PEtOx85-PEI15-Mal 2.5 mg/mL; PEtOx88-PEI12-
Mal 3.5 mg/mL; PEtOx73-PEI27 -Mal 2.9 mg/mLPEtOx60-PEI40 -Mal 2.5/mL mgPEtOx60-PEI40-Glc 2.5 
mg/mL) and dissolved in PBS buffer solution. The concentration of the ConA solution was 5 mg/mL (0.4 
mM) in PBS buffer. The ConA was added drop-wise to the polymer solution, and the resulting mixture 
was immediately measured in the DLS at 37°C. 
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6.3 Results and discussion 
6.3.1 Synthesis of polymers 
Previously, carbohydrates have been attached to hyperbranched PEI and aminopropyl methacrylamide 
by reductive amination.24,26,27,51,52 In this work, we evaluated whether carbohydrates can be coupled to the 
secondary amines of linear PEI units contained with defined statistical PEtOx-PEI copolymers with 
varying amounts of PEI. The starting PEtOx can be readily prepared via microwave-assisted CROP with 
narrow Ð values and high purity. This seems a good starting product for further applications because the 
PEtOx polymer is easily obtained in high purity based on the readily available EtOx monomer, making it 
significantly cheaper than other functional PAOx that have been used to prepare glyco-PAOx while 
avoiding the sometimes difficult process of monomer synthesis. Several publications show that PEtOx has 
an excellent biocompatibility, and PEtOx is claimed to be a good alternative for PEG, the gold standard in 
this field.19,21,46,47,53 The partial acidic hydrolysis of PEtOx is straightforward, and the degree of hydrolysis 
can be kinetically controlled by adjusting the temperature and time or by stoichiometric control over the 
variation of the amount of acid.46–48 Scheme 1 shows that there is a statistical distribution of PEI along the 
backbone, whereby it should be noted that the exact monomer distribution for such partially hydrolysed 
polymers is more block-like as shown in chapter 2. In this work, the hydrolysis was performed at 73°C or 
100°C, which were selected based on a previous work and depending on the amount of PEI required. When 
a higher percentage of PEI was required, the reactions were performed at a higher temperature to increase 
the reaction speed, whereas a lower degree of hydrolysis was performed at a lower temperature to have 
more accurate control over the final degree of hydrolysis. The PEtOx(100-x)-PEIx copolymers ( Table 1) were 
prepared with 4 mol% until 40 mol% of PEI units. The resulting copolymers were analyzed by 1H and 13C 
NMR spectroscopy in D2O. Figures 6-1, 6-2 and 6-3 show the respective 1H-NMR spectra of PEtOx60-PEI40, 
PEtOx60-PEI40 modified with glucose and modified with maltose. The 13C NMR spectra of all PEtOx60-PEI40, 
are presented in the Figures 6-5,6-6 and 6-7. The 1H and 13C NMR spectra of PEtOx73-PEI27 are shown in 
Figures 6-4 and 6-5. The PEI units appear at 2.5-3 ppm in the 1H-NMR spectrum (CH2-groups assigned as 
b) and at 45 and 52 ppm in the 13C-NMR spectrum (CH2-groups assigned  as b), whereas the residual CH2-
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groups of PEtOx appear at 3.2-3.7 ppm in the 1H-NMR spectrum and at 45 and 52 ppm in the 13C-NMR 
spectrum (assigned with “a” in Figure 6-4). The degree of hydrolysis in the PEtOx-PEI copolymers was 
calculated based on the integrals of the CH2 groups of (a) PEtOx and the CH2-groups of (b) PEI units.46 
 
 
 
4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
A + d
A
c
b
a
Figure 6-1: 1H-NMR spectrum of the PEtOx60-PEI40 copolymer (D2O). The signal (A) 
corresponds to propionic acid. 
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Figure 6-2: 1H NMR spectrum of PEtOx60-PEI40-Glc (x = 40) obtained from reductive amination of PEtOx60-PEI40 in 
the presence of excess glucose (Glc). (D2O)  
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Figure 6-3: 1H NMR spectrum of PEtOx60-PEI40-Mal (x = 40) obtained from reductive amination of PEtOx60-PEI40 in 
the presence of excess maltose (Mal). (D2O).  
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Figure 6-4:  1H NMR spectrum of PEtOx-PEI27 (x = 27) obtained from 27% hydrolysis of PEtOx with 100 repeating 
units. (D2O) 
 
Figure 6-5: 13C NMR spectrum of PEtOx-PEI27 (x = 27) obtained from 27% hydrolysis of PEtOx with 100 repeating 
units. (D2O) 
After purification, the formed propionic acid could be removed by evaporation and precipitation from 
all hydrolysed PEtOx(100-x)-PEIx copolymers, except PEtOx60-PEI40, which still contained some propionic 
acid (shown as signal assignment “A” in the NMR spectra of PEtOx60-PEI40 in Figure 6-1), and PEtOx73-
PEI27 (Figure 6-4) which still contained a very small amount of propionic acid after purification. The larger 
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retention of propionic acid in the PEtOx(100-x)-PEIx, which contained a larger PEI content, can be ascribed 
to stronger hydrogen bonding interactions that increased the difficulty of evaporating the propionic acid. 
Although the remaining propionic acid could be removed by dialysis, using a higher vacuum for 
evaporation, or preparative SEC, the obtained copolymers were directly used for the reductive aminations 
because the presence of the propionic acid was not expected to interfere with the reductive amination 
process. 
The reductive amination of PEtOx-PEI was first investigated with the monosaccharide glucose (Table 1: 
PEtOx88-PEI12, PEtOx73-PEI27 and PEtOx60-PEI40, SI) to evaluate whether all of the secondary amine units 
in the PEtOx-PEI derivatives could be modified. The PEtOx-PEI derivatives were reacted with a large 
excess of glucose in the presence of a borane-pyridine complex to reduce the formed imine linkage to a 
stable tertiary amine in situ (Scheme 1). The most abundant structure of glucose in aqueous solution is 
the cyclic hemiacetal form; only a minor portion of aqueous glucose is present as the linear aldehyde 
structure, which is required for the reductive amination. Due to this equilibrium or the low accessibility 
of the secondary amine, a large excess of carbohydrate was used and longer reaction times were needed. 
The secondary amine functionality of the PEI attacked the aldehyde of the ring-opened glucose, which 
yielded the desired glucose-containing PEtOx-PEI derivatives after reduction (Scheme 1).26 The glucose-
containing copolymers were analyzed by NMR spectroscopy (Figure 6-2 and Figures 6-6 and 6-7) and 
HFIP-SEC (Figure 6-8 and 6-18). The 1H NMR spectrum of PEtOx60-PEI40-Glc revealed broadening of the 
linear EI units (CH2-groups assigned as “b” in Figure 6-2), indicating the successful coupling of glucose 
units to the secondary amine units of PEtOx60-PEI40 leading to tertiary amine groups. Successful coupling 
was further supported by the analysis of the 13C NMR spectrum of PEtOx60-PEI40-Glc (Figure 6-6), in which 
the presence of the CH2 next to the tertiary amine units was found at 52-56 ppm showing the conversion 
of the imine group. Moreover, the successful coupling of Glc units to PEI units in PEtOx60-PEI40 was 
supported by the conversion of the quaternary carbon of the aldehyde group in Glc into a CH2-group at 
59.2 ppm in the 13C-NMR spectrum (assigned as 1´). These new CH2-groups (1´) demonstrate the presence 
of the tertiary amino groups by addition of the saccharide unit to the secondary amine group. These 
structural patterns are in agreement with those reported for other PEI glycoarchitectures.26 Moreover, 
PEtOx60-PEI40-Glc did not contain any low molar mass impurities, including propionic acid, which was 
still present in PEtOx60-PEI40 after purification by dialysis. 
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Figure 6-2:  13C NMR spectrum of PEtOx-PEI40-Glc (x = 40) obtained from reductive 
amination of PEtOx-PEI40 in the presence of excess glucose (Glc). (D2O) 
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Figure 6-7: 13C NMR spectrum of PEtOx-PEI40-Mal (x = 40) obtained from reductive amination of PEtOx-PEI40 in the 
presence of excess maltose (Mal). (D2O) 
 
 
Figure 6-8: SEC traces of PEtOx(100-x)-PEIx-Glc (left) and PEtOx(100-x)-PEIx-Mal (right) measured using HFIP as the 
eluent. 
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The degree of functionalization accompanied by the conversion of secondary into tertiary amines was 
calculated via quantitative 13C NMR spectroscopy as shown in Figure 6-9. This was done for both PEtOx60-
PEI40-Glc and PEtOx73-PEI27-Glc. The integrals of the C atom C6´ of glucose and the methyl group of 
residual EtOx units were used. The signal of the methyl PEtOx was calibrated to 60 and the value of 6’ was 
34 giving the exact amount of coupled sugars. The degree of glucose functionality was: 34 EI units (85%) 
with glucose for PEtOx60-PEI40-Glc, and 23 EI units (85%) for PEtOx73-PEI27-Glc. Size exclusion 
chromatograms of glycosylated PEtOx-PEI derivatives were obtained using HFIP as the eluent (Figure 6-
8 and 6-17) and showed that the desired glycopolymers had a narrow molar mass distribution with Ð ≤ 
1.4. The increase in Đ may be caused by column interactions resulting from the addition of the highly 
polar carbohydrates as seen with other PEtOx copolymers before.47 This value indicated that neither chain 
coupling nor degradation occurred. Moreover, the low dispersity of the obtained glycopolymers may be 
beneficial for further biomedical applications. 
 
Figure 6-9: Determination of attached glucose in PEtOx60-PEI40-Glc is given by the direct read out of the integral 
number of 13C signal C6´, when 13C signal of d is calibrated with 60 (1C of EtOx x 60 repeating units in PEtOx60-
PEI40-Glc). 
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Even though glucose grafted glycopolymers were successfully obtained, they contained the ring-opened 
glucose in the side chain, which is not efficiently recognized by carbohydrate binding proteins such as 
lectins. This implies that this sugar modification strategy will not have further useful applications in a 
biological context except to enhance the biocompatibility of those polymers. In preparing biologically 
active glycopolymers based on the reductive amination of PEtOx(100-x)-PEIx,(Scheme 1) we, therefore, 
focused our attention on the introduction of a disaccharide, namely maltose. The first saccharide unit of 
maltose was used in its linear aldehyde form as a linker in the coupling via the reductive amination 
reaction. The second saccharide unit, however, remained intact as a cyclic structure, enabling the 
biological recognition of the obtained glycopolymers. For this purpose, maltose was coupled to various 
PEtOx(100-x)-PEIx derivatives (Table 1) under reductive amination conditions in the presence of excess 
maltose (Scheme 6-1). The resulting maltose-containing copolymers PEtOx96-PEI4-Mal, PEtOx93-PEI7-Mal, 
PEtOx89-PEI11-Mal, PEtOx88-PEI12-Mal, PEtOx85-PEI15-Mal, PEtOx73-PEI27-Mal and PEtOx60-PEI40-Mal were 
analyzed by NMR spectroscopy and SEC. Figure 6-10 depicts the 1H NMR and Figure 6-7 the 13C NMR 
spectra of PEtOx60-PEI40-Mal as representative examples. Similar structural characteristics (e.g., the 
appearance of the PEI unit and the conversion of the aldehyde group into a CH2-group) were identified in 
PEtOx60-PEI40-Mal and PEtOx60-PEI40-Glc. A comparison with a previously reported maltosylated 
hyperbranched PEI obtained by reductive amination54 further confirmed the successful quantitative 
coupling of maltose to the PEtOx-PEI derivatives. Moreover, the chemical structure of PEtOx in PEtOx60-
PEI40-Mal remained intact after the successful integration of maltose into the PEtOx-PEI derivatives 
(Figure 6-3). SEC traces of the polymers showed narrow dispersity, which proved that the coupling but no 
degradation of the polymer chains occurred (Figure 6-8). However, the higher Đ is probably caused by 
the column interaction. 
Additionally, the functionalization was calculated via 1H NMR spectroscopy using the integrals for 
PEtOx60-PEI40-Mal as shown in Figure 6-10. The integrals of the signal of the anomeric proton of the 
residual glucose ring in maltose, (1), was used as well as the integrals of the signal of the methyl group of 
residual PEtOx (d). The latter was calibrated and, thus, allows calculation of the converted EI units to be 
37.5 (94%) for PEtOx60-PEI40-Mal, and 24 EI units (88%) PEtOx73-PEI27-Mal. When using the 
quantitative 13C NMR spectra to calculate the conversion, the signal of the C atom of the C6´and the C6 
of maltose in the corresponding PEtOx60-PEI40-Mal and PEtOx73-PEI27-Mal were used as well as the 
signal of the methyl group of residual EtOx units. The degree of functionalization using this method is 
determined to be 99% for PEtOx60-PEI40-Mal and of 96% for EI for PEtOx73-PEI27-Mal.  
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Figure 6-10: Determination of attached maltose in PEtOx73-PEI27-Mal is given by the direct read out of integral number 
for 1H signal 1, when 1H signal d is calibrated with 219 (3H x 73 repeating units in PEtOx73-PEI27-Mal). 
 
6.3.2 Solution behavior  
The solution behavior of the synthesized glycopolymers was thoroughly investigated by DLS to 
investigate whether the polymers were soluble as unimers, were thermo-responsive, or whether they 
formed aggregates. This is of great importance in a biomedical context, in which macroscopic aggregation 
must be avoided. Before the temperature-dependent DLS was measured, the stability of the glycopolymers 
in solution was assessed by measuring a sample that was equilibrated for a few hours before and after 
filtration. As shown in Figure 6-5 the equilibrated PEtOx60-PEI40-Glc revealed the presence of large 
aggregates; these aggregates were no longer observed after filtration. The syringes have a 0.22 µm 
threshold, so either the aggregates remained on the filter, or they were destroyed by shear forces when 
the sample was pushed over the filter due to their loosely bound state and, thus, their ease of dissociation. 
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Therefore, the derived count rate before and after filtration was compared, which revealed a minor 
decrease from 127.33 kcps before filtration to 94.66 kcps after filtration. Although some polymer appears 
to remain on the filter, the major fraction of aggregates was transformed back into unimers, indicating 
that mostly loose aggregates were formed, which could be easily disaggregated by filtration. 
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Figure 6-11: Effect of the filtration on DLS measurements of PEtOx60-PEI40-Glc. The dotted lines indicate the filtered 
polymer solution; the solid line indicates the unfiltered solution. 
 
Because the parent PEtOx showed a lower critical solution temperature (LCST) occurring approximately 
60 °C,55,56 the temperature-dependent solubility behaviors of the glycopolymers were subsequently 
investigated. The temperature-dependent DLS was measured in water between 10 °C and 70 °C (Figure 6-
12) and clearly indicated the difference between the glucose and maltose grafted glycopolymers. All of the 
PEtOx-PEI-Glc polymers (Figure 6-12, left) show macroscopic aggregation at all temperatures; though the 
DLS of PEtOx73-PEI27-Glc did not show large aggregates, a macroscopic precipitate was formed on the 
bottom of the cuvette. The strong agglomeration of these glucose modified polymers was ascribed to the 
strong intermolecular hydrogen bonding between the PEtOx amide groups and the hydroxyl groups of 
the linear grafted glucose units, as well as between the glucose units.  
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Figure 6-12: Temperature-dependent hydrodynamic diameter of PEtOx(100-x)-PEIx-Glc (left) and PEtOx(100-x)-PEIx-
Mal (right) as obtained by DLS (z-average size from cumulant analysis). (pH ~8) 
 
In contrast, the PEtOx-PEI-Mal glycopolymers (left Figure 6-12) containing low amounts of maltose (less 
than 12%) did not show aggregation, and only unimers were detected by DLS at all temperatures. It may 
be speculated that the larger size of the saccharide side chain, in combination with the cyclic saccharide 
unit, suppresses the hydrogen bonding interactions with the amide groups in the polymer backbone. The 
maltose glycopolymers with 12 and 15% showed LCST behaviors with cloud point temperatures of 37 °C 
and 60 °C, respectively. These behaviors were probably caused by an increase in the hydrogen bonding 
interactions between the sugar units and the polymer backbone, which competes for hydration and lowers 
the solubility of the polymers. Even higher percentages of maltose induced macroscopic aggregation and 
thus behaved similarly to the glucose-functionalized glycopolymers, supporting the proposed decrease in 
polymer solubility resulting from enhanced competition for efficient hydration by interpolymer hydrogen 
bonding. 
In addition to temperature dependence, the pH-responsive solution behavior of the glycopolymers was 
also investigated based on the (de)protonation of the tertiary amine groups of the glyco-PAOx prepared 
by reductive amination. 
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 13 shows the DLS measurements for the 40% grafted copolymers containing either glucose or maltose. 
These polymers were expected to reveal the largest pH-responsiveness, as they contained the largest 
amount of tertiary amine groups. The initial polymer solutions had a pH of ~8 in PBS buffer. The pH was 
raised to 12 by the addition of NaOH and lowered to pH 2 by the addition of HCl to ensure full 
deprotonation and protonation of the tertiary amine groups, respectively. Also the pH was lowered to pH 
6.22 to see the solubility effect. Unexpectedly, neither glycopolymer showed a large change in solution 
behavior as a function of pH despite the (de)protonation state of the tertiary amine groups indicating that 
the amine groups are shielded by the sugar side chains and have little influence on the polymer solubility 
as was also found for the partially hydrolysed poly(22-n-propyl-2-oxazoline)s in chapter 3. 
 
Figure 6-13: pH dependence of PEtOx60-PEI40-Mal (left) and PEtOx60-PEI40-Glc (right) measured by DLS at 25°C 
(solutions in PBS). 
 
The biomedical relevance of the synthesized glycopolymers was investigated by studying their 
interaction with the glucose binding protein Concanavalin A (ConA). This lectin specifically binds to 
glucose or maltose12. First, the binding of PEtOx60-PEI40-Glc to ConA was investigated at 37°C; no 
aggregation was observed upon the addition of ConA to the glycopolymer (Figure 6-14 and 6-15). The 
absence of interactions between this polymer and ConA was anticipated because the polymer was 
functionalized with the linear form of glucose, which is not recognized by this lectin. Subsequently, the 
interaction between PEtOx60-PEI40–Mal and ConA was studied, as this glycopolymer was functionalized 
with maltose; in this glycopolymer, the first glucose unit (in the linear form) was used for conjugation and 
the second glucose unit, which remained intact in its cyclic form, was predicted to be able to bind ConA. 
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Figure 6-11 shows the DLS volume plots of the PEtOx60-PEI40–Mal unimers after filtration (bottom). Upon 
the addition of ConA, the solution immediately became turbid, and the DLS measurements shows in 
Figure 6-16 middle and Figure 6-19) revealed the presence of large aggregates of approximately 1000 nm 
as well as some smaller aggregates with a hydrodynamic size of 200 nm. This clear agglutination of ConA 
with PEtOx60-PEI40-Mal confirmed that the second glucose unit after the conjugation of maltose to 
PEtOx60-PEI40 was still biologically active and was thus prone to interact with ConA. To further prove that 
the interaction between the glycopolymer and ConA was based on specific saccharide binding, an excess 
of glucose was added to the agglutinated solution, resulting in the destruction of the aggregates due to 
the interactions between the large excess of soluble glucose with ConA, which freed the polymer as 
unimers (Figure 6-16, top). The 15 % grafted maltose showed that this contained not enough glucose units 
to interact with the Con A (Figure 6-20). 
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Figure 6-14: DLS volume plot of the 27% glucose grafted polymer with different amounts of the Concavalin A. 
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Figure 6-15: DLS volume plot of the 12% glucose grafted polymer with different amounts of the Concavalin A. 
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Figure 6-16: DLS volume plots of PEtOx60-PEI40–Mal (10 mg/mL in PBS buffer at 37 °C) measured after filtration 
(bottom), after the addition of 40 µL of Concanavalin A solution (middle), and after the further addition of an excess 
of glucose (top). 
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Figure 6-17: HFIP-SEC of PEtOx-PEI-Mal (x ) obtained from reductive amination of PEtOx-PEI in the presence of 
excess maltose (Mal). 
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Figure 6-18: HFIP-SEC of PEtOx-PEI-GlC (x ) obtained from reductive amination of PEtOx-PEI in the presence of 
excess maltose (Glc) 
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Figure 6-19: DLS volume plot of the 40% maltose grafted polymer with different amounts of Concavalin A in µl. 
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Figure 6-20: DLS volume plot of the 15% maltose grafted polymer with different amounts of the Concavalin A 
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6.4 Conclusion  
The successful exploration of PEtOx-PEI as a reactive platform for post-polymerisation modification 
was shown by the coupling of two sugars, glucose and maltose, via reductive amination to yield glyco-
PAOx. The linear aldehyde form of glucose efficiently forms imine linkages with the secondary amine 
units of PEI followed by the in situ reduction to the stable tertiary amines. The solution behavior of the 
resulting glycopolymers shows that there are strong interactions via hydrogen bonding between the 
backbone and the side chains, leading to the formation of the loose aggregates of all glucose-modified 
copolymers. The maltose functionalized copolymers containing less than 12% maltose are stable as 
unimers, whereas polymers with 12% to 15% maltose show LCST behavior. Higher maltose contents 
resulted in aggregation. Because our aim is the development of glycopolymers for biomedical applications, 
the interaction of the obtained glyco-PAOx with ConA, a sugar binding lectin, was investigated. As 
expected, the glucose modified copolymers do not interact with ConA, as they contain linear glucose units. 
The polymer grafted with maltose does, however, still contain a ring closed glucose unit that is available 
for binding and leads to the efficient and specific agglutination with ConA. Future works will focus on 
using the developed synthetic strategy for the preparation of glyco-PAOx containing more biologically 
relevant sugars that show specific interactions with certain tissues or proteins associated with certain 
diseases, such as influenza or HIV. The carbohydrate will then be used as a targeting agent or as an 
inhibitor. We also hope that this work inspires the use of the PEtOx-PEI platform for coupling of other 
biologically relevant carbohydrates. 
 
This coupling of carbohydrate is of vast importance for the PAOx field as the carbohydrates are 
important in all kind of biological processes. It may open up a new field of post polymerisation added 
carbohydrates making polymers which may be used in cell trafficking or other biological processes. 
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7.1 English Summary and outlook 
During this PhD research the world of poly(2-alkyl-2-oxazoline)s (PAOx) was explored. This class of 
polymers was discovered in 1966 by four independent research groups.1–4 Nowadays, these polymers find 
their applications mostly in the biomedical field as the polymers show excellent behavior in a biomedical 
context.5 When PAOx is brought in contact with a living organism no adverse reactions are observed.6 
Although specific protein adsorption is observed, these proteins actually ensure that macrophages do 
remove the polymer.7 These beneficial biological properties in combination with the large chemical 
versatility could potentially make PAOx “the new kid on the block” in the field of polymer therapeutics. 
The future is prosper as the first PAOx drug conjugate, SER 214, has entered phase I of the clinical trials. 
SER 214 is a PAOx-Parkinson drug developed by Serina Therapeutics and many more are expected to 
follow. 
Next to its excellent biomedical behavior PAOx is known as the precursor of L-PEI.8 L-PEI is obtained 
either via an acidic or basic hydrolysis of PAOx, to remove all the amide side chains of the PAOx.9 If only 
a part of the side chains is removed we obtain PAOx-PEI copolymers, that contain the original polymer 
and newly formed L-PEI units.10–12 These copolymers are used in gene transfection and in post-
polymerisation modification procedures.13,14 In this thesis we focused on the post-polymerisation 
modification of PEI-units along the backbone. For the development of new polymer therapeutics a 
polyvalent polymer platform is needed with a broad range of chemical versatility. For PAOx this includes 
the functionalisation of the side chains and/or the end groups either via termination agents and/or 
initiators. The third option for functionalisation is the post polymerisation modification route. This route 
uses well-defined homopolymers such as PEtOx or PMeOx as a starting point. The polymerisation of these 
polymers can happen in a defined way, in large scale and the polymers are commercially available in 
different grades. The latter is important for labs which have no specific installation for the synthesis of 
PAOx and cannot synthesise special polymers. The amines of the PEI units can be used in post 
polymerisation modification steps as it is a good nucleophile. However the distribution of PEI units along 
the backbone is not known. Knowing this distribution is of great importance as it will influence the 
behavior and reactivity in further steps. 
In chapter 2 the acidic hydrolysis was investigated via different 1D NMR techniques, namely 1H-NMR, 
13C-NMR spectroscopy and 2D NMR techniques namely  HSQC, HMBC and COSY spectroscopy. These 
techniques were used to gain insight in the distribution of L-PEI units along the PAOx chain after partial 
hydrolysis. (Figure 7-1, center) Three types of CH2 in the PEI units were revealed. All three CH2 groups 
have different chemical environment and, therefore, could be identified in the 13C-NMR spectrum  with 
the help of various 2D NMR techniques. The first CH2 type is surrounded by other CH2 groups originating 
from PEI and was identified as the middle of a block of PEI units, an all PEI triad. The second type of CH2 
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is the frontier of the block as it showed interactions with CH2 groups of both PEI and PEtOx. The third 
type of CH2 only showed interactions with CH2 originating from PEtOx. The three types of CH2 reflect 
three types of PEI-units, indicating that the hydrolysis proceeds in a block like fashion as already at lower 
hydrolysis degree all PEI triads were present. This means that starting from one PEI-unit the neighbouring 
groups are more likely to be hydrolysed into PEI. We stipulate that the block formation is caused by the 
presence of the neighbouring protonated amine. This facilitates the reaction by the formation of a seven-
membered intramolecular ring thereby overcoming the repulsion effect which is induced by the 
protonation of the amines. The seven ring induces an acceleration during the beginning of the hydrolysis 
reaction which was already observed in the kinetics, while at higher hydrolysis degree the effect of the 
protonation becomes significant and decreases the hydrolysis speed.9,11 With increasing hydrolysis degrees 
a higher percentage of block-like PEI structures were found as expected. The second proof for the block 
like PEI distribution was given by straightforward statistics. The random hydrolysis can be compared with 
Bernoulli statistics, meaning that the effect of the neighbouring group is nonexistent. The experimental 
data showed that the experimental hydrolysis does not agree with the Bernoulli statistics and that there 
is an effect of neighbouring groups on the hydrolysis. After 50 years the question of the PEI units 
distribution resulting from partial hydrolysis is finally answered, as it yields block-like PAOx-PEI 
copolymers. The investigated hydrolysis reactions were performed in HCl. The effect of adding different 
kinds of salt could potentially influence the protonation and related seven ring formation. Different effects 
on the protonation, like addition of salts, could provide some mechanistic insights and probably could 
make it possible to prepare statistical copolymers. The option of different solvents could also be 
interesting as this influences the protonation and the solubility of the resulting PEI units. With this 
chapter the copolymer distribution is unraveled and this knowledge can be used to understand the 
polymer behavior  in the following chapters and maybe useful for functionalisation. 
The hydrolysis of PPrOx was investigated in the third chapter (Figure 7-1, left top corner). For the 
hydrolysis of PAOx into L-PEI mostly PMeOx and PEtOx are used due to their good water solubility. The 
PPrOx is water soluble at room temperature, but the polymer has a temperature dependent solubility and 
crashes out of solution at elevated temperatures as used during the hydrolysis reactions. Therefore the 
hydrolysis of PPrOx was investigated and the kinetics were determined, showing a slower hydrolysis for 
PPrOx compared to PEtOx and PMeOx.8,15 This result was anticipated as the extra carbon present in the 
side chain obstruct the access to the amide. The Tcp of PPrOx of 25°C makes that the polymer is insoluble 
at the reaction temperature thereby decreasing the reaction speed. Due to the presence of the PEI units 
along the backbone an increase in Tcp was observed for the PPrOx-PEI copolymers. A higher percentage 
of PEI induced a higher Tcp as expected as the hydrophobic propyl side chains were removed. The 
solubility behavior of the PPrOx-PEI copolymers was examined in different salts and this showed that the 
hydration layers are influenced by the salt addition, when there was an addition of a “salting in” salt there 
  
 
229 
 
CHAPTER 7 
was an even higher increase for the TCP. There was no pH influence on the Tcp. After the thorough 
examination of the hydrolysis reaction of PPrOx, polymers with different lengths were partially hydrolysed 
and used to prepare polyplexes with DNA for transfection experiments. These polymers formed well-
defined particles, which could subsequently act as a scaffold when heated beyond the TCP. When forming 
the particles the positive charges were found on the outside, enabling a strong interaction with the DNA. 
This chapter showed that together with PEtOx and PMeOx, PPrOx could have potential as non-viral gene 
vector for gene transfection. For further work the polymer could be modified or partially cross-linked to 
form hydrogels in situ.  
In the fourth chapter both PEI and PEtOx-PEI were used to develop a post-polymerisation modification 
procedure (Figure 7-1, right top corner). By using the well-known reaction between an amine and CO2 , a 
carbamate containing polymer could be obtained. However the reaction between a secondary amine and 
CO2 is slow and therefore the modification reactions were done in scCO2 yielding partially carbamate 
functionalized PEI and PEtOx. It was however impossible to convert all of the PEI units into carbamates 
with scCO2 due to the formation of a zwitterion. The zwitterionic carbamate was formed when remaining 
amines of L-PEI were protonated and the carbamate was deprotonated. The deprotonation by the amines 
is important as this stabilizes the carbamate. A detailed NMR study on the formed polymer structure 
revealed the occurrence of a side reaction at longer exposure times leading to the formation of a cyclic 
urea that was irreversibly formed by locking the CO2 on the backbone. The introduction of this cyclic 
urea had a huge influence on the properties of the final polymers. The polymers with the cyclic urea 
showed fluorescence similar to the carbamate polymer. After removal of the carbamate units by using 
heat, a linear PEI analogue was obtained having some cyclic urea groups, which suppresses the 
crystallization making it better water-soluble while simultaneously providing intrinsic fluorescence. Such 
amorphous fluorescent PEI analogues have huge prospect for gene delivery and cell trafficking. Also 
zwitterionic polymers are getting more attention in biomedical context as they show non-fouling 
behaviour. The carbamate functionalized PEtOx also have intrinsic fluorescence making them interesting 
for biomedical applications and for theranostic. 
 
In the fifth chapter, the  PEtOx-PEI reaction platform was further explored (Figure 7-1, left bottom 
corner). Expanding the chemical toolbox is important as this could help the development of new polymer 
therapeutics. Four different copolymers bearing methyl ester side chains were synthesised. Al linkers were 
coupled by using a reaction between the amine of the PEI unit and a reactive group. The first modification 
reaction with an acid chloride yielded a copolymer with the original PEtOx and the newly formed 
PMestOx. The second and the third copolymers used a thiourea and urea group to couple the linker. The 
last linker formed a tertiary amine and was developed by the reaction of L-PEI with bromo-acetate. All of 
the polymers have a latent methyl ester functionality, which could be transformed in an amide via a direct 
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amidation reaction with an excess of amine. Different kind of amines were used to transform the methyl 
ester group into an amide to introduce a wide range of (functional) side chains. This chapter not only 
showed the versatility of PEtOx-PEI platform, it also introduced new linkers. The linkers could be used to 
couple drugs, peptides or any other active molecule in future works. 
In the sixth chapter the PEtOx-PEI platform was examined as basis for carbohydrate containing 
polymers (Figure 7-1, right bottom corner) This is important as there is a need for biocompatible polymers 
with potential targeting groups. This was done by the synthesis of PEtOx-PEI copolymers containing 
different hydrolysis degrees. The PEI units were subsequently reacted with a carbohydrate via a reductive 
amination. This reductive amination of the linear form of carbohydrates was already shown on the primary 
amino groups of branched PEI, however not on copolymers with L-PEI that only contain secondary amino 
groups. The successful synthesis of these polymers showed that PEtOx-carbohydrate copolymers were 
accessible, whereby the first part of the carbohydrate is ring opened. In our case two carbohydrates were 
used, glucose and maltose. The solution behaviour of the resulting polymers was examined and the 
possibility for binding with ConA was evaluated. This showed that the second carbohydrate unit was still 
available for binding with the enzyme when a disaccharide was used, whereby one ring is opened for 
coupling to the PEtOx-PEI but the second ring remains intact. The reductive amination is however not a 
straightforward process, so it could be suggested that carbohydrates should be coupled via different 
methods as carbohydrates with all kind of functionalities are being developed. 
This work provides some insights in the world of post polymerisation modification of PAOx-PEI. It 
could potentially help to ensure a better access to the PAOx class. The polymer class is pushing its way to 
the top of the polymer therapeutic field. However if there will be no FDA approval, polymer therapeutics 
based on PAOx are just a dream. Luckily a firm such as Serina Therapeutics is focused on developing and 
exploring the PAOx platform. The PAOx field could learn a lot from Serina as they used different 
molecules than those often found in polymer papers. The main factor to convince the pharmaceutical and 
biomedical community is by producting biological relevant data.  
If PAOx cannot play a role in polymer therapeutics it will play a role in the field of macroscopic 
polymers. Here the FDA approval is not crucial and the Dutch company GATT is brining PAOx polymer 
to the patient and the medical world. This is of vast importance for the PAOx field showing that innovation 
and new products can push the gates open to new markets. 
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Figure 7-1: Overview figure 
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7.2 Nederlandstalige samenvatting 
 
In dit doctoraat werd de wondere wereld van poly(2-alkyl-2-oxazoline)s (PAOx) verder onderzocht. 
Deze polymeren behoren tot de klasse van de biomedische polymeren en werden gelijktijdig door 4 
onderzoeksgroepen ontdekt in 1966. PAOx zijn enorm geschikt voor toepassingen in het medische veld 
door excellente farmaceutische kwaliteiten. Wanneer deze polymeren in contact komen met een 
organisme, bijvoorbeeld in de bloedbaan, wordt geen afstotingsgedrag opgemerkt. Ze zijn als het ware 
onherkenbaar voor het immuunsysteem waardoor ze ideale kandidaten zijn voor toepassingen in de 
farmaceutische wereld. Daarnaast biedt dit polymeer ook een enorme chemische diversiteit omdat de 
polymeren op verschillende niveaus chemisch gemodificeerd kunnen worden, dit via de eindgroepen en 
de zijketens. Daarom is het ook fantastisch nieuws dat voor het eerst een PAOx gebaseerd medicijn naar 
fase I van de klinische trials wordt getest door de farmaceutische firma Serina Therapeutics. 
Naast hun kwaliteiten op biologisch vlak zijn deze PAOx polymeren ook gekend als precursors van 
lineair poly(ethylene imine) (L-PEI). Dit polymeer is een van de belangrijkste referenties op het vlak van 
gen transcriptie. Via een zure of basische hydrolyse van PAOx wordt het L-PEI verkregen. Niet alleen het 
volledig gehydrolyseerd polymeer kan worden verkregen maar ook copolymeren, die bestaan gedeeltelijk 
uit het PAOx en PEI. De PAOx-PEI polymeren hebben hun toepassingen op het vlak van gen therapie 
maar kunnen daarnaast ook dienen als startpolymeer voor het maken van nieuwe copolymeren. Door de 
vele ontwikkelingen in het veld op het vlak van goed gedefinieerde polymeren kunnen startpolymeren 
worden verkregen met een Đ < 1.1. Hiermee kunnen zeer goed gedefinieerde polymeren op maat van de 
toepassing gemaakt worden met als groot voordeel dat er geen moeilijke monomeersynthese moeten 
worden gedaan. Daarnaast zijn deze startpolymeren commercieel beschikbaar en is de hydrolyse een 
proces waarbij geen gespecialiseerde apparatuur voor nodig is. 
Omdat de gedeeltelijke hydrolyse van PAOx een zo belangrijke rol kan spelen moet deze eerst tot in het 
detail gekend zijn. In het eerste deel van dit doctoraat werd daarom nagegaan hoe de zure hydrolyse in 
zijn werk gaat. Via nucleaire magnetische resonantie technieken werd de monomeer distributie langs de 
keten onderzocht. Hierbij kwamen we tot de conclusie dat er drie types L-PEI methyleen populaties 
aanwezig zijn in het copolymeer. Het eerste type is de methyleen populatie waarbij deze enkel en alleen 
is omringd door andere methyleen molecule van PEI. Dit wil zeggen dat deze methyleen groep zich in het 
midden van een PEI block bevindt. De tweede populatie wordt omringd door enerzijds PEI methyleen en 
anderzijds een PEtOx methyleen. Deze vormt de grens van een PEI gebied en een PEtOx gebied. De laatste 
methyleen populatie bevindt zich in een PEtOx rijke omgeving. Tijdens de hydrolyse wordt blokvorming 
verkregen die niet overeenkomt met een willekeurige hydrolyse. Dit werd aangetoond via de Bernoulli 
statistiek, waarbij de kans zeer klein is dat willekeurig drie methyleen PEI units naast elkaar komen te 
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staan by lage hydrolyse graad. De blokvorming wordt verkregen doordat de NH geprotoneerd is en zo een 
zeven ring kan vormen met de carbonyl van het amide op de zijketen. Hierdoor is dit amide veel gevoeliger 
voor een nucleofiele aanval. Het zou het zeker interessant zijn om te kijken wat de invloed is van het zuur 
en de eventuele toevoeging van zouten op deze zure hydrolyse. Indien er enige optimalisatie gebeurt zou 
het mogelijk moeten zijn om de hydrolyse uit te voeren waarbij statistische polymeren worden verkregen. 
Vervolgend op het verhaal van de hydrolyse van PEtOx werd ook de hydrolyse van poly(n-
propyloxazoline) (PPrOx) bestudeerd. Dit polymeer vertoont temperatuurafhankelijk oplossingsgedrag 
wat wil zeggen dat het PPrOx boven de 25°C onoplosbaar wordt en dat de oplossing melkachtig wordt. De 
hydrolyse werd onderzocht en gedeeltelijk gehydrolyseerde polymeren werden bekomen. Door de additie 
van hydrofiele PEI blokken langs de keten werd de Tcp hoger dan deze van het startpolymeer. Hoe hoger 
de PEI fractie hoe hoger de Tcp. Daarnaast werden ook polymeren gemaakt met verschillende 
ketenlengten en verschillende PEI hoeveelheden voor de complexatie met DNA. Bij het vormen van de 
complexen werd opgemerkt dat het temperatuurgedrag van de polymeren terug was gewijzigd en dat er 
nanogelen werden gevormd. De lading van de polymeren in oplossing, zeta potentiaal, waren boven de 
LCST gegroepeerd aan de buitenzijde. Deze werden dan verder onderzocht in het kader van gen transfer. 
In het vierde hoofdstuk werd een andere post modificatie reactie geïntroduceerd waarbij zowel L-PEI 
als PEI-PEtOx in super kritisch CO2 werden gebracht. Door deze modificatie vertoonde deze polymeren 
fluorescent gedrag door de gevormde carbamaat binding. Opmerkelijk was wel dat er ook een zijreactie 
optrad waardoor de carbamaat verder reageerde naar het cyclisch ureum. Deze was opmerkelijk genoeg 
ook nog steeds fluorescent. Het mooie aan deze polymeren is dat ze zwitterionisch zijn maar toch nog 
steeds positieve ladingen dragen op de keten waardoor interactie mogelijk is met DNA. 
In het vijfde hoofdstuk werd de verscheidenheid aangetoond van het polymeer platform door de 
synthese van 4 verschillende copolymeren van PEtOx. Vier verschillende linkers werden gekoppeld aan 
het PEtOx-PEI platform. De eerste linker werd gekoppeld met een zuurchloride waarbij het  amide werd 
gevormd. Bij de twee volgende linkers werden respectievelijk een ureum en een thio-ureum gevormd door 
het koppelen van een isocyanaat en een thio-isocyanaat. De koppeling vormde een tertiair amine door de 
reactie van het amine met bromo-methylacetaat. Elk van de vier linkers hebben een methyl ester die kan 
reageren met een amine en zo een amide vormt. Verschillende types amines werden dan ook onderzocht 
voor de reacti met het methylester via directe amidatie. De gevormde polymeren kunnen als basis dienen 
in verschillende toepassingen en zeker op het vlak van polymeer drug conjugaten. De linker methode is 
simpel en verscheidene, zelfs degradeerbare, linkers kunnen worden ingebouwd.  
In het laatste hoofdstuk van dit doctoraat werd het PEtOx-PEI platform verder uitgebreid naar het 
koppelen van carbohydraten. Deze koppeling verliep via een reductieve aminatie waarbij de aldehyde van 
de ring geopende versie van het suiker werd verbonden via een imine linker op de backbone. Deze trage 
reactie was succesvol en toonde aan dat carbohydraten bevattende polymeren ook een optie zijn voor het 
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PEtOx platform en uitgevoerd kan worden op de secundaire amine van de L-PEI groepen in gedeeltelijk 
gehydrolyseerde polymeren. De karakterisatie van het gedrag in oplossing toonde aan dat naargelang het 
koppelen van verschillende suikers diverse gedraging optraden. Het gekoppelde maltose toonde aan dat 
het glucose die aanwezig was in de zijketen kon gebruikt worden voor bio recognitie met ConA. De 
reductieve aminatie is niet het gemakkelijks en meest zuinig proces dus in de toekomst zou het zeker 
mogelijk moeten zijn om via gefunctionaliseerde carbohydraten PEtOx-PEI te modificeren. 
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